News on Chronic Myeloid Leukemia (CML)
New Market Report: PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022
June 17, 2013, SBWire
CML Experts Raise Industry Hackles by Decrying High-and-Rising Costs of Treatments
June 15, 2013, Genetic Engineering Biotechnology News
Imatinib Discontinuation in Chronic Phase CML Doesn’t Always Lead to Relapse
June 14, 2013, Cancer Network
Intermittent Imatinib for Elderly CML Patients Shows Promise
June 14, 2013, Cancer Network
Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early
treatment modifications in suboptimal responders: A retrospective study on 91 unselected patients.
June 11, 2013, PublMed
Quality-of-life issues need to be addressed for CML patients, Moffitt researchers say
June 10, 2013, Science Codex
Quality-of-life issues need to be addressed for CML patients, researchers say
June 10, 2013, MedicalXpress
Society, GRU doctor work to cure leukemia
June 9, 2013, Aiken Standard
Kareem Abdul-Jabbar on life beyond the court VIDEO
June 9, 2013, CBSnews
Emily Grider fights leukemia; fundraiser set
June 6, 2013, The Star Press
PharmaPoint: Chronic Myeloid Leukemia (CML) - US Drug Forecast and Market Analysis to 2022
June 6 2013, USPRWIre
Work of 2013 Nobel Prize Winners on Induced Pluripotent Stem Cells to be Presented at the 18th Congress of the
European Hematology Association in Stockholm, June 13-16, 2013
June 5, 2013, PR-Portal.com
Targeted cancer therapy pioneers tapped to receive the 2013 $100,000 Taubman Prize
June 5, 2013, PRNewswire
Research and Markets: Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
June 5, 2013, Fort Mills Times
Research and Markets: PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market
Analysis to 2022
Jun. 4, 2013, Fort Mills Times
New Drug Target Identified For Treating Deadly Form Of Leukemia
June 4, 2013, AsianScientist
Singapore research team identifies new drug target in deadly form of leukemia
June 3, 2013, EurekAlert
Research and Markets: PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022
Jun. 3, 2013, Fort Mills Times
ARIAD Announces Long-Term Durability-of-Response Data on Ponatinib from Ongoing Phase 1 Study
Jun 2, 2013, DailyFinance
ARIAD Presents Analysis of Cardiovascular Risk Profile of Patients from Pivotal PACE Trial of Iclusig ® (Ponatinib)
Jun 1, 2013, Daily Finance
Research and Markets: PharmaPoint Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022
May. 31, 2013, Fort Mill Times
Add A Little Medical History To Your Summer Reading Plans
May 30, 2013, Philebrity.com
Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers
at ASCO and EHA
May 29, 2013, FierceBiotech
American Cancer Society Legends: Dr. Brian Druker VIDEO
May 28, 2013, American Cancer Society
Going one-on-one with Kareem Abdul-Jabbar
May 28, 2013, Bay Area, Biz Talk
PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
May 28, 2013, heraldonline.com
Revs, fan group to hold trivia night in support of Alston and his leukemia battle
May 28, 2013, Boston.com
Run4Beka raising funds for cancer group
May 28, 2013, Santa Ynez Vallez News
Karyopharm Therapeutics to Present New Data on Selective Inhibitor of Nuclear Export (SINE), KPT-330, at 2013 EHA Congress
May 28, 2013, Market Watch
Revolution, Fans To Hold Trivia Night Fundraiser in Support of Kevin Alston, Leukemia and Lymphoma Society on May 30
May 26, 2013, NESN
Skyhook king, Abdul-Jabbar, in town to support leukemia fight
May 25, 2013, San Jose Mercury News
New law helps Whitefish woman battle cancer
May 24, 2013, Daily Inter Lake.com
Topper's adds crowdsourced pizza to menu
May 24, 2013, Pizza Market Place
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER Study
May 23, 2013, PublMed
Man's dream of marriage comes true even as he fights cancer
May 22, 2013, WDRB.com
Bankruptcy or Cure? A Cancer Patient's Dilemma
May 22, 2013, Medscape Today
Ariad's Cancer Drug Iclusig Extends The Gleevec Magic
May 22 2013, Seeking Alpha
Cancer's Bitter Medicine
May 22, 2013 , Genetic Engineering News
Teen Develops Computer Algorithm to Diagnose Leukemia
May 21, 2013, Mashable
A computer algorithm developed by a teen to diagnose Leukemia
May 21, 2013, site trail
18-yr-old teaches computer to diagnose cancer
May 21, 2013, rappler.com
Dawn Tyler Watson headlines all-star Blues for Life concert to benefit leukemia survivors
May 21, 2013, Montreal Gazette
New leukemia mutation offers therapeutic targets
May 21, 2013, 2 minutes medicine
QuantuMDx, A*STAR To Develop Asia-Specific Genetic Tests
May 21, 2013, Asian Scientist
CML Drug Revenue in Japan to Grow, Despite Global Decline
May 20 2013, Pharmiweb.com
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
May 19, 2013, Motley Fool
Cancer Drug Prevents Build-up of Toxic Brain Protein
May 16, 2013, HealthCanal.com
Woman with leukemia meets researchers of her life-saving drug
May 16, 2013 , UPI.com
The cost of my cancer survival
May 16, 2013, timesunion.com
Albany Medical Center to award Prize in Medicine and Biomedical Research Friday
May 16, 2013, The Record
How I Manage: Chronic Myeloid Leukemia
May 2013, Clinical Oncology News
Faith, family help Brooks fight leukemia
May 16, 2013, ThisWeekNews
Medivo Launches Free Mobile App for Monitoring Chronic Myeloid Leukemia (CML)
May 15, 2013, Market Watch
Discovery pinpoints cause of two types of leukemia, providing insights into new treatment approach
May 14, 2013, HeathCanal
Nilotinib Associated With Increased Peripheral Artery Disease Rate in CML
May 13, 2013, Cancer Network
Mice Study Finds Cancer Drug May Work on Common Brain Diseases
May 13, 2013 PsychCentral.com
Direct hit on cancer
May 12, 2013, New York Post
Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
May 10, 2013, PNAS
Mouse study shows leukemia halts accumulation of toxic proteins linked to Parkinson's disease
May 10, 2013, News Medical
Cancer treatments "unaffordable" and will drive rapid transition to generics and market decline, says GlobalData
May 10, 2013, the pharmaletter
The Story Behind a Miracle Cancer Drug [Excerpt]
May 10, 2013, Scientific American
Discovery pinpoints cause of two types of leukemia - Science Daily
May 10, 2013, Science Daily
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib
discontinuation in patients with CML
May 9, 2013, PublMed
Mutations in CSF3R common in CNL, atypical CML - Medical Xpress
May 9, 2013, Medical Xpress
New leukemia mutation offers therapeutic targets
May 8, 2013, 2 minutes medicine
Do Blood Cancers Need Prophylactic Platelet Transfusions? - Medscape
May 8, 2013, Medscape
Costs of drugs force sick into bankruptcy, or worse
May 8, 2013, St. Cloud Times
High costs of leukemia may be harming patients
May 7, 2013, Oncology Nurse Advisor
The Model Approach to Drug Development
May 6, 2013, Bio It World
Ruling thrills patients and boosts Indian generic drug makers
May 6, 2013, Smart Planet
Volunteering for clinical trials
May 5, 2013, The Star Online
Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation
May 4, 2013, 7th Space
Pharmaceutical Companies Profits Reach 30 Percent, Author Says
May 3, 2013, The Lund Report
News from the Front in War on Cancer--Mission Not Accomplished
May 2, 2013, , Scientiific American
Are CML Drugs Priced Out of Reach?
May 2, 2013, Cancer Network
News from the Front in War on Cancer--Mission Not Accomplished
May 2, 2013, Yahoo! News
Essential profits vs. medical profiteering
May 1, 2013, Journal Inquirer
The Beginning of the End of the Beginning in Cancer Genomics
May 1, 2013, The New England Journal of Medicine
Genomic Mutation Studies Unlock Details on Cancers
May 1, 2013, The Wall Street Journal
Exorbitant Prices for Leukemia Drugs
May 1, 2013, New York Times
PITTS: When generics win, patients lose
May 1, 2013, Washington Times
Ponatinib Excels in Heavily Pretreated Population
April 2013, Clinical Oncology News
Research and Markets: EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022
April 30, 2013, The Wall Street Journal
The real cancer killer: rip-off prices for drugs
April 29, 2013, The independent
Drug industry 'profiteering' threatens lives
April 29, 2013, News Mail
Leukaemia drug prices "unsustainable" say cancer experts
April 29, 2013, PMLive
Scientists Challenge Pharmaceutical Companies On Drug Pricing
April 29, 2013, OPB News
Doctors rebel against rip-off drug costs - Consumer Reports News
April 29, 2013, ConsumerReports.org
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013
April 29, 2013, Seeking Alpha
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid
leukemia resistant or intolerant to imatinib.
April 28, 2013, Publmed
How Much Is Your Life Worth? - San Diego Free Press
April 28, 2013, San Diego Free Press
Doctors around the world criticize drug companies for high cost of life-saving pills
April 27, 2013, abc action news
Lifestyle and Dietary Factors in Relation to Risk of Chronic Myeloid Leukemia in the NIH-AARP Diet and Health Study
April 26, 2013, Publmed
Oncologists protest cancer drug profiteering - Party for Socialism and Liberation
April 26, 2013, Party for Socialism and Liberation
Doctors blast ethics of $100000 cancer drugs
April 26, 2013, CNNMoney
Are $100000 cancer drugs unethical?
April 26, 2013, The week
Doctors blast high price of cancer drugs VIDEO
April 25, 2013, CBSNews
Top Oregon Health & Science University researcher to doctors: Rise up over drug prices
April 25, 2013, OregonLive
Cancer Doctors Raise Pressure On Pharma Industry To Cut Drug Prices
April 25, 2013, Forbes
Chronic Myeloid Leukemia Market Explored in New Cutting-Edge GlobalData Study Published at MarketPublishers.com
April. 25, 2013, Fort Mills Times
Leading leukemia experts: High leukemia treatment costs may be harming patients
April 25, 2013, Eurekalert
Slings fights back -Leukemia can't keep Altoona man off the field
April 24, 2013, Herald Index
DelMar IPO Obscurity Could Offer Investors Favorable Entry
April 24, 2013, Seeking Alpha
Lehigh Valley students take top honors at regional research event
April 23, 2013, Penn State News
Novartis AG v Union of India & Others (Civil Appeal Nos. 2706-2716 of 2013, 1 April 2013)
April 23, 2013, Lexology
Asuragen Announces Publication on Standardization of BCR-ABL1 Testing on the International Scale
April 23, 2013, The Wall Street Journal
A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia
April 22, 2013, PubLMed
Hope for Karen wrestling benefit in Millersville Friday
April 22, 2013, Examiner.com
One-on-one with Kareem Abdul-Jabbar
April 22, 2013, redeyechicago
EpiCast Report Chronic Myeloid Leukemia - Epidemiology Forecast to 2022
April 22, 2013, Wall Street Journal
Vanderbilt Patients Collaborate With Nashville’s Music Row Superstars To Bring Their Songs To Life
April 22, 2013, Newswise
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
April 22, 2013, 7th Space Interactive
In a first, Rajasthan govt to provide free leukemia drugs
April 21, 2013, Times of India
Landmark verdict
April 20, 2013, Frontline
Novartis Indian Supreme Court judgment: what is efficacy for pharmaceutical invention?
April 19 2013, Lexocology
What Makes a Good Founder? Hint: it's in the details
April 19, 2013 , Forbes
More research needed on causes of leukemia, as growing lifespan of patients enables study, says GlobalData
April 18, 2013, the pharmaletter
Eden Prairie mother beats rare cancer with 'master key' drug
April 17, 2013, FOX 9 News
New Mechanism of Resistance Identified in Brain Tumors
April 17, 2013, OncLive
Phases of Chronic Myeloid Leukemia (CML) - Chronic, Accelerated and Blast Crisis
April 17, 2013, SBWire
C. William Johnson, band director
April 17, 2013, Washington Post
Scientist wins Albany prize for leukemia cell research
April 17, 2013, Chicago Tribune
Cancer research pioneers to share $500K Albany Med prize
April 16, 2013, timesunion.com
Chronic Fatigue Limits Quality of Life in Imatinib-Treated CML Patients
April 16, 2013, Cancer Network
Long-Term Treatment With Imatinib Affected Bone Mineral Density
April 15, 2013, Cancer Network
Teenager Died From Leukemia Days After Misdiagnosis
April 15, 2013, The Inquisitr
AVEO Poised To Move Higher Before May 2 FDA Adcomm Catalyst, Obama Care, And Platform Potential
April 15, 2013, Trefis
A dose of transparency
April 15, 2013, The Indian Express
Research and Markets: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2013
April 15, 2013, heraldonline.com
Pharmaceutical companies must balance profits and affordability
April 14, 2013, The New Indian Express
Cancer 'parity' bills churn through Florida Legislature
April 13, 2013, The Miami Herald
TASIGNA (nilotinib) - Possible Risk of Developing Atherosclerosis-Related Conditions - For the Public
April 12, 2013, Health Canada
Glasford inspires runners, donors to join fight against blood cancer
April 12, 2013, NCNewsPress.com
Smartphones and Social Media Transforming Health Care
April 12, 2013, Pharmacy Times
Nilotinib for CML Leads to Fewer Treatment-Emergent Mutations Than Imatinib
April 12, 2013, Cancer Network
Patients or patents?
Apr 12, 2013. Livemint
Health research in jeopardy
April 11, 2013, Vindy.com
Teenager dies of leukaemia ten days after tonsillitis diagnosis
April 11, 2013, Metro
Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in India
April 10, 2013, The Atlantic
Drug sales reps often don't inform docs about adverse effects: Study
April 10, 2013, lfpress.com
Study: Pharma Reps Don't Tell Docs About Side Effects
April 10, 2013, PharmaLive
Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis
April 9, 2013, The Sacremento Bee
Pre-Clinical Data on Ariad's Iclusig
April 9, 2013, Zacks
The Cost of Cancer Drugs and Research
April 9, 2013, Huffpost Healthy Living
Nilotinib associated with fewer BCR-ABL mutations in chronic phase CML
April 9, 2013, Healio
Kareem launches campaign for cancer research
April 9, 2013, WAVENewspapers
Prof. Levitzki chosen for American Cancer Research Award
April 9, 2013, IsraelNationalNews
This woman needs funds for treatment
April 9, 2013, Hindustan Times
ARIAD Pharmaceuticals presents preclinical data on ponatinib at AACR Annual Meeting 2013
April 9, 2013, NewsMedical
ARIAD’s leukemia drug Iclusig may be used in other cancer treatments
April 8, 2013, bioflash
Take the Skyhook Challenge and Help Beat Blood Cancer -The Leukemia & Lymphoma Society Helps Launch Contest to Honor NBA Legend Kareem Abdul-Jabbar and Raise Awareness of Blood Cancer
April 8, 2013, PRNewswire
ARIAD Presents New Preclinical Data Showing Ponatinib is a Potent Inhibitor of RET and FGFR, Two Oncogenic Drivers
of Non-Small Cell Lung Cancer
April 8, 2013, Fort Mill Time
Revolution's Alston takes leave of absence
April 8, 2013, FOXnews.com
New England Revolution defender Kevin Alston diagnosed with treatable form of leukemia
April 8, 2013, MLSsoccer.com
HU biochemistry professor to receive major award
April 7, 2013, Jerusalem Post
Dr. Hagop Kantarjian Receives the 18th Annual AACR Joseph H. Burchenal Memorial Award
April 6, 2013, American Association for Cancer Research
"Father of targeted therapies" receives top U.S. award
April 6, 2013, English.news.cn
National Cancer Institute reveals milestones in the treatment of breast cancer and leukemia
April 6, 2013, AMEInfo.com
Cancer drugs to stop bioweapons
April 5, 2013, Fox News.com
Dr. Alexander Levitzki Awarded Seventh Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research
April 5, 2013, American Association for Cancer Research
CML-Living with a Chronic Disease
April 5, 2013, PRNewswire
Novartis Loses Historic India Patent Case On Cancer Drug Glivec
April 5, 2013, Asian Scientist
Conditional EU Approval for Pfizer's Bosulif - Analyst Blog
April 4, 2013, NASDAQ
ARIAD's CEO fights back, defends leukemia drug despite report
April 4, 2013, Boston Business Journal
A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research
April 4, 2013, News Maker
MolecularMD Announces Launch of Next Generation Sequencing Services for Oncology Drug Development
April 4, 2013,, Market Watch
The Philadelphia chromosome
April 4 2013, live mint
Ariad's Leukemia Drug Toxic, Survey Says
April 3, 2013m, The Street
Dr. Alex Matter Awarded 2013 Szent-Györgyi Prize For Progress In Cancer Research
April 3, 2013, Asian Scientist
Guest Post: The Patent Failure of Novartis with Gleevec
April 3, 2013, Patenty O.
Father of Glivec hails SC ruling
April 3, 2013, The Times of India
‘Deterred by cost of Glivec, many embraced death’
April 3, 2013, The New Indian Express
Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary
leukemia cells of chronic myeloid leukemia
April 2, 2013, 7th Space
Promising stem cell therapy for leukemia patients
April 2, 2013, MedicalXpress
ARIAD Announces Support of Patients with Resistant or Intolerant CML Through Its Donation to Chronic Disease Fund
April 2, 2013, Fort Miles Times
Supreme Court's Glivec ruling will ruin innovation, says Ranjit Shahani, Novartis India MD
April 2, 2013, The Economic Times
Don't cut lifesaving dollars - Health research and medical progress are in peril amid NIH budget cuts
April 2, 2013, Los Angeles Times
Glivec ruling: Putting patients before profits
April 2 2013, Live Mint
This will discourage innovative drug discovery, Novartis MD Ranjit Shahani says
April 2, 2013, Times of India
Man behind Glivec hails SC verdict
April 2, 2013, Business Standard
Supreme Court Rejects Novartis Appeal; Upholds high standard for Section 3(d)
April 1, 2013, Lawyers Collective
Transplant girl: thank you for saving my life
April 1, 2013, The Telegraph
Novartis Loses Glivec Patent Battle in India
April 1, 2013, The Wall Street Journal
Novartis: India rejects patent plea for cancer drug Glivec
April 1, 2013, BBC News
Novartis cancer drug patent bid rejected by Indian court in landmark ruling
April 1, 2013, The Guardian
Novartis patent case: Five facts about cancer drug Glivec
Apr 1, 2013, Firstpost
India's top court to deliver Novartis judgment
March 31, 2013, U.S. News & World Report
Gene Alfred Brothers
March 31, 2013 , Amarillo.com
Indian pharma industry awaits SC verdict on Novartis patent claim on April 1
March 29, 2013, Indiatvnews.com
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation:
prognostic relevance of the initial CD3+ T cel dose
March 29, 2013, Biol Blood Marrow Transplant
Low Volume Volatile Trading Likely Ahead Of Long Weekend
March 28, 2013, RTT News
Conditional EU approval for Pfizer's CML drug Bosulif
March 28, The Pharma Letter
Big Pharma waits nervously on India drug patent verdict
March 27, 2013, Reuters
New Monoclonal Antibody Targets Intracellular Oncogenic Proteins in Leukemias
March 26, 2013, Cancer Network
The 2013 Leukemia Ball Features Dana Carvey and Jim Belushi
March 25, 2013, Washingtontonian
Parents and Children's Hospital researchers await results on an experimental leukemia gene therapy
March 25, 2013, philly.com
European Panel Gives Nod to Leukemia Drug
March 25, 2013, Medscape Todqy News
ICLUSIG
March 25, 2013, Monthly Prescribing Reference
Leukemia Ball Co-Chair Saved By One Drug
March 22, 2013, WUSA*9
East Coast Biotech Roundup: Moderna, bluebird, Blueprint
March 22, 2013, Xconomy
ARIAD Announces That Iclusig™ (Ponatinib) Receives Positive CHMP Opinion for Approval in the European Union
March 22, 2013, Fort Mill Times
Experimental Cancer Treatment Offers Hope VIDEO
March 21, 2013, ABCNews
Can Therapy With TKIs for CML Ever Be Stopped?
March 21, 2013, OncLIve
Researchers study use of dasatinib for patients with high-risk MDS
March 21, 2013, Medical Xpress
Cell-Based Immune Therapy Shows Promise in Leukemia Patients
March 20, 2013. Memorial Sloan-Kettering Cancer Center
Girlyman concert at Creole canceled More about Doris Muramatsu
March 20, 2013, CityPulse
Altered T-Cell Therapy Shows Promise from Acute Type of Leukemia
March 20, 2013, The New York Times
Blueprint Medicines Combs Through Genome for the Next Gleevec(s)
March 20, 2013, Xconomy
Mumbai company seeks cancer drug licence
Mar 19, 2013, The Times of India
Training for a race is well within Justin Ozuna’s control — unlike leukemia
March 18, 2013, The Dallas Morning News
Novartis' Life-Changing Blockbuster Drug
March 18, 2013, The Motley fool
What you need to know about leukemia
March 17, 2013, Seacoast Online
Is the war on cancer an ‘utter failure’?: A sobering look at how billions in research money is spent
March 16, 2013, National Post
An Interview With Leo Ehrlich, Cellceutix CEO
March 14 2013, Seeking Alpha
Labceutics, Asuragen to jointly conduct pan European study on CML
March 13, 2013, Pharmaceutical Business Review
Labceutics to Conduct Pan European Quality Assurance Study on Standardization of BCR-ABL1 Testing to Improve Patient
Management in CML
March 12, 2013, Marketwir
Patient stories centre stage at cancer summit
March 12, 2013, Benefits Canada
CML Stem Cell Burden at Diagnosis Associated With Treatment Outcomes
March 11, 2013, Cancer Network
Bio-Path Holdings Begins Enrollment in Fifth Cohort of Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2
in Leukemias
March 8, 2013, Pharmiweb.com
Major new clinical trial to improve treatment for leukaemia patients
March 7, 2013, HealthCanal.com
Join the local fight to cure blood cancer
March 7, 2013, Ventura County Reporter
Bosutinib Heads Toward Conditional Approval for CML in Europe
March 6, 2013 , Cancer Network
A World Without Cancer: Is Prevention the Cure?
March 6, 2013, The Motley fool
Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with
tyrosine kinase inhibitors
March 6, 2013, PublMed
Transplant advocate understands the need, personally
March 6, 2013, Atlanta Journal Constitution
Survivor steps up to raise money for cancer research
Mar 6, 2013, Blaine Northem Light
Beth Schrader | 39, Fort Wayne
March 4, 2013, journalgazette.net
Dasatinib thwarts brain cancer metastasis after bevacizumab use
March 1, 2013, Oncology Nurse Advisor
Why Are Investors Excited About Ariad?
February 28, 2013, Seeking Alpha
Novartis provides multimedia support to Rare Diseases Day
February 28, 2013, PMLiVE
Interest groups barrage Congress with sequester pleas
February 28, 2013, USA Today
Being chronically ill or in pain can feel like a full-time job
February 27, 2013, KevinMd.com
Canada: Pharma In Brief - Canada: Federal Court Upholds Validity Of GLEEVEC® Patent - See the decision
February 27, 2013, Mondaq
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib
February 26, 2013, PublMed
Archdeacon: A lifetime of stories - diagnosed with CML in 2010
February 26, 2013, Flyer News
CHMP recommends approval of Imatinib Actavis
February 25, 2013, National Electronic Library for Medicines
Lottie Duthu - loss of a CML warrior - See the Guest Book
February 25, 2013, CML2
New TKI Ponatinib Effective in Resistant CML
February 2013, Clinical Oncology News
DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
February 25, 2013, Providence Journal
Show helped bride-to-be plan, despite cancer diagnosis
February 25, 2013, Western Star
After transplant, she's ready to get home
February 24, 2013, Omaha World-Herald
Doctor's motto proves to be true for 2 cancer patients
February 22, 2013, abc13.com
Stem Cells For Leukemia: New Hope From Newborns
February 22, 0213, WFTV Orlando
Seahorse Bioscience XF Technology Yields Insights on Leukemia Stem Cell Metabolism and Potential New Leukemia Therapies
February 22, 0213, Providence Journal
Granting wishes
February 22, 2013, Democrat Missourian
Bio-Path Shares are Attractive now - L-Grb-2 is a liposomal delivered antisense cancer drug that targets an multibillion dollar annual market for CML
February 22, 2013, Nasdaq
Leukemia arsenal has new drugs
February 22, 2013, Oncology Nurse Advisor
Lawsuit: Cancer patient didn't get medication at jail
February 21, 2013, The Salem News
From Chromosomes To Cures: The Lifesaving Cancer Research Of Dr. Janet Rowley VIDEO
February 21, 2013, Chicago Blood Cancer·
Memorial Sloan-Kettering scientist wins Breakthrough Prize in Life Sciences
February 21, 2013, News Medical
Court affirms utility of Gleevec patent
February 20 2013, Lexology
Inaugural Breakthrough Prizes Recognize Excellence in Research
February 20, 2013, Howard Hughes Medical Institute
As CML Drugs Improve, Earlier Surrogate Outcome Markers Needed
February 20, 2013, Cancer Network
China sets up first CML molecular testing platform
February 20, 2013, China Daily
Society to celebrate progress at ball
February 19, 2013, WIVB.com
Targeting Leukemic Stem Cells in Marrow Could Stave Off TKI Resistance
February 19, 2013, Cancer Network
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors
February 2013, American Journal of Hematology
Igniting the conversation about rare diseases
February 19, 2013, Palatka Daily News
Igniting the conversation about rare diseases
February 18, 2013, The Exponent Telegram
The Philadelphia Chromosome by Jessica Wapner - Book Trailer Video
February 15, 2013, experimentpublishing
Show solidarity for International Childhood Cancer Day
February 15, 2013, Wort.lu
Leukemia, the first and second time around
February 15, 2013, HealthCanal
Use of Digital PCR Ramping Up
February 15, 2013, Gen
Living With Chronic Myeloid Leukemia
February 14, 2013, dailyRx
Epigenetic inactivation of the MIR129-2 in hematological malignancies
February 14, 2013, 7th Space
TalkPoint and FDAAdvisoryCommittee.com partner for series of FDA public workshops
February 13, 2013, PRWeb
Choosing a Tyrosine Kinase Inhibitor in CML
February 12, 2013, Targeted Healthcare
Couple fights leukemia together as they celebrate their first anniversary
February 11, 2013, MD Anderson Cancer Center
Cancer battle: Scientists engineer new tumor-killing virus
February 11, 2013, RT News
The role of peptide and DNA vaccines in myeloid leukemiaimmunotherapy
February 11, 2013, 7h Space
“Borne Out of Necessity and Data”: Conquering Mutations in Leukemia
February 6, 2013, PLOS Blog
Scene in Edmonds: The Edsel Hermoso Moscoso Mural (Donation to Max Foundation)
February 9, 2013, My Edmonds News
One Million Americans with Blood Cancer in Jeopardy of Losing Access to Needed Medications
February 6, 2013, PRNewswire
Raymore students help send ailing boy to Disney World
February 6, 2013, KCTV
“Borne Out of Necessity and Data”:Conquering Mutations in Leukemia
February 6, 2013, Work in Progress
Wesley Willis lives… as Wonder Woman’s half-brother, no less!
February 6, 2013, Wbez
Sandy and Tommy Edge, with their Valentine's tree in Baileyton
February 6, 2013, The Arab Tribune
Wilm’s Tumor Vaccine Effective for CML
February 5, 2013, Medical Automation
Chronic myeloid leukemia: Advances in diagnosis and management
February 5, 2013, Journal of the American Academy of Physician Assistants
Japanese Researchers Claim Detection Of Cancer-Causing Gene
February 5, 2013, RTTNews
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation
February 5, 2013, 7th Space
Could An Asthma Medicine Stop CML? VIDEO
February 4, 2013, Patient Power
Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies
February 4, 2013, Blood Journal
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
February 4, 2013, Market Wire
Local woman fights cancer one workout at a time
February 3, 2013, Fredericksburg.com
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
February 1, 2013, Leukemia
Deaths from cancer have declined 20% over 20 years
January 31, 2013, Oncology Nurse Advisor
World cancer day – 2013 – Pat Garcia-Gonzalez VIDEO
January 30 2013, The Max Foundation
Sabutoclax (ONT-701) May BeThe Next Magic Bullet To Combat The Root Of Cancer
January 30 2013, Science 2.0
FDA Approves Imatinib (Gleevec) for Pediatric ALL
January 30, 2013, Cancer Network
Kurokawa contributes to leukemia treatment
January 30, 2013, The Dartmouth
Swiss scientist wins US award for cancer research
January 30, 2013, Shanghai Daily.com (subscription)
Nplate May Be Safe For Lower-Risk MDS Patients (ASH 2012)
January 29, 2013, The MDS Beacon
“I Can’t Afford Any More Advances in Cancer Care, Doc!”
January 28, 2013, Cancer Network
Top Blood Cancer Team Joins NY-Presbyterian/Columbia
January 28, 2013, Newswise
IPO Preview: Stemline Therapeutics
January 28, 2013, Seeking Alpha
Targeted cancer treatment case study: 'I'm so grateful that I can live a normal life'
January 28, 2013, The Independant
FDA approves Gleevec for children with acute lymphoblastic leukemia
January 28, PharmaLive
Lanterns carry message of hope for fight against disease
January 25, 2013, The Independent.com
FDA approves Gleevec for children with acute lymphoblastic leukemia
January 25, 2013, FDA
Novartis pulls imatinib file in EU for hypertension
January 25, 2013, Pharma Times Online
Pan–BCL-2 Inhibition Sensitizes Leukemic Stem Cells to Kinase Inhibitors
January 24, 2013, Cancer Discovery
ARIAD prices $300M stock offering to support launch of leukemia drug
January 24, 2013, Boston Business Journal
C3G forms complexes with Bcr-Abl and p38alpha MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion
January 24, 2013, 7th Space
Helping healthy cells could be key to fighting leukaemia, research suggests
January 23, 2013, Imperial College London
CHMP Positive on Pfizers Bosutinib
January 23, 2013, Zacks.com
National Academy of Sciences Paper: Dartmouth researchers take novel approach to fighting treatment-resistant chronic myeloid leukemia
January 22, 2013, HeathCanal.com
Novartis return to growth in 2014, Vasella replaced by Reinhardt
January 22, 2013, PharmaTimes Online
Kareem Abdul-Jabbar joins Florida Forum series
January 22, 2013, Daily Record
The power of patents
January 22, 2013, Scienceline
10 Predictions That Will Transform Healthcare
January 22, 2013, Genetic Engineering News
Advances in treatment for chronic myelogenous leukaemia
January 22, 20131, South China Morning Post
Flow synthesis for anticancer drug
January 21, 2013, RSC Advancing the Chemical Sciences
Pfizer gets CHMP backing for leukaemia drug bosutinib
Juanuary 21, 2013, PMLIve
Pfizer’s Bosutinib Receives Positive Opinion For Conditional Marketing Authorization From The Committee For Medicinal Products For Human Use For The Treatment Of Ph+ Chronic Myelogenous Leukemia With Resistance Or Intolerance To Prior Therapy In Europe
January 19, 2013, Pipelinereview.com
Pfizer’s Bosutinib Receives Positive Opinion For Conditional Marketing Authorization From The Committee For Medicinal Products For Human Use For The Treatment Of Ph+ Chronic Myelogenous Leukemia With Resistance Or
Intolerance To Prior Therapy In Europe
January 18, 2013, Pfizer Press Releases
Pfizer's Bosulif set for greater sales with EMA approval
January 18, 2013, Fierce Pharna
Sanford-Burnham cancer drug targets hard-to-reach leukemia stem cells
January 18, 2013, Sanford Burnham
Sabutoclax appears to selectively target leukemia stem cells that are responsible for relapses
January 18, 2013, News Medical
Drug Targets Hard-To-Reach Leukemia Stem Cells Responsible for Relapses
January 18, 2013, Science Daily
Newly Founded Optum Labs will Analyze Big Data to Improve Patient are, Lower Costs of Care
January 18, 2013, HealthTechZone.com
Pfizer, Novartis win EU nods for new leukemia, eye drugs
January 18, 2013, FierceBiotech
Bosutinib in CML Cleared for Approval in Europe
January 18, 2013,, Medscape
Study: Enzyme Plays Important Role in CML Stem Cell Reprogramming
January 18, 2013, Cancer Network
EMA- CHMP ( Committee for Medicinal Products for Human Use)recommends the EU Commission grant a
conditional marketing authorisation for 'Bosulif' (bosutinib)
January 17, 2013, European Medicines Agency
An Expert's Perspective on Changing CML Treatment Options VIDEO
January 17, 2013, Patient Power
Is Stopping CML Treatment a Viable Option Now? VIDEO
January 17, 2013, Patient Power
Optum and Mayo Clinic look to improve patient care
January 17, 2013, Mas Device
Drug targets hard-to-reach leukemia stem cells responsible for relapses
January 17, 2013, Science Codex
Making Oncology History: Imatinib Pioneer Created His Own Opportunities
January 17, 2013, Onc LIve
Pat Has Conquered Cancer Twice - Offers Hints for the Rest of Us
January 16, 2013, About.com
Sporting KC Weekly Update: Jan. 16, 2013
January 16, 2013, WIBW
AHS volleyball team holds "Pink Out Campaign" – Donation for CML
January 16, 2013, Akron Newsreporter
Omacetaxine for Chronic or Accelerated Phase CML Patients with Resistance/Intolerance to Tyrosine Kinase Inhibitors
January 15, 2013, The ASCO Post
Meet the face of the new Make-A-Wish program Kids for Wish Kids
January 15, 2013, 41 Actions News
India to issue compulsory licences on Roche, B-MS drugs
January 15, 2013, PharmaTimet
Early molecular response may predict outcomes for nilotinib in CML
January 14, 2013, Healio
Double-unit cord blood transplants don't boost survival
January 14, 2013, The Oncology Report
Who should be subsidised?
January 14, 2013, Today Online
Pharma MNCs upset as govt issues more compulsory licences - Mandatory licences have been planned for cancer drugs such
as Trastuzumab, Ixabepilone and Dasatinib
January 13, 2013, Business Standard
Major new clinical trial to improve treatment for leukaemia patients
January 12, 2013, domain-b.com
Two-time Cancer Survivor's 10 Tips for the Healthcare System
January 12, 2013, Forbes
ARIAD and NCRI to collaborate on Phase III chronic myeloid leukemia trial
January 9, 2013, equities.com
Cancer gave us our vows meaning
January 8, 2013, Express.co.uk
ARIAD teams up with UK National Cancer Institute on leukemia treatment study
January 7, 2013, Boston Business Journal
The spirit of Star Trek
January 7, 2013, MPRnews
ARIAD and the U.K. National Cancer Research Institute to Collaborate on SPIRIT 3 Clinical Study
January 7, 2013, Pharma Live
Patrick signs bill requiring oral cancer drug coverage, over business groups' opposition
January 4, 2013, Boston Business Journal
Sorry, but there's no such thing as a diet that cures cancer
January 1, 2013, Mail Online
DNA vaccine for leukemia has early positive results
January 1, 2013, Oncology Nurse Advisor
Study Finds Enzyme Linked to the Acceleration of Malignant Proliferation in CML
January 1, 2013, Doctor Tipster
A new enzyme that contributes to the proliferation of leukemia is discovered
December 26, 2012, Private MD News
DNA-repair problems destroy hardy leukemia cells
December 26, 2012, OncologyNurseAdvisor
Reprogramming enzyme promotes chronic myeloid leukemia
Decenber 25, 2012, Omglobe.com
Leukemia stem cell trigger discovered by UCSD-led research
December 24, 2012, UT San Diego
Latest Treatment and Research for Chronic Myeloid Leukemia
December 24, 2012, Cancer Network
Enzyme accelerates malignant stem cell cloning in chronic myeloid leukemia
December 24, 2012, Eurekalert
A CML Advocate's Perspective on News from ASH 2012 VIDEO
December 21, 2012, Patient Power
News on CML from the 2012 ASH Conference – our Patients' Perspective
December 21, 2012, CML Advocates Network
At the Heart of Genetic Shenanigans
December 21, 2012, DailyRx
Parthenolide eliminates leukemia initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic
leukemia
December 20, 2012, Blood Journal
Can we safely stop TKI therapies? Experience from the STOP trials VIDEO
Dr. Delphine Rea, Hôpital Saint-Louis, Paris, France
December 2012, iCMLf
Options increase for CML patients failed by existing drugs
December 21, 2012, EurekAlert
Ponatinib Could Herald “Revolution”in CML Treatment
December 20, 2012, OncLive
Bosutinib a New Option for Chronic Myeloid Leukemia
December 2012, Clinical Oncology
New group CML Life – Africa on Facebook
December 20, 2012, CMLeukemia
New group CML Tunisia on Facebook
December 20, 2012, CMLeukemia
Choosing a Tyrosine Kinase Inhibitor in Chronic Myelogenous Leukemia
December 19, 2012, OncLive
When it comes to treating his CML, Kareem Abdul-Jabbar shoots and scores
December 18, 2012, JSOnline
Ariad's Wonder Drug For Leukemia Patients
December 17, 2012, Seeking Alpha
Drug Approved To Treat Rare Forms Of Leukemia
December 16, 2012, Medical News Today
New Leukemia Rx Hits Market
December 14, 2012, dailyRx
OHSU-developed ponatinib wins FDA approval
December 14, 2012, Portland Business Journal
FDA Approves Ponatinib to Treat Leukemia
December 14, 2012, Cancer Network
FDA grants approval for potential‘blockbuster’ leukemia drug made
by Cambridge-based Ariad
December 14, 2012, Boston.com
F.D.A. Gives Early Approval to Drug for Rare Leukemia
December 14, 2012, The New York Times
ARIAD Announces Accelerated Approval by FDA of Iclusig (Ponatinib) for Patients with CML and Ph+ ALL Resistant or Intolerant to Prior Tyrosine Kinase Inhibitor Therapy
December 14, 2012, Ariad
FDA Approves Ariad Pharma Leukemia Drug
December 14, 2012, The Street
The prognosis for chronic myeloid leukaemia dramatically improved over time
December 12, 2012, Doctor Tipster
TKI-resistant human leukemia stem cells are the source of genomic instability
December 12, 2012, News Medical
Study Brings Positive Results For the Most Resistant Types of CML VIDEO
December 12, 2012, Patient Power
Abstracts and notes on CML presentations - ASH 2012 Atlanta
December 11, 2012, CMLsupport
ASH: Updated PACE Findings Uphold Ponatinib Benefit in CML and Ph+ ALL
December 11, 2012, Cancer Network
ASH: Higher Imatinib Exposures Associated with Better Chronic-Phase CML Outcomes
December 11, 2012, Chemotherapy advisor
Learning about CML
December 11, 2012, Cure Today
NVS Provides Tasigna Study Data
December 11, 2012, Zacks Equity Research
Ariad reports most patients cancer-free after 1 year in ponatinib study
December 11, 2012, Atlanta Business Journal
Ponatinib Works in CML When Nothing Else Is Effective
December 11, 2012, Medscape Today
Drug resistant leukemia stem cells may be source of genetic chaos, Temple scientists find
December 11, 2012, Science Codex
Fundraiser nets $8,000 for Hanover 6-year-old
December 10, 2012, The Evening Sun
Fatigue Is the Major Aspect Compromising Health-Related Quality of Life of Chronic Myeloid Leukemia Patients Receiving
Long-Term Imatinib Therapy
December 10, 2012, ASH 2012
Novartis says trial results back Tasigna drug
December 10, 2012, Chicago Tribune
Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
December 10, 2012, ASH2012
Novartis long-term Phase III data show Ph+ CML patients on Tasigna(R) achieved significantly deeper molecular response versus Glivec(R)
December 10, 2012, Reuters
A 7-year-old pixie named Emily Whitehead has erased any remaining doubts about the power of a University of Pennsylvania gene therapy to eradicate certain blood cancers.
December 10, 2012, philly.com
In Girl’s Last Hope, Altered Immune Cells Beat Leukemia
December 10, 2012, CBS Philly
Ariad rises on positive leukemia drug results
December 10, 2012, Boston Herald.com
In Girl’s Last Hope, Altered Immune Cells Beat Leukemia
December 9, 2012, The New York Times
Temple scientists target DNA repair to eradicate leukemia stem cells
December 9, 2012, MedicalXpress
Ariad drug proves effective in curbing chronic leukemia in study
December 9, 2012, Reuters
RAD52-Dependent Synthetic Lethality Eradicates Leukemia Stem Cells
December 9, 2012, ASH 2012
Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
December 9, 2012, Science Codex
ASH 2012: Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia
December 9, 2012, ecancernews
Understanding Why MDS Patients Have Anemia VIDEO
December 8, 2012, Patient Power
Is going for cure in chronic myeloid leukemia possible and justifiable?
December 8, 2012, Hematology
Studies Assess Role of Genetics, Modified Treatment Strategies to Improve Outcomes and Reduce Toxicity for Patients with Blood Cancers
December 8, 2012, The Sacramento Bee
Winning the Battle Against Leukemia: Positive Early Results in Clinical Trial for DNA Vaccine
December 7, 2012, Science Daily
Bristol-Myers Squibb Launches an Online Resource for Patients with Chronic Myeloid Leukaemia in 15 European Countries
December 7, 2012, equities.com
Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
December 6, 2012, The Sacramento Bee
Ponatinib offers new hope in drug-resistant leukemia
December 5, 2012 , News-Medical.net
What's Hot at ASH This Year?
December 3, 2012, Medscape Today
Ky. voices: Dr. John D'Orazio says funding for cures is slipping
December 2, 2012, Kentucky.com
Chronic Myeloid Leukemia Mutation Thwarted By Ponatinib
December 2, 2012, Science 2.0
Data Published on ARIAD Candidate - Analyst Blog
November 30, 2012, Nasdaq
In CML, Next-Generation TKIs Aim to Boost Outcomes
November 30, 2012, Onc LIve
Ponatinib - New Pill Could Do Wonders for Cancer Patients
November 30, 2012, FM NEWS 101 KXL
Ponatinib for Chronic Myeloid Leukemia
November 29, 2012, The New England Journal of Medicine
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
November 29, 2012, The New England Journal of Medicine
Ponatinib - Cancer pill targets previously impenetrable disease-causing gene mutation in leukemia patients
November 29, 2012, OHSU
Pfizer to Present Clinical Data from Its Hematology Portfolio at the 54th Annual Meeting of the American Society of Hematology
November 29, 2012, Market Watch
Ponatinib thwarts T315I gene mutation in chronic myeloid leukemia
November 29, 2012, News Medical
Ponatinib for Chronic Myeloid Leukemia
November 29, 2012, The New England Journal Of Medecine
Ponatinib acts against the most resistant types of chronic myeloid leukemia
November 28, 2012, MD Anderson News
Attacking Leukemia Resistance
November 28, 2012, dailyRx
Drug (Ponatinib) Shows Potential in Leukemia
November 28, 2012, Medpage Today
Ponatinib acts against the most resistant types of chronic myeloid leukemia
November 28, 2012, Science Codex
Ponatinib Acts Against the Most Resistant Types of Chronic Myeloid Leukemia
November 28, 2012, Science Daily
Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
November 28, 2012, Reuters
Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemia
November 21, 2012, Journal Blood
BELA: Bosutinib No Better Than Imatinib in Newly Diagnosed CML
November 19, 2012, Cancer Network
OHSU's War on Cancer
November 17, 2012, Portland Monthly
Successful treatment of nilotinib-induced pleural effusion with prednisone.
November 15, 2012, PublMed
Taking care of the caregiver: tips to help yourself and your loved one live with a chronic disease
November 15, 2012, JSOnline
Nilotinib-Resistant CML Cells Show Abnormal Expression of Several Genes, Suggests Therapeutic Targets
November 15, 2012, Cancer Network
Novartis Provides R&D Update - Analyst Blog
November 15, 2012, Nasdaq
ARIAD Pharmaceuticals' CEO Presents at Lazard Capital Markets Healthcare Conference (Transcript)
November 15, 2012, Seeking Alpha
Bio-Path Holdings Successfully Completes Fourth Cohort in Phase I Clinical Trial of Lead Product Can
November 14, 2012, Daily Finance
Leukaemia drug can help treat lymphoma
November 14, 2012, Cambridge News
Can Ariad Survive on 2 Drugs?
November 13, 2012, Motley Fool
Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2012 Update
November 13, 2012, HeraldOnline.com
Ariad: A Very Interesting Biotech With An Even More Promising Pipeline
November 13, 2012, Seeking Alpha
Rwanda: Scientists Call for More Research On Leukemia
November 13, 2012, allAfrica.com
Druker speaks on Gleevec, combating leukemia
November 13, 2012, The Daily Barometer
Leukaemia 'wonder drug' could be used to treat range of blood cancers
November 12, 2012, HealthCanal.com
Your Immune System 101: Introduction to Clinical Immunology VIDEO
November 11, 2012, UCtelevision
Novartis Future Growth Prospects Secured by Industry-leading Pipeline, with More than 139 Projects with 73 New Compounds -Tasigna: "Path to Cure" - a potential paradigm shift in CML treatment
November 9, 2012, PharmaLIve
Will cancer breakthroughs pass economic test?
November 9, 2012, Austin American-Statesman
Joseph Philips Blames Drug Combination for Leukemia
November 9, 2012, Opposing Views
Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects.
November 8, 2012, PublMed
Ariad CEO discusses company’s battle against cancer
November 8, 2012, Boston Herald
CML: the good, the better, and the difficult choices
November 8, 2012, Journal Blood
Novartis future growth prospects secured by industry-leading pipeline, with more than 139 projects with 73 new compounds
November 8, 2012, Reuters
Switching Therapy Following Suboptimal Response in Chronic Myelogenous Leukemia
November 7, 2012, OncLive
PropThink: Management says Ariad is Well-Prepared for Ponatinib Launch
November 7, 2012, Reuters
BioLineRx Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 ASH Annual Meeting
November 7, 2012, CNBC
BioLineRx Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 ASH Annual Meeting
November 7, 2012, Market Watch
How a CML Patient and Doctor Work Together VIDEO
November 6, 2012, Patient Power
Dandelion root extract human trials approved by Health Canada. Findings could change cancer treatment
November 5, 2012, The Windsor Star
Doctor still knows best
November 5, 2012, Chron
Will progress on cancer pass the price test?
November 4, 2012, The Bulletin News
Column: Disabled-sports mentor leader we can get behind
November 2, 2012, azcentral.com
Imatinib mesylate effectively treats children with neurofibromatosis type 1 tumors
November 2, 2012, News Medical
GALLAGHER: Morningside linebacker tackles leukemia
November 1, 2012, Sioux City Journal.com
Mustang Football Team To Hold "Fight Leukemia Day"
November 1, 2012, MorningSide College
What`s new in chronic myeloid leukemia research and treatment?
October 31, 2012, Cancer.org
Zumbathon to raise money for cancer patient
October 31, 2012, Xenia Daily Gazette
UWindsor prof looks at dandelion cancer cure
October 30, 2012, The Lance
Mustang Football Team To Hold Fight Leukemia Day
October 29, 2012, Sports Spot lights
Firms Partner on Global Development of China-Approved Chemotherapy
October 29, 2012, Genetic Engineering & Biotechnology News
Synergy of two drugs may treat imatinib-resistant chronic myeloid leukemia
October 29, 2012, OncologyNurseAdvisor
FDA approves Teva's Synribo for CML; Novartis plans for Tasigna switch
October 29, 2012, ThePharmaLetter
Obesity - one of risk factors for chronic myelogenous leukemia
October 28, 2012, Food Consumer
FDA Approves Omacetaxine for Chronic Myeloid Leukemia
October 26, 2012, The Oncology Report
FDA Approves Omacetaxine (Synribo) for CML
October 26, 2012, Cancer Network
FDA approves Synribo for chronic myelogenous leukemia
October 26, 2012, FDA
FDA Update - September/October 2012
October 26, 2012, Oncology Nurse Advisor
Imatinib – the dawn of targeted treatments
October 25, 2012, Cancer research UK
Novartis Cannibalizes Gleevec to Boost New Cancer Drug
October 25, 2012, Bloomberg BusinessWeek
FDA Agrees to Speed Review of Ariad Drug
October 25, 2012, DailyFinance
Moffitt researcher investigates 2-drug synergy to treat drug-resistant chronic myeloid leukemia
October 24, 2012, Cancer
Golfers raise funds for Leukemia and Lymphoma
October 23, 2012, Community Times
Ariad: FDA doing priority review of leukemia drug
October 23, 2012,CBSNews.com
Improving Harmonious Precision
October 23, 2012, Cancer Network
Targeted Therapy for Cancer: Asking the Right Questions
October 23, 2012, Cancer Network
Ariad Pharma downgraded on gains over last year
October 23, 2012, CBS News
A trial of dasatinib and BMS-833923 for chronic myeloid leukaemia (CA180323)
October 22, 2012, Cancer Research UK
Novartis' Glivec (imatinib) will soon face generic competition in Europe after Teva’s copycat version of the blockbuster cancer drug was recommended for approval.
October 22, 2012, PMLive
Father of bone marrow transplant E. Donnall Thomas dies at 92
October 22, 2012, Fox News
E. Donnall Thomas, Who Advanced Bone Marrow Transplants, Dies at 92
October 21, 2012, The New York Times
Leukemia patient Andy Johnston wins the 22 n d Great Floridian Triathlon
October 20, 2012, Orlando Sentinel
Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy
October 19, 2012, Blood Cancer Journal
Bob Kiesendahl is a survivor and an inspiration
October 18, 2012, NEagle.com
Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus
October 15, 2012, Scibite
Trends in the treatment changes and medication persistence of chronic myeloid leukemia in Taiwan from 1997 to 2007: a longitudinal population database analysis
October 15, 2012, 7th Space
Government of Tanzania receives consignment of leukemia drugs from Max foundation VIDEO
October 12, 2012, Capital TV News
The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia.
October 12, 2012, PublMed
Is Imatinib Still an Acceptable First-Line Treatment for CML in Chronic Phase?
October 12, 2012, Cancer Network
Which TKI Should Be Recommended as Initial Treatment for CML in Chronic Phase?
October 12, 2012, Cancer Network
Front-Line TKI Therapy for Chronic-Phase CML: the Luxury of Choice
October 12, 2012, Cancer Network
Healing through tragedy
October 12, 2012, Petaluma Argus Courier
Following 'Bottle Hill Day,' Madison turned to Martell Walkathon
October 8, 2012, New Jersey Hills
PropThink: ARIAD Building an Oncology Business Around Discovery, Development, and Commercialization
October 4, 2012, Reuters
Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus
October 1, 2012, PublMed
FDA approves orphan drug for CML
October 1, 2012, HemOnc Today
Ariad Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
October 1, 2012, Seeking Alpha
Pitt's Science 2012--Translation Showcases Region's Research in Science, Engineering, Medicine and Computation
October 1, 2012, Equities.com
Why imatinib remains an exception of cancer research
September 27, 2012, Journal of Cellular Physiology
Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors
September 26, 2012, American Journal of Hematology
Foreseeing a Cure for CML – Dr. Michele Baccarani VIDEO
September 26, 2012, Patient Power
Read and Share FAQ's on PCR by Dr. Michael Mauro
September 2012, Whatismypcr.org
CML Adherence Survey
September 22, 2012, CML Advocates Network
Launching a new war on cancer
September 21, 2012, CNN Health
MolecularMD voluntarily withdraws PMA for BCR-ABL mutation test
September 20, 2012, Equities.com
Kareem Abdul-Jabbar: Helping Unite Those Who Live with Rare Leukemia
September 19, 2012, EmpowHER
Beating the odds: Survivor shares inspirational story
September 18, 2012, DentonRC.com
MolecularMD Withdraws PMA for Leukemia CDx
September 18, 2012, GenomeWeb
'Chewing betel leaf may help fight cancer'
September 18, 2012, Times of India
Patents law provisions conflicting, Novartis tells SC
September 18, 2012, NYDaily News
Quality of Life - Survey II
September 17, 2012, CML Society of Canada
European Approval Sought for CML Drug Ponatinib
September 17, 2012, Cancer network
Common Drugs Can Hinder Targeted Chemotherapy Agents
September 16, 2012, Cure
A Promise Will Be Kept Again In Oct. 7 Walk Against Cancer In Madison
September 14, 2012, New Jersey Hills
The Battle Over Generic Drugs in India (and elsewhere)
September 12, 2012, Work in Progress
SC again asks Novartis to cut cancer drug price
September 12, 2012, Daily News
EMA approves first generic imatinib
September 11, 2012, GaBi
Novartis argues for Glivec patent at SC
September 11, 2012, Chandigarh Tribune
If the plays aren't working, re-adjust the game plan
September 11, 2012, The Oracle Online
Novartis argues for Glivec patent at India's top court
September 11, 2012, Reuters
New Orphan Drug for Chronic Myelogenous Leukemia Approved
September 10, 2012, Kansas City InfoZine
46-Year-Old CML Patient Develops Painful Ulceration
September 10, 2012, Cancer Network
Martell Foundation for cancer research to stage 18th annual Madison walkathon
September 9, 2012, Madison Eagle
Dasatinib Achieves Higher Response Rate Than Imatinib in CML
September 6, 2012, Cancer Network
New Rochelle Researcher Finds Cancer Gene
September 6, 2012, NewRochellePatch
Bosutinib approved for chronic myelogenous leukemia
September 5, 2012, Clinical Advisor
FDA Approves Bosutinib (Bosulif) for Chronic Myeloid Leukemia (CML)
September 5, 2012, Cancer Network
Bosutinib tablets for chronic myelogenous leukemia
September 5, 2012, Foodconsumer
Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial.
September 4, 2012, PublMed.gov
Pfizer Wins Approval for Drug to Treat Type of Leukemia
September 4, 2012, Bloomberg
The FDA (U.S. Food and Drug Administration) approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML)
September 4, 2012, U.S. Food and Drug Administration
U.S. Food and Drug Administration Approves BOSULIF® (bosutinib) for Patients with Previously Treated Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (CML)
September 4, 2012, Pfizer Press Releases
A virus that kills cancer: the cure that's waiting in the cold
August 31, 2012, The Telegraph
June 17, 2013, SBWire
CML Experts Raise Industry Hackles by Decrying High-and-Rising Costs of Treatments
June 15, 2013, Genetic Engineering Biotechnology News
Imatinib Discontinuation in Chronic Phase CML Doesn’t Always Lead to Relapse
June 14, 2013, Cancer Network
Intermittent Imatinib for Elderly CML Patients Shows Promise
June 14, 2013, Cancer Network
Excellent therapeutic results achieved in chronic myeloid leukemia patients with front-line imatinib and early
treatment modifications in suboptimal responders: A retrospective study on 91 unselected patients.
June 11, 2013, PublMed
Quality-of-life issues need to be addressed for CML patients, Moffitt researchers say
June 10, 2013, Science Codex
Quality-of-life issues need to be addressed for CML patients, researchers say
June 10, 2013, MedicalXpress
Society, GRU doctor work to cure leukemia
June 9, 2013, Aiken Standard
Kareem Abdul-Jabbar on life beyond the court VIDEO
June 9, 2013, CBSnews
Emily Grider fights leukemia; fundraiser set
June 6, 2013, The Star Press
PharmaPoint: Chronic Myeloid Leukemia (CML) - US Drug Forecast and Market Analysis to 2022
June 6 2013, USPRWIre
Work of 2013 Nobel Prize Winners on Induced Pluripotent Stem Cells to be Presented at the 18th Congress of the
European Hematology Association in Stockholm, June 13-16, 2013
June 5, 2013, PR-Portal.com
Targeted cancer therapy pioneers tapped to receive the 2013 $100,000 Taubman Prize
June 5, 2013, PRNewswire
Research and Markets: Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
June 5, 2013, Fort Mills Times
Research and Markets: PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market
Analysis to 2022
Jun. 4, 2013, Fort Mills Times
New Drug Target Identified For Treating Deadly Form Of Leukemia
June 4, 2013, AsianScientist
Singapore research team identifies new drug target in deadly form of leukemia
June 3, 2013, EurekAlert
Research and Markets: PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022
Jun. 3, 2013, Fort Mills Times
ARIAD Announces Long-Term Durability-of-Response Data on Ponatinib from Ongoing Phase 1 Study
Jun 2, 2013, DailyFinance
ARIAD Presents Analysis of Cardiovascular Risk Profile of Patients from Pivotal PACE Trial of Iclusig ® (Ponatinib)
Jun 1, 2013, Daily Finance
Research and Markets: PharmaPoint Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022
May. 31, 2013, Fort Mill Times
Add A Little Medical History To Your Summer Reading Plans
May 30, 2013, Philebrity.com
Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers
at ASCO and EHA
May 29, 2013, FierceBiotech
American Cancer Society Legends: Dr. Brian Druker VIDEO
May 28, 2013, American Cancer Society
Going one-on-one with Kareem Abdul-Jabbar
May 28, 2013, Bay Area, Biz Talk
PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022
May 28, 2013, heraldonline.com
Revs, fan group to hold trivia night in support of Alston and his leukemia battle
May 28, 2013, Boston.com
Run4Beka raising funds for cancer group
May 28, 2013, Santa Ynez Vallez News
Karyopharm Therapeutics to Present New Data on Selective Inhibitor of Nuclear Export (SINE), KPT-330, at 2013 EHA Congress
May 28, 2013, Market Watch
Revolution, Fans To Hold Trivia Night Fundraiser in Support of Kevin Alston, Leukemia and Lymphoma Society on May 30
May 26, 2013, NESN
Skyhook king, Abdul-Jabbar, in town to support leukemia fight
May 25, 2013, San Jose Mercury News
New law helps Whitefish woman battle cancer
May 24, 2013, Daily Inter Lake.com
Topper's adds crowdsourced pizza to menu
May 24, 2013, Pizza Market Place
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER Study
May 23, 2013, PublMed
Man's dream of marriage comes true even as he fights cancer
May 22, 2013, WDRB.com
Bankruptcy or Cure? A Cancer Patient's Dilemma
May 22, 2013, Medscape Today
Ariad's Cancer Drug Iclusig Extends The Gleevec Magic
May 22 2013, Seeking Alpha
Cancer's Bitter Medicine
May 22, 2013 , Genetic Engineering News
Teen Develops Computer Algorithm to Diagnose Leukemia
May 21, 2013, Mashable
A computer algorithm developed by a teen to diagnose Leukemia
May 21, 2013, site trail
18-yr-old teaches computer to diagnose cancer
May 21, 2013, rappler.com
Dawn Tyler Watson headlines all-star Blues for Life concert to benefit leukemia survivors
May 21, 2013, Montreal Gazette
New leukemia mutation offers therapeutic targets
May 21, 2013, 2 minutes medicine
QuantuMDx, A*STAR To Develop Asia-Specific Genetic Tests
May 21, 2013, Asian Scientist
CML Drug Revenue in Japan to Grow, Despite Global Decline
May 20 2013, Pharmiweb.com
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
May 19, 2013, Motley Fool
Cancer Drug Prevents Build-up of Toxic Brain Protein
May 16, 2013, HealthCanal.com
Woman with leukemia meets researchers of her life-saving drug
May 16, 2013 , UPI.com
The cost of my cancer survival
May 16, 2013, timesunion.com
Albany Medical Center to award Prize in Medicine and Biomedical Research Friday
May 16, 2013, The Record
How I Manage: Chronic Myeloid Leukemia
May 2013, Clinical Oncology News
Faith, family help Brooks fight leukemia
May 16, 2013, ThisWeekNews
Medivo Launches Free Mobile App for Monitoring Chronic Myeloid Leukemia (CML)
May 15, 2013, Market Watch
Discovery pinpoints cause of two types of leukemia, providing insights into new treatment approach
May 14, 2013, HeathCanal
Nilotinib Associated With Increased Peripheral Artery Disease Rate in CML
May 13, 2013, Cancer Network
Mice Study Finds Cancer Drug May Work on Common Brain Diseases
May 13, 2013 PsychCentral.com
Direct hit on cancer
May 12, 2013, New York Post
Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function
May 10, 2013, PNAS
Mouse study shows leukemia halts accumulation of toxic proteins linked to Parkinson's disease
May 10, 2013, News Medical
Cancer treatments "unaffordable" and will drive rapid transition to generics and market decline, says GlobalData
May 10, 2013, the pharmaletter
The Story Behind a Miracle Cancer Drug [Excerpt]
May 10, 2013, Scientific American
Discovery pinpoints cause of two types of leukemia - Science Daily
May 10, 2013, Science Daily
Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib
discontinuation in patients with CML
May 9, 2013, PublMed
Mutations in CSF3R common in CNL, atypical CML - Medical Xpress
May 9, 2013, Medical Xpress
New leukemia mutation offers therapeutic targets
May 8, 2013, 2 minutes medicine
Do Blood Cancers Need Prophylactic Platelet Transfusions? - Medscape
May 8, 2013, Medscape
Costs of drugs force sick into bankruptcy, or worse
May 8, 2013, St. Cloud Times
High costs of leukemia may be harming patients
May 7, 2013, Oncology Nurse Advisor
The Model Approach to Drug Development
May 6, 2013, Bio It World
Ruling thrills patients and boosts Indian generic drug makers
May 6, 2013, Smart Planet
Volunteering for clinical trials
May 5, 2013, The Star Online
Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation
May 4, 2013, 7th Space
Pharmaceutical Companies Profits Reach 30 Percent, Author Says
May 3, 2013, The Lund Report
News from the Front in War on Cancer--Mission Not Accomplished
May 2, 2013, , Scientiific American
Are CML Drugs Priced Out of Reach?
May 2, 2013, Cancer Network
News from the Front in War on Cancer--Mission Not Accomplished
May 2, 2013, Yahoo! News
Essential profits vs. medical profiteering
May 1, 2013, Journal Inquirer
The Beginning of the End of the Beginning in Cancer Genomics
May 1, 2013, The New England Journal of Medicine
Genomic Mutation Studies Unlock Details on Cancers
May 1, 2013, The Wall Street Journal
Exorbitant Prices for Leukemia Drugs
May 1, 2013, New York Times
PITTS: When generics win, patients lose
May 1, 2013, Washington Times
Ponatinib Excels in Heavily Pretreated Population
April 2013, Clinical Oncology News
Research and Markets: EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022
April 30, 2013, The Wall Street Journal
The real cancer killer: rip-off prices for drugs
April 29, 2013, The independent
Drug industry 'profiteering' threatens lives
April 29, 2013, News Mail
Leukaemia drug prices "unsustainable" say cancer experts
April 29, 2013, PMLive
Scientists Challenge Pharmaceutical Companies On Drug Pricing
April 29, 2013, OPB News
Doctors rebel against rip-off drug costs - Consumer Reports News
April 29, 2013, ConsumerReports.org
A Tale Of Three Pharmaceuticals: Getting Exciting In 2013
April 29, 2013, Seeking Alpha
Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid
leukemia resistant or intolerant to imatinib.
April 28, 2013, Publmed
How Much Is Your Life Worth? - San Diego Free Press
April 28, 2013, San Diego Free Press
Doctors around the world criticize drug companies for high cost of life-saving pills
April 27, 2013, abc action news
Lifestyle and Dietary Factors in Relation to Risk of Chronic Myeloid Leukemia in the NIH-AARP Diet and Health Study
April 26, 2013, Publmed
Oncologists protest cancer drug profiteering - Party for Socialism and Liberation
April 26, 2013, Party for Socialism and Liberation
Doctors blast ethics of $100000 cancer drugs
April 26, 2013, CNNMoney
Are $100000 cancer drugs unethical?
April 26, 2013, The week
Doctors blast high price of cancer drugs VIDEO
April 25, 2013, CBSNews
Top Oregon Health & Science University researcher to doctors: Rise up over drug prices
April 25, 2013, OregonLive
Cancer Doctors Raise Pressure On Pharma Industry To Cut Drug Prices
April 25, 2013, Forbes
Chronic Myeloid Leukemia Market Explored in New Cutting-Edge GlobalData Study Published at MarketPublishers.com
April. 25, 2013, Fort Mills Times
Leading leukemia experts: High leukemia treatment costs may be harming patients
April 25, 2013, Eurekalert
Slings fights back -Leukemia can't keep Altoona man off the field
April 24, 2013, Herald Index
DelMar IPO Obscurity Could Offer Investors Favorable Entry
April 24, 2013, Seeking Alpha
Lehigh Valley students take top honors at regional research event
April 23, 2013, Penn State News
Novartis AG v Union of India & Others (Civil Appeal Nos. 2706-2716 of 2013, 1 April 2013)
April 23, 2013, Lexology
Asuragen Announces Publication on Standardization of BCR-ABL1 Testing on the International Scale
April 23, 2013, The Wall Street Journal
A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia
April 22, 2013, PubLMed
Hope for Karen wrestling benefit in Millersville Friday
April 22, 2013, Examiner.com
One-on-one with Kareem Abdul-Jabbar
April 22, 2013, redeyechicago
EpiCast Report Chronic Myeloid Leukemia - Epidemiology Forecast to 2022
April 22, 2013, Wall Street Journal
Vanderbilt Patients Collaborate With Nashville’s Music Row Superstars To Bring Their Songs To Life
April 22, 2013, Newswise
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
April 22, 2013, 7th Space Interactive
In a first, Rajasthan govt to provide free leukemia drugs
April 21, 2013, Times of India
Landmark verdict
April 20, 2013, Frontline
Novartis Indian Supreme Court judgment: what is efficacy for pharmaceutical invention?
April 19 2013, Lexocology
What Makes a Good Founder? Hint: it's in the details
April 19, 2013 , Forbes
More research needed on causes of leukemia, as growing lifespan of patients enables study, says GlobalData
April 18, 2013, the pharmaletter
Eden Prairie mother beats rare cancer with 'master key' drug
April 17, 2013, FOX 9 News
New Mechanism of Resistance Identified in Brain Tumors
April 17, 2013, OncLive
Phases of Chronic Myeloid Leukemia (CML) - Chronic, Accelerated and Blast Crisis
April 17, 2013, SBWire
C. William Johnson, band director
April 17, 2013, Washington Post
Scientist wins Albany prize for leukemia cell research
April 17, 2013, Chicago Tribune
Cancer research pioneers to share $500K Albany Med prize
April 16, 2013, timesunion.com
Chronic Fatigue Limits Quality of Life in Imatinib-Treated CML Patients
April 16, 2013, Cancer Network
Long-Term Treatment With Imatinib Affected Bone Mineral Density
April 15, 2013, Cancer Network
Teenager Died From Leukemia Days After Misdiagnosis
April 15, 2013, The Inquisitr
AVEO Poised To Move Higher Before May 2 FDA Adcomm Catalyst, Obama Care, And Platform Potential
April 15, 2013, Trefis
A dose of transparency
April 15, 2013, The Indian Express
Research and Markets: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2013
April 15, 2013, heraldonline.com
Pharmaceutical companies must balance profits and affordability
April 14, 2013, The New Indian Express
Cancer 'parity' bills churn through Florida Legislature
April 13, 2013, The Miami Herald
TASIGNA (nilotinib) - Possible Risk of Developing Atherosclerosis-Related Conditions - For the Public
April 12, 2013, Health Canada
Glasford inspires runners, donors to join fight against blood cancer
April 12, 2013, NCNewsPress.com
Smartphones and Social Media Transforming Health Care
April 12, 2013, Pharmacy Times
Nilotinib for CML Leads to Fewer Treatment-Emergent Mutations Than Imatinib
April 12, 2013, Cancer Network
Patients or patents?
Apr 12, 2013. Livemint
Health research in jeopardy
April 11, 2013, Vindy.com
Teenager dies of leukaemia ten days after tonsillitis diagnosis
April 11, 2013, Metro
Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in India
April 10, 2013, The Atlantic
Drug sales reps often don't inform docs about adverse effects: Study
April 10, 2013, lfpress.com
Study: Pharma Reps Don't Tell Docs About Side Effects
April 10, 2013, PharmaLive
Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies & Clinical Trials) to 2017: Global Analysis
April 9, 2013, The Sacremento Bee
Pre-Clinical Data on Ariad's Iclusig
April 9, 2013, Zacks
The Cost of Cancer Drugs and Research
April 9, 2013, Huffpost Healthy Living
Nilotinib associated with fewer BCR-ABL mutations in chronic phase CML
April 9, 2013, Healio
Kareem launches campaign for cancer research
April 9, 2013, WAVENewspapers
Prof. Levitzki chosen for American Cancer Research Award
April 9, 2013, IsraelNationalNews
This woman needs funds for treatment
April 9, 2013, Hindustan Times
ARIAD Pharmaceuticals presents preclinical data on ponatinib at AACR Annual Meeting 2013
April 9, 2013, NewsMedical
ARIAD’s leukemia drug Iclusig may be used in other cancer treatments
April 8, 2013, bioflash
Take the Skyhook Challenge and Help Beat Blood Cancer -The Leukemia & Lymphoma Society Helps Launch Contest to Honor NBA Legend Kareem Abdul-Jabbar and Raise Awareness of Blood Cancer
April 8, 2013, PRNewswire
ARIAD Presents New Preclinical Data Showing Ponatinib is a Potent Inhibitor of RET and FGFR, Two Oncogenic Drivers
of Non-Small Cell Lung Cancer
April 8, 2013, Fort Mill Time
Revolution's Alston takes leave of absence
April 8, 2013, FOXnews.com
New England Revolution defender Kevin Alston diagnosed with treatable form of leukemia
April 8, 2013, MLSsoccer.com
HU biochemistry professor to receive major award
April 7, 2013, Jerusalem Post
Dr. Hagop Kantarjian Receives the 18th Annual AACR Joseph H. Burchenal Memorial Award
April 6, 2013, American Association for Cancer Research
"Father of targeted therapies" receives top U.S. award
April 6, 2013, English.news.cn
National Cancer Institute reveals milestones in the treatment of breast cancer and leukemia
April 6, 2013, AMEInfo.com
Cancer drugs to stop bioweapons
April 5, 2013, Fox News.com
Dr. Alexander Levitzki Awarded Seventh Annual AACR Award for Outstanding Achievement in Chemistry in Cancer Research
April 5, 2013, American Association for Cancer Research
CML-Living with a Chronic Disease
April 5, 2013, PRNewswire
Novartis Loses Historic India Patent Case On Cancer Drug Glivec
April 5, 2013, Asian Scientist
Conditional EU Approval for Pfizer's Bosulif - Analyst Blog
April 4, 2013, NASDAQ
ARIAD's CEO fights back, defends leukemia drug despite report
April 4, 2013, Boston Business Journal
A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research
April 4, 2013, News Maker
MolecularMD Announces Launch of Next Generation Sequencing Services for Oncology Drug Development
April 4, 2013,, Market Watch
The Philadelphia chromosome
April 4 2013, live mint
Ariad's Leukemia Drug Toxic, Survey Says
April 3, 2013m, The Street
Dr. Alex Matter Awarded 2013 Szent-Györgyi Prize For Progress In Cancer Research
April 3, 2013, Asian Scientist
Guest Post: The Patent Failure of Novartis with Gleevec
April 3, 2013, Patenty O.
Father of Glivec hails SC ruling
April 3, 2013, The Times of India
‘Deterred by cost of Glivec, many embraced death’
April 3, 2013, The New Indian Express
Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary
leukemia cells of chronic myeloid leukemia
April 2, 2013, 7th Space
Promising stem cell therapy for leukemia patients
April 2, 2013, MedicalXpress
ARIAD Announces Support of Patients with Resistant or Intolerant CML Through Its Donation to Chronic Disease Fund
April 2, 2013, Fort Miles Times
Supreme Court's Glivec ruling will ruin innovation, says Ranjit Shahani, Novartis India MD
April 2, 2013, The Economic Times
Don't cut lifesaving dollars - Health research and medical progress are in peril amid NIH budget cuts
April 2, 2013, Los Angeles Times
Glivec ruling: Putting patients before profits
April 2 2013, Live Mint
This will discourage innovative drug discovery, Novartis MD Ranjit Shahani says
April 2, 2013, Times of India
Man behind Glivec hails SC verdict
April 2, 2013, Business Standard
Supreme Court Rejects Novartis Appeal; Upholds high standard for Section 3(d)
April 1, 2013, Lawyers Collective
Transplant girl: thank you for saving my life
April 1, 2013, The Telegraph
Novartis Loses Glivec Patent Battle in India
April 1, 2013, The Wall Street Journal
Novartis: India rejects patent plea for cancer drug Glivec
April 1, 2013, BBC News
Novartis cancer drug patent bid rejected by Indian court in landmark ruling
April 1, 2013, The Guardian
Novartis patent case: Five facts about cancer drug Glivec
Apr 1, 2013, Firstpost
India's top court to deliver Novartis judgment
March 31, 2013, U.S. News & World Report
Gene Alfred Brothers
March 31, 2013 , Amarillo.com
Indian pharma industry awaits SC verdict on Novartis patent claim on April 1
March 29, 2013, Indiatvnews.com
Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation:
prognostic relevance of the initial CD3+ T cel dose
March 29, 2013, Biol Blood Marrow Transplant
Low Volume Volatile Trading Likely Ahead Of Long Weekend
March 28, 2013, RTT News
Conditional EU approval for Pfizer's CML drug Bosulif
March 28, The Pharma Letter
Big Pharma waits nervously on India drug patent verdict
March 27, 2013, Reuters
New Monoclonal Antibody Targets Intracellular Oncogenic Proteins in Leukemias
March 26, 2013, Cancer Network
The 2013 Leukemia Ball Features Dana Carvey and Jim Belushi
March 25, 2013, Washingtontonian
Parents and Children's Hospital researchers await results on an experimental leukemia gene therapy
March 25, 2013, philly.com
European Panel Gives Nod to Leukemia Drug
March 25, 2013, Medscape Todqy News
ICLUSIG
March 25, 2013, Monthly Prescribing Reference
Leukemia Ball Co-Chair Saved By One Drug
March 22, 2013, WUSA*9
East Coast Biotech Roundup: Moderna, bluebird, Blueprint
March 22, 2013, Xconomy
ARIAD Announces That Iclusig™ (Ponatinib) Receives Positive CHMP Opinion for Approval in the European Union
March 22, 2013, Fort Mill Times
Experimental Cancer Treatment Offers Hope VIDEO
March 21, 2013, ABCNews
Can Therapy With TKIs for CML Ever Be Stopped?
March 21, 2013, OncLIve
Researchers study use of dasatinib for patients with high-risk MDS
March 21, 2013, Medical Xpress
Cell-Based Immune Therapy Shows Promise in Leukemia Patients
March 20, 2013. Memorial Sloan-Kettering Cancer Center
Girlyman concert at Creole canceled More about Doris Muramatsu
March 20, 2013, CityPulse
Altered T-Cell Therapy Shows Promise from Acute Type of Leukemia
March 20, 2013, The New York Times
Blueprint Medicines Combs Through Genome for the Next Gleevec(s)
March 20, 2013, Xconomy
Mumbai company seeks cancer drug licence
Mar 19, 2013, The Times of India
Training for a race is well within Justin Ozuna’s control — unlike leukemia
March 18, 2013, The Dallas Morning News
Novartis' Life-Changing Blockbuster Drug
March 18, 2013, The Motley fool
What you need to know about leukemia
March 17, 2013, Seacoast Online
Is the war on cancer an ‘utter failure’?: A sobering look at how billions in research money is spent
March 16, 2013, National Post
An Interview With Leo Ehrlich, Cellceutix CEO
March 14 2013, Seeking Alpha
Labceutics, Asuragen to jointly conduct pan European study on CML
March 13, 2013, Pharmaceutical Business Review
Labceutics to Conduct Pan European Quality Assurance Study on Standardization of BCR-ABL1 Testing to Improve Patient
Management in CML
March 12, 2013, Marketwir
Patient stories centre stage at cancer summit
March 12, 2013, Benefits Canada
CML Stem Cell Burden at Diagnosis Associated With Treatment Outcomes
March 11, 2013, Cancer Network
Bio-Path Holdings Begins Enrollment in Fifth Cohort of Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2
in Leukemias
March 8, 2013, Pharmiweb.com
Major new clinical trial to improve treatment for leukaemia patients
March 7, 2013, HealthCanal.com
Join the local fight to cure blood cancer
March 7, 2013, Ventura County Reporter
Bosutinib Heads Toward Conditional Approval for CML in Europe
March 6, 2013 , Cancer Network
A World Without Cancer: Is Prevention the Cure?
March 6, 2013, The Motley fool
Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with
tyrosine kinase inhibitors
March 6, 2013, PublMed
Transplant advocate understands the need, personally
March 6, 2013, Atlanta Journal Constitution
Survivor steps up to raise money for cancer research
Mar 6, 2013, Blaine Northem Light
Beth Schrader | 39, Fort Wayne
March 4, 2013, journalgazette.net
Dasatinib thwarts brain cancer metastasis after bevacizumab use
March 1, 2013, Oncology Nurse Advisor
Why Are Investors Excited About Ariad?
February 28, 2013, Seeking Alpha
Novartis provides multimedia support to Rare Diseases Day
February 28, 2013, PMLiVE
Interest groups barrage Congress with sequester pleas
February 28, 2013, USA Today
Being chronically ill or in pain can feel like a full-time job
February 27, 2013, KevinMd.com
Canada: Pharma In Brief - Canada: Federal Court Upholds Validity Of GLEEVEC® Patent - See the decision
February 27, 2013, Mondaq
Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib
February 26, 2013, PublMed
Archdeacon: A lifetime of stories - diagnosed with CML in 2010
February 26, 2013, Flyer News
CHMP recommends approval of Imatinib Actavis
February 25, 2013, National Electronic Library for Medicines
Lottie Duthu - loss of a CML warrior - See the Guest Book
February 25, 2013, CML2
New TKI Ponatinib Effective in Resistant CML
February 2013, Clinical Oncology News
DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
February 25, 2013, Providence Journal
Show helped bride-to-be plan, despite cancer diagnosis
February 25, 2013, Western Star
After transplant, she's ready to get home
February 24, 2013, Omaha World-Herald
Doctor's motto proves to be true for 2 cancer patients
February 22, 2013, abc13.com
Stem Cells For Leukemia: New Hope From Newborns
February 22, 0213, WFTV Orlando
Seahorse Bioscience XF Technology Yields Insights on Leukemia Stem Cell Metabolism and Potential New Leukemia Therapies
February 22, 0213, Providence Journal
Granting wishes
February 22, 2013, Democrat Missourian
Bio-Path Shares are Attractive now - L-Grb-2 is a liposomal delivered antisense cancer drug that targets an multibillion dollar annual market for CML
February 22, 2013, Nasdaq
Leukemia arsenal has new drugs
February 22, 2013, Oncology Nurse Advisor
Lawsuit: Cancer patient didn't get medication at jail
February 21, 2013, The Salem News
From Chromosomes To Cures: The Lifesaving Cancer Research Of Dr. Janet Rowley VIDEO
February 21, 2013, Chicago Blood Cancer·
Memorial Sloan-Kettering scientist wins Breakthrough Prize in Life Sciences
February 21, 2013, News Medical
Court affirms utility of Gleevec patent
February 20 2013, Lexology
Inaugural Breakthrough Prizes Recognize Excellence in Research
February 20, 2013, Howard Hughes Medical Institute
As CML Drugs Improve, Earlier Surrogate Outcome Markers Needed
February 20, 2013, Cancer Network
China sets up first CML molecular testing platform
February 20, 2013, China Daily
Society to celebrate progress at ball
February 19, 2013, WIVB.com
Targeting Leukemic Stem Cells in Marrow Could Stave Off TKI Resistance
February 19, 2013, Cancer Network
Phase 2 study of subcutaneous omacetaxine mepesuccinate for chronic-phase chronic myeloid leukemia patients resistant to or intolerant of tyrosine kinase inhibitors
February 2013, American Journal of Hematology
Igniting the conversation about rare diseases
February 19, 2013, Palatka Daily News
Igniting the conversation about rare diseases
February 18, 2013, The Exponent Telegram
The Philadelphia Chromosome by Jessica Wapner - Book Trailer Video
February 15, 2013, experimentpublishing
Show solidarity for International Childhood Cancer Day
February 15, 2013, Wort.lu
Leukemia, the first and second time around
February 15, 2013, HealthCanal
Use of Digital PCR Ramping Up
February 15, 2013, Gen
Living With Chronic Myeloid Leukemia
February 14, 2013, dailyRx
Epigenetic inactivation of the MIR129-2 in hematological malignancies
February 14, 2013, 7th Space
TalkPoint and FDAAdvisoryCommittee.com partner for series of FDA public workshops
February 13, 2013, PRWeb
Choosing a Tyrosine Kinase Inhibitor in CML
February 12, 2013, Targeted Healthcare
Couple fights leukemia together as they celebrate their first anniversary
February 11, 2013, MD Anderson Cancer Center
Cancer battle: Scientists engineer new tumor-killing virus
February 11, 2013, RT News
The role of peptide and DNA vaccines in myeloid leukemiaimmunotherapy
February 11, 2013, 7h Space
“Borne Out of Necessity and Data”: Conquering Mutations in Leukemia
February 6, 2013, PLOS Blog
Scene in Edmonds: The Edsel Hermoso Moscoso Mural (Donation to Max Foundation)
February 9, 2013, My Edmonds News
One Million Americans with Blood Cancer in Jeopardy of Losing Access to Needed Medications
February 6, 2013, PRNewswire
Raymore students help send ailing boy to Disney World
February 6, 2013, KCTV
“Borne Out of Necessity and Data”:Conquering Mutations in Leukemia
February 6, 2013, Work in Progress
Wesley Willis lives… as Wonder Woman’s half-brother, no less!
February 6, 2013, Wbez
Sandy and Tommy Edge, with their Valentine's tree in Baileyton
February 6, 2013, The Arab Tribune
Wilm’s Tumor Vaccine Effective for CML
February 5, 2013, Medical Automation
Chronic myeloid leukemia: Advances in diagnosis and management
February 5, 2013, Journal of the American Academy of Physician Assistants
Japanese Researchers Claim Detection Of Cancer-Causing Gene
February 5, 2013, RTTNews
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation
February 5, 2013, 7th Space
Could An Asthma Medicine Stop CML? VIDEO
February 4, 2013, Patient Power
Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies
February 4, 2013, Blood Journal
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger
February 4, 2013, Market Wire
Local woman fights cancer one workout at a time
February 3, 2013, Fredericksburg.com
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
February 1, 2013, Leukemia
Deaths from cancer have declined 20% over 20 years
January 31, 2013, Oncology Nurse Advisor
World cancer day – 2013 – Pat Garcia-Gonzalez VIDEO
January 30 2013, The Max Foundation
Sabutoclax (ONT-701) May BeThe Next Magic Bullet To Combat The Root Of Cancer
January 30 2013, Science 2.0
FDA Approves Imatinib (Gleevec) for Pediatric ALL
January 30, 2013, Cancer Network
Kurokawa contributes to leukemia treatment
January 30, 2013, The Dartmouth
Swiss scientist wins US award for cancer research
January 30, 2013, Shanghai Daily.com (subscription)
Nplate May Be Safe For Lower-Risk MDS Patients (ASH 2012)
January 29, 2013, The MDS Beacon
“I Can’t Afford Any More Advances in Cancer Care, Doc!”
January 28, 2013, Cancer Network
Top Blood Cancer Team Joins NY-Presbyterian/Columbia
January 28, 2013, Newswise
IPO Preview: Stemline Therapeutics
January 28, 2013, Seeking Alpha
Targeted cancer treatment case study: 'I'm so grateful that I can live a normal life'
January 28, 2013, The Independant
FDA approves Gleevec for children with acute lymphoblastic leukemia
January 28, PharmaLive
Lanterns carry message of hope for fight against disease
January 25, 2013, The Independent.com
FDA approves Gleevec for children with acute lymphoblastic leukemia
January 25, 2013, FDA
Novartis pulls imatinib file in EU for hypertension
January 25, 2013, Pharma Times Online
Pan–BCL-2 Inhibition Sensitizes Leukemic Stem Cells to Kinase Inhibitors
January 24, 2013, Cancer Discovery
ARIAD prices $300M stock offering to support launch of leukemia drug
January 24, 2013, Boston Business Journal
C3G forms complexes with Bcr-Abl and p38alpha MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion
January 24, 2013, 7th Space
Helping healthy cells could be key to fighting leukaemia, research suggests
January 23, 2013, Imperial College London
CHMP Positive on Pfizers Bosutinib
January 23, 2013, Zacks.com
National Academy of Sciences Paper: Dartmouth researchers take novel approach to fighting treatment-resistant chronic myeloid leukemia
January 22, 2013, HeathCanal.com
Novartis return to growth in 2014, Vasella replaced by Reinhardt
January 22, 2013, PharmaTimes Online
Kareem Abdul-Jabbar joins Florida Forum series
January 22, 2013, Daily Record
The power of patents
January 22, 2013, Scienceline
10 Predictions That Will Transform Healthcare
January 22, 2013, Genetic Engineering News
Advances in treatment for chronic myelogenous leukaemia
January 22, 20131, South China Morning Post
Flow synthesis for anticancer drug
January 21, 2013, RSC Advancing the Chemical Sciences
Pfizer gets CHMP backing for leukaemia drug bosutinib
Juanuary 21, 2013, PMLIve
Pfizer’s Bosutinib Receives Positive Opinion For Conditional Marketing Authorization From The Committee For Medicinal Products For Human Use For The Treatment Of Ph+ Chronic Myelogenous Leukemia With Resistance Or Intolerance To Prior Therapy In Europe
January 19, 2013, Pipelinereview.com
Pfizer’s Bosutinib Receives Positive Opinion For Conditional Marketing Authorization From The Committee For Medicinal Products For Human Use For The Treatment Of Ph+ Chronic Myelogenous Leukemia With Resistance Or
Intolerance To Prior Therapy In Europe
January 18, 2013, Pfizer Press Releases
Pfizer's Bosulif set for greater sales with EMA approval
January 18, 2013, Fierce Pharna
Sanford-Burnham cancer drug targets hard-to-reach leukemia stem cells
January 18, 2013, Sanford Burnham
Sabutoclax appears to selectively target leukemia stem cells that are responsible for relapses
January 18, 2013, News Medical
Drug Targets Hard-To-Reach Leukemia Stem Cells Responsible for Relapses
January 18, 2013, Science Daily
Newly Founded Optum Labs will Analyze Big Data to Improve Patient are, Lower Costs of Care
January 18, 2013, HealthTechZone.com
Pfizer, Novartis win EU nods for new leukemia, eye drugs
January 18, 2013, FierceBiotech
Bosutinib in CML Cleared for Approval in Europe
January 18, 2013,, Medscape
Study: Enzyme Plays Important Role in CML Stem Cell Reprogramming
January 18, 2013, Cancer Network
EMA- CHMP ( Committee for Medicinal Products for Human Use)recommends the EU Commission grant a
conditional marketing authorisation for 'Bosulif' (bosutinib)
January 17, 2013, European Medicines Agency
An Expert's Perspective on Changing CML Treatment Options VIDEO
January 17, 2013, Patient Power
Is Stopping CML Treatment a Viable Option Now? VIDEO
January 17, 2013, Patient Power
Optum and Mayo Clinic look to improve patient care
January 17, 2013, Mas Device
Drug targets hard-to-reach leukemia stem cells responsible for relapses
January 17, 2013, Science Codex
Making Oncology History: Imatinib Pioneer Created His Own Opportunities
January 17, 2013, Onc LIve
Pat Has Conquered Cancer Twice - Offers Hints for the Rest of Us
January 16, 2013, About.com
Sporting KC Weekly Update: Jan. 16, 2013
January 16, 2013, WIBW
AHS volleyball team holds "Pink Out Campaign" – Donation for CML
January 16, 2013, Akron Newsreporter
Omacetaxine for Chronic or Accelerated Phase CML Patients with Resistance/Intolerance to Tyrosine Kinase Inhibitors
January 15, 2013, The ASCO Post
Meet the face of the new Make-A-Wish program Kids for Wish Kids
January 15, 2013, 41 Actions News
India to issue compulsory licences on Roche, B-MS drugs
January 15, 2013, PharmaTimet
Early molecular response may predict outcomes for nilotinib in CML
January 14, 2013, Healio
Double-unit cord blood transplants don't boost survival
January 14, 2013, The Oncology Report
Who should be subsidised?
January 14, 2013, Today Online
Pharma MNCs upset as govt issues more compulsory licences - Mandatory licences have been planned for cancer drugs such
as Trastuzumab, Ixabepilone and Dasatinib
January 13, 2013, Business Standard
Major new clinical trial to improve treatment for leukaemia patients
January 12, 2013, domain-b.com
Two-time Cancer Survivor's 10 Tips for the Healthcare System
January 12, 2013, Forbes
ARIAD and NCRI to collaborate on Phase III chronic myeloid leukemia trial
January 9, 2013, equities.com
Cancer gave us our vows meaning
January 8, 2013, Express.co.uk
ARIAD teams up with UK National Cancer Institute on leukemia treatment study
January 7, 2013, Boston Business Journal
The spirit of Star Trek
January 7, 2013, MPRnews
ARIAD and the U.K. National Cancer Research Institute to Collaborate on SPIRIT 3 Clinical Study
January 7, 2013, Pharma Live
Patrick signs bill requiring oral cancer drug coverage, over business groups' opposition
January 4, 2013, Boston Business Journal
Sorry, but there's no such thing as a diet that cures cancer
January 1, 2013, Mail Online
DNA vaccine for leukemia has early positive results
January 1, 2013, Oncology Nurse Advisor
Study Finds Enzyme Linked to the Acceleration of Malignant Proliferation in CML
January 1, 2013, Doctor Tipster
A new enzyme that contributes to the proliferation of leukemia is discovered
December 26, 2012, Private MD News
DNA-repair problems destroy hardy leukemia cells
December 26, 2012, OncologyNurseAdvisor
Reprogramming enzyme promotes chronic myeloid leukemia
Decenber 25, 2012, Omglobe.com
Leukemia stem cell trigger discovered by UCSD-led research
December 24, 2012, UT San Diego
Latest Treatment and Research for Chronic Myeloid Leukemia
December 24, 2012, Cancer Network
Enzyme accelerates malignant stem cell cloning in chronic myeloid leukemia
December 24, 2012, Eurekalert
A CML Advocate's Perspective on News from ASH 2012 VIDEO
December 21, 2012, Patient Power
News on CML from the 2012 ASH Conference – our Patients' Perspective
December 21, 2012, CML Advocates Network
At the Heart of Genetic Shenanigans
December 21, 2012, DailyRx
Parthenolide eliminates leukemia initiating cell populations and improves survival in xenografts of childhood acute lymphoblastic
leukemia
December 20, 2012, Blood Journal
Can we safely stop TKI therapies? Experience from the STOP trials VIDEO
Dr. Delphine Rea, Hôpital Saint-Louis, Paris, France
December 2012, iCMLf
Options increase for CML patients failed by existing drugs
December 21, 2012, EurekAlert
Ponatinib Could Herald “Revolution”in CML Treatment
December 20, 2012, OncLive
Bosutinib a New Option for Chronic Myeloid Leukemia
December 2012, Clinical Oncology
New group CML Life – Africa on Facebook
December 20, 2012, CMLeukemia
New group CML Tunisia on Facebook
December 20, 2012, CMLeukemia
Choosing a Tyrosine Kinase Inhibitor in Chronic Myelogenous Leukemia
December 19, 2012, OncLive
When it comes to treating his CML, Kareem Abdul-Jabbar shoots and scores
December 18, 2012, JSOnline
Ariad's Wonder Drug For Leukemia Patients
December 17, 2012, Seeking Alpha
Drug Approved To Treat Rare Forms Of Leukemia
December 16, 2012, Medical News Today
New Leukemia Rx Hits Market
December 14, 2012, dailyRx
OHSU-developed ponatinib wins FDA approval
December 14, 2012, Portland Business Journal
FDA Approves Ponatinib to Treat Leukemia
December 14, 2012, Cancer Network
FDA grants approval for potential‘blockbuster’ leukemia drug made
by Cambridge-based Ariad
December 14, 2012, Boston.com
F.D.A. Gives Early Approval to Drug for Rare Leukemia
December 14, 2012, The New York Times
ARIAD Announces Accelerated Approval by FDA of Iclusig (Ponatinib) for Patients with CML and Ph+ ALL Resistant or Intolerant to Prior Tyrosine Kinase Inhibitor Therapy
December 14, 2012, Ariad
FDA Approves Ariad Pharma Leukemia Drug
December 14, 2012, The Street
The prognosis for chronic myeloid leukaemia dramatically improved over time
December 12, 2012, Doctor Tipster
TKI-resistant human leukemia stem cells are the source of genomic instability
December 12, 2012, News Medical
Study Brings Positive Results For the Most Resistant Types of CML VIDEO
December 12, 2012, Patient Power
Abstracts and notes on CML presentations - ASH 2012 Atlanta
December 11, 2012, CMLsupport
ASH: Updated PACE Findings Uphold Ponatinib Benefit in CML and Ph+ ALL
December 11, 2012, Cancer Network
ASH: Higher Imatinib Exposures Associated with Better Chronic-Phase CML Outcomes
December 11, 2012, Chemotherapy advisor
Learning about CML
December 11, 2012, Cure Today
NVS Provides Tasigna Study Data
December 11, 2012, Zacks Equity Research
Ariad reports most patients cancer-free after 1 year in ponatinib study
December 11, 2012, Atlanta Business Journal
Ponatinib Works in CML When Nothing Else Is Effective
December 11, 2012, Medscape Today
Drug resistant leukemia stem cells may be source of genetic chaos, Temple scientists find
December 11, 2012, Science Codex
Fundraiser nets $8,000 for Hanover 6-year-old
December 10, 2012, The Evening Sun
Fatigue Is the Major Aspect Compromising Health-Related Quality of Life of Chronic Myeloid Leukemia Patients Receiving
Long-Term Imatinib Therapy
December 10, 2012, ASH 2012
Novartis says trial results back Tasigna drug
December 10, 2012, Chicago Tribune
Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
December 10, 2012, ASH2012
Novartis long-term Phase III data show Ph+ CML patients on Tasigna(R) achieved significantly deeper molecular response versus Glivec(R)
December 10, 2012, Reuters
A 7-year-old pixie named Emily Whitehead has erased any remaining doubts about the power of a University of Pennsylvania gene therapy to eradicate certain blood cancers.
December 10, 2012, philly.com
In Girl’s Last Hope, Altered Immune Cells Beat Leukemia
December 10, 2012, CBS Philly
Ariad rises on positive leukemia drug results
December 10, 2012, Boston Herald.com
In Girl’s Last Hope, Altered Immune Cells Beat Leukemia
December 9, 2012, The New York Times
Temple scientists target DNA repair to eradicate leukemia stem cells
December 9, 2012, MedicalXpress
Ariad drug proves effective in curbing chronic leukemia in study
December 9, 2012, Reuters
RAD52-Dependent Synthetic Lethality Eradicates Leukemia Stem Cells
December 9, 2012, ASH 2012
Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
December 9, 2012, Science Codex
ASH 2012: Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia
December 9, 2012, ecancernews
Understanding Why MDS Patients Have Anemia VIDEO
December 8, 2012, Patient Power
Is going for cure in chronic myeloid leukemia possible and justifiable?
December 8, 2012, Hematology
Studies Assess Role of Genetics, Modified Treatment Strategies to Improve Outcomes and Reduce Toxicity for Patients with Blood Cancers
December 8, 2012, The Sacramento Bee
Winning the Battle Against Leukemia: Positive Early Results in Clinical Trial for DNA Vaccine
December 7, 2012, Science Daily
Bristol-Myers Squibb Launches an Online Resource for Patients with Chronic Myeloid Leukaemia in 15 European Countries
December 7, 2012, equities.com
Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
December 6, 2012, The Sacramento Bee
Ponatinib offers new hope in drug-resistant leukemia
December 5, 2012 , News-Medical.net
What's Hot at ASH This Year?
December 3, 2012, Medscape Today
Ky. voices: Dr. John D'Orazio says funding for cures is slipping
December 2, 2012, Kentucky.com
Chronic Myeloid Leukemia Mutation Thwarted By Ponatinib
December 2, 2012, Science 2.0
Data Published on ARIAD Candidate - Analyst Blog
November 30, 2012, Nasdaq
In CML, Next-Generation TKIs Aim to Boost Outcomes
November 30, 2012, Onc LIve
Ponatinib - New Pill Could Do Wonders for Cancer Patients
November 30, 2012, FM NEWS 101 KXL
Ponatinib for Chronic Myeloid Leukemia
November 29, 2012, The New England Journal of Medicine
Ponatinib in Refractory Philadelphia Chromosome–Positive Leukemias
November 29, 2012, The New England Journal of Medicine
Ponatinib - Cancer pill targets previously impenetrable disease-causing gene mutation in leukemia patients
November 29, 2012, OHSU
Pfizer to Present Clinical Data from Its Hematology Portfolio at the 54th Annual Meeting of the American Society of Hematology
November 29, 2012, Market Watch
Ponatinib thwarts T315I gene mutation in chronic myeloid leukemia
November 29, 2012, News Medical
Ponatinib for Chronic Myeloid Leukemia
November 29, 2012, The New England Journal Of Medecine
Ponatinib acts against the most resistant types of chronic myeloid leukemia
November 28, 2012, MD Anderson News
Attacking Leukemia Resistance
November 28, 2012, dailyRx
Drug (Ponatinib) Shows Potential in Leukemia
November 28, 2012, Medpage Today
Ponatinib acts against the most resistant types of chronic myeloid leukemia
November 28, 2012, Science Codex
Ponatinib Acts Against the Most Resistant Types of Chronic Myeloid Leukemia
November 28, 2012, Science Daily
Novartis highlights key data in patients with hematologic diseases and breast cancer with more than 140 abstracts at ASH and SABCS
November 28, 2012, Reuters
Model-based decision rules reduce the risk of molecular relapse after cessation of tyrosine kinase inhibitor therapy in chronic myeloid leukemia
November 21, 2012, Journal Blood
BELA: Bosutinib No Better Than Imatinib in Newly Diagnosed CML
November 19, 2012, Cancer Network
OHSU's War on Cancer
November 17, 2012, Portland Monthly
Successful treatment of nilotinib-induced pleural effusion with prednisone.
November 15, 2012, PublMed
Taking care of the caregiver: tips to help yourself and your loved one live with a chronic disease
November 15, 2012, JSOnline
Nilotinib-Resistant CML Cells Show Abnormal Expression of Several Genes, Suggests Therapeutic Targets
November 15, 2012, Cancer Network
Novartis Provides R&D Update - Analyst Blog
November 15, 2012, Nasdaq
ARIAD Pharmaceuticals' CEO Presents at Lazard Capital Markets Healthcare Conference (Transcript)
November 15, 2012, Seeking Alpha
Bio-Path Holdings Successfully Completes Fourth Cohort in Phase I Clinical Trial of Lead Product Can
November 14, 2012, Daily Finance
Leukaemia drug can help treat lymphoma
November 14, 2012, Cambridge News
Can Ariad Survive on 2 Drugs?
November 13, 2012, Motley Fool
Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2012 Update
November 13, 2012, HeraldOnline.com
Ariad: A Very Interesting Biotech With An Even More Promising Pipeline
November 13, 2012, Seeking Alpha
Rwanda: Scientists Call for More Research On Leukemia
November 13, 2012, allAfrica.com
Druker speaks on Gleevec, combating leukemia
November 13, 2012, The Daily Barometer
Leukaemia 'wonder drug' could be used to treat range of blood cancers
November 12, 2012, HealthCanal.com
Your Immune System 101: Introduction to Clinical Immunology VIDEO
November 11, 2012, UCtelevision
Novartis Future Growth Prospects Secured by Industry-leading Pipeline, with More than 139 Projects with 73 New Compounds -Tasigna: "Path to Cure" - a potential paradigm shift in CML treatment
November 9, 2012, PharmaLIve
Will cancer breakthroughs pass economic test?
November 9, 2012, Austin American-Statesman
Joseph Philips Blames Drug Combination for Leukemia
November 9, 2012, Opposing Views
Prospective Histomorphometric and DXA Evaluation of Bone Remodeling in Imatinib-Treated CML Patients: Evidence for Site-Specific Skeletal Effects.
November 8, 2012, PublMed
Ariad CEO discusses company’s battle against cancer
November 8, 2012, Boston Herald
CML: the good, the better, and the difficult choices
November 8, 2012, Journal Blood
Novartis future growth prospects secured by industry-leading pipeline, with more than 139 projects with 73 new compounds
November 8, 2012, Reuters
Switching Therapy Following Suboptimal Response in Chronic Myelogenous Leukemia
November 7, 2012, OncLive
PropThink: Management says Ariad is Well-Prepared for Ponatinib Launch
November 7, 2012, Reuters
BioLineRx Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 ASH Annual Meeting
November 7, 2012, CNBC
BioLineRx Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 ASH Annual Meeting
November 7, 2012, Market Watch
How a CML Patient and Doctor Work Together VIDEO
November 6, 2012, Patient Power
Dandelion root extract human trials approved by Health Canada. Findings could change cancer treatment
November 5, 2012, The Windsor Star
Doctor still knows best
November 5, 2012, Chron
Will progress on cancer pass the price test?
November 4, 2012, The Bulletin News
Column: Disabled-sports mentor leader we can get behind
November 2, 2012, azcentral.com
Imatinib mesylate effectively treats children with neurofibromatosis type 1 tumors
November 2, 2012, News Medical
GALLAGHER: Morningside linebacker tackles leukemia
November 1, 2012, Sioux City Journal.com
Mustang Football Team To Hold "Fight Leukemia Day"
November 1, 2012, MorningSide College
What`s new in chronic myeloid leukemia research and treatment?
October 31, 2012, Cancer.org
Zumbathon to raise money for cancer patient
October 31, 2012, Xenia Daily Gazette
UWindsor prof looks at dandelion cancer cure
October 30, 2012, The Lance
Mustang Football Team To Hold Fight Leukemia Day
October 29, 2012, Sports Spot lights
Firms Partner on Global Development of China-Approved Chemotherapy
October 29, 2012, Genetic Engineering & Biotechnology News
Synergy of two drugs may treat imatinib-resistant chronic myeloid leukemia
October 29, 2012, OncologyNurseAdvisor
FDA approves Teva's Synribo for CML; Novartis plans for Tasigna switch
October 29, 2012, ThePharmaLetter
Obesity - one of risk factors for chronic myelogenous leukemia
October 28, 2012, Food Consumer
FDA Approves Omacetaxine for Chronic Myeloid Leukemia
October 26, 2012, The Oncology Report
FDA Approves Omacetaxine (Synribo) for CML
October 26, 2012, Cancer Network
FDA approves Synribo for chronic myelogenous leukemia
October 26, 2012, FDA
FDA Update - September/October 2012
October 26, 2012, Oncology Nurse Advisor
Imatinib – the dawn of targeted treatments
October 25, 2012, Cancer research UK
Novartis Cannibalizes Gleevec to Boost New Cancer Drug
October 25, 2012, Bloomberg BusinessWeek
FDA Agrees to Speed Review of Ariad Drug
October 25, 2012, DailyFinance
Moffitt researcher investigates 2-drug synergy to treat drug-resistant chronic myeloid leukemia
October 24, 2012, Cancer
Golfers raise funds for Leukemia and Lymphoma
October 23, 2012, Community Times
Ariad: FDA doing priority review of leukemia drug
October 23, 2012,CBSNews.com
Improving Harmonious Precision
October 23, 2012, Cancer Network
Targeted Therapy for Cancer: Asking the Right Questions
October 23, 2012, Cancer Network
Ariad Pharma downgraded on gains over last year
October 23, 2012, CBS News
A trial of dasatinib and BMS-833923 for chronic myeloid leukaemia (CA180323)
October 22, 2012, Cancer Research UK
Novartis' Glivec (imatinib) will soon face generic competition in Europe after Teva’s copycat version of the blockbuster cancer drug was recommended for approval.
October 22, 2012, PMLive
Father of bone marrow transplant E. Donnall Thomas dies at 92
October 22, 2012, Fox News
E. Donnall Thomas, Who Advanced Bone Marrow Transplants, Dies at 92
October 21, 2012, The New York Times
Leukemia patient Andy Johnston wins the 22 n d Great Floridian Triathlon
October 20, 2012, Orlando Sentinel
Managing chronic myeloid leukemia patients intolerant to tyrosine kinase inhibitor therapy
October 19, 2012, Blood Cancer Journal
Bob Kiesendahl is a survivor and an inspiration
October 18, 2012, NEagle.com
Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus
October 15, 2012, Scibite
Trends in the treatment changes and medication persistence of chronic myeloid leukemia in Taiwan from 1997 to 2007: a longitudinal population database analysis
October 15, 2012, 7th Space
Government of Tanzania receives consignment of leukemia drugs from Max foundation VIDEO
October 12, 2012, Capital TV News
The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second line nilotinib or dasatinib treatment in patients with chronic myeloid leukemia.
October 12, 2012, PublMed
Is Imatinib Still an Acceptable First-Line Treatment for CML in Chronic Phase?
October 12, 2012, Cancer Network
Which TKI Should Be Recommended as Initial Treatment for CML in Chronic Phase?
October 12, 2012, Cancer Network
Front-Line TKI Therapy for Chronic-Phase CML: the Luxury of Choice
October 12, 2012, Cancer Network
Healing through tragedy
October 12, 2012, Petaluma Argus Courier
Following 'Bottle Hill Day,' Madison turned to Martell Walkathon
October 8, 2012, New Jersey Hills
PropThink: ARIAD Building an Oncology Business Around Discovery, Development, and Commercialization
October 4, 2012, Reuters
Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus
October 1, 2012, PublMed
FDA approves orphan drug for CML
October 1, 2012, HemOnc Today
Ariad Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
October 1, 2012, Seeking Alpha
Pitt's Science 2012--Translation Showcases Region's Research in Science, Engineering, Medicine and Computation
October 1, 2012, Equities.com
Why imatinib remains an exception of cancer research
September 27, 2012, Journal of Cellular Physiology
Three novel patient-derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors
September 26, 2012, American Journal of Hematology
Foreseeing a Cure for CML – Dr. Michele Baccarani VIDEO
September 26, 2012, Patient Power
Read and Share FAQ's on PCR by Dr. Michael Mauro
September 2012, Whatismypcr.org
CML Adherence Survey
September 22, 2012, CML Advocates Network
Launching a new war on cancer
September 21, 2012, CNN Health
MolecularMD voluntarily withdraws PMA for BCR-ABL mutation test
September 20, 2012, Equities.com
Kareem Abdul-Jabbar: Helping Unite Those Who Live with Rare Leukemia
September 19, 2012, EmpowHER
Beating the odds: Survivor shares inspirational story
September 18, 2012, DentonRC.com
MolecularMD Withdraws PMA for Leukemia CDx
September 18, 2012, GenomeWeb
'Chewing betel leaf may help fight cancer'
September 18, 2012, Times of India
Patents law provisions conflicting, Novartis tells SC
September 18, 2012, NYDaily News
Quality of Life - Survey II
September 17, 2012, CML Society of Canada
European Approval Sought for CML Drug Ponatinib
September 17, 2012, Cancer network
Common Drugs Can Hinder Targeted Chemotherapy Agents
September 16, 2012, Cure
A Promise Will Be Kept Again In Oct. 7 Walk Against Cancer In Madison
September 14, 2012, New Jersey Hills
The Battle Over Generic Drugs in India (and elsewhere)
September 12, 2012, Work in Progress
SC again asks Novartis to cut cancer drug price
September 12, 2012, Daily News
EMA approves first generic imatinib
September 11, 2012, GaBi
Novartis argues for Glivec patent at SC
September 11, 2012, Chandigarh Tribune
If the plays aren't working, re-adjust the game plan
September 11, 2012, The Oracle Online
Novartis argues for Glivec patent at India's top court
September 11, 2012, Reuters
New Orphan Drug for Chronic Myelogenous Leukemia Approved
September 10, 2012, Kansas City InfoZine
46-Year-Old CML Patient Develops Painful Ulceration
September 10, 2012, Cancer Network
Martell Foundation for cancer research to stage 18th annual Madison walkathon
September 9, 2012, Madison Eagle
Dasatinib Achieves Higher Response Rate Than Imatinib in CML
September 6, 2012, Cancer Network
New Rochelle Researcher Finds Cancer Gene
September 6, 2012, NewRochellePatch
Bosutinib approved for chronic myelogenous leukemia
September 5, 2012, Clinical Advisor
FDA Approves Bosutinib (Bosulif) for Chronic Myeloid Leukemia (CML)
September 5, 2012, Cancer Network
Bosutinib tablets for chronic myelogenous leukemia
September 5, 2012, Foodconsumer
Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial.
September 4, 2012, PublMed.gov
Pfizer Wins Approval for Drug to Treat Type of Leukemia
September 4, 2012, Bloomberg
The FDA (U.S. Food and Drug Administration) approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML)
September 4, 2012, U.S. Food and Drug Administration
U.S. Food and Drug Administration Approves BOSULIF® (bosutinib) for Patients with Previously Treated Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia (CML)
September 4, 2012, Pfizer Press Releases
A virus that kills cancer: the cure that's waiting in the cold
August 31, 2012, The Telegraph
Upcoming ASCO Meeting Could Move These Stocks
April 4, 2012. Seeking Alpha
Piramal to present data on its three IND candidates at AACR annual meeting in Chicago
April 4, 2012, Pharmabiz.com
ARIAD: Xiaotian Zhu on Ponatinib
April 3, 2012, Executive video
Positive Data on Novartis' Glivec
April 3, 2012, Zacks
Research and Markets: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2012
April 2, 2012, Business Wire
ARIAD Presents New Preclinical Data on Ponatinib and AP26113
April 2, 2012,The Wall Street Journal
Are Cancer Stem Cells Ready for Prime Time?
April 1, 2012, The Scientist
Clinical Conundrums - quiz for the community hematologist/oncologist
March 2012, Clinical Oncology
Leukemia Drug Fails Mesothelioma Trial
March 31, 2012, Surviving Mesothelioma
Pulling together to help C.J.
March 30, 2012, Petaluma360.com
Petrov diagnosed with acute leukaemia
March 30, 2012, Foxsports
A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line
March 30, 2012, 7th Space
Fighting cancer on the home front
March 30, 2012, IrishTimes.com
New inhibitors of a cancer-causing protein may lead to targeted therapeutics
March 29, 2012, Physorg.com
Cancer Research Depends On Clinical Trial Participants
March 29, 2012, 10TV.com
Novartis versus India patent case postponed to July 10
March 29, 2012, Pharma Times
Despite Significant Advances in the Treatment of Chronic Myeloid Leukemia (CML) Over the Last Decade, Hematologist-Oncologists Report High Unmet Need for New Therapies in TKI Treatment-Resistant Patients
March 29, 2012, Market Watch
NIH scientists resolve how chromosomal mix-ups lead to tumors
March 28, 2012, PharmPro
Myeloid Malignancies Underreported In U.S
March 28, 2012, Newswise
Fighter pilot donates bone marrow
March 28, 2012, The Korea Herald
One in a Million – Children with CML
March 28, 2012, Petaluma Patch
Study in JAMA reports significant survival benefit in certain GIST patients taking Novartis drug GlivecR for three years after surgery
March 27, 2012,Reuter
Relay for Life unites people in the Story County community.
March 24, 2012, Iowa State Daily
How bodies resist cancer drugs
March 23, 2012, Science Alert
Phase 1 Dose-Escalation Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients With Select Hematologic Malignancies VIDEO
March 22, 2012, The Science Network
"NICE" news for Novartis CML drugs, but not for Bristol-Myers
March 22, 2012, Pharma Letter
It’s In The Genes: East Asians More Likely To Be Resistant To Some Cancer Drugs
March 21, 2012, Asian Scientist
Envita Medical Centers cancer treatment
March 20, 2012, abc15.com
‘We want a world without blood cancer,’ Bowie survivors say
March 20, 2012, Gazette.net
For the Treatment of Refractory Chronic Myeloid Leukemia, Interviewed Thought Leaders Indicate That Ponatinib Has Efficacy Advantages over Sprycel, the Sales Leading Agent in the United States
March 19, 2012, Market Watch
Genetic Variation in East Asians Found to Explain Resistance to Cancer Drugs
March 18, 2012, Science Daily
Ohio legislator wants insurance coverage to be same for oral, injectable chemotherapy treatments
March 17, 2012, Cleveland.com
The Reactivity of the Cellular Transcriptome to Xenobiotic Compound Perturbation
March 16, 2012, The New York Academy of Sciences
Inovio Pharmaceuticals Reports 2011 Fourth Quarter and Year-End Financial Results
March 15, 2012,Bradenton.com
AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
March 15, 2012, Market Watch
Scientists map genetic evolution of leukemia
March 14, 2012, Medical Xpress
Postal worker saves life of British cancer patient VIDEO
March 15, 2012, msnbc.com
Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs
Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs
Lisa Velasco: Managing CML With A Husband's Strong Support VIDEO
March 11, 2012, Patient Power
Del Norte students trying to raise $10,000 to fight cancer
March 10, 2012, Pomerado News
Pfizer Looks Set To Dominate With Takeovers
March 9, 2012, Seeking Alpha
Insights into early child hood leukemia - Early T cell precursor acute lymphoblastic leukemia has myeloid aspects
March 8, 2012, daily RX
Imatinib helpful after interferon fails in CML treatment
March 8, 2012, OncologyNurseAdvisor
Planned Pregnancy in CML Patient in Molecular Remission
March 6, 2012, Hindawi
Pain is more Painful in Poor Place - Chronic pain tougher to manage for young patients
Mar 6, 2012, Daily Rx
India’s Supreme Court to Hear Dispute on Drug Patents
March 6, 2012, The New York Times
Possible bone marrow match for firefighter
March 5, 2012, U-T News San Diego
Ariad Pharmaceuticals - Much to live up to
March 5, 2012, Edison Investment Research
A local university student has become the 3,000th bone marrow donor in South Korea.
March 4, 2012, The Korea Herald
I won my cancer battle thanks to wonder drug
March 2, 2012, Weekly News
Cancer drugs to help halt Ebola virus
March 2, 2012,PakTibune
Leukemia drugs found effective limiting Ebola
March 1, 2012, The Vancouver Sun
Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR–ABL inhibitors as first-line therapy
February 2012, Leukemia
Myelofibrosis Drug Shrinks Symptoms
February 29, 2012, Medpage Today
Cancer: Solving an age-old problem
February 29, 2012, Nature
Rare disease day – 29 February 2012
February 29, 2012, rarediseaseday.org
Leukemia Survival Up with Gleevec
February 29, 2012, MedPage Today
Cancer drugs could halt Ebola virus
February 29, 2012, MSN News
Blood ambassadors
February 29, 2012, Goulburn Post
Drug Helps Leukemia Patients Live Longer
February 29, 2012, Ivanhoe
ARIAD Reports 2011 Financial Results and Outlines Key Development and Commercialization Plans for 2012
February 28, 2012, Market Watch
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 28, 2012, OncologyNurseAdvisor
EU approves new label for Novartis drug Glivec extending adjuvant therapy to 3-years for certain GIST patients
February 28, 2012, Pharmabiz.com
Imatinib Effective in CML Patients Who Failed Interferon
February 27, 2012, Medscape Today
Dr. Erba Describes Proper Diagnostic Testing of CML VIDEO
February 27, 2012, Onc Live
Managing Chronic Myeloid Leukemia Treatment
February 27, 2012, Onc Live
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 27, 2012, DoctorsLounge
CML patients can benefit from imatinib after unsuccessful interferon therapies
February 27, 2012, News-Medical.net
Novartis' Glivec extends European GIST licence
February 27, 2012, PMLiVE
Novartis explains stance over India patent law challenge
February 27, 2012, Pharma Times Online
GOING?TO?THE?TOP
February 27, 2012, Sun-Gazette
Blocking the Blockers – CML stem cell enzyme may become new target
February 26, 2012, Daily RX
Cutting-edge research dulled by lack of funding
February 26, 2012, DentonRc.com
Exploring Disease Risk and Treatment Options for CML VIDEO
February 24, 2012, Patient Power
Dr. Liu makes the case for genomics and personalized medicine
February 24, 2012, The CT mirror
Novartis again urged to drop India patent lawsuit
February 24, 2012, PharmaTimes Online
Montrealer looking for a bone marrow hero
February 23, 2012, CTV.ca
Protest against Novartis' Indian lawsuit on Glivec
February 23, 2012, AFP
New heart drug will get government subsidy
February 21, 2012, The Australian
Hopes high for dandelion root trials in Windsor
February 20, 2012, The Windsor Star
Gleevec reformulated eliminates morphine tolerance in animal study
February 20, 2012, dailyRx
Ont. researchers probe use of dandelion root on cancer cells
February 19, 2012, Nanaimo Daily News
John Mailes freed from death sentence
February 19, 2012, Herald Sun
New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat of Leukemia from Benzene
February 17, 2012, Timesunion.com
New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat of Leukemia from Benzene
February 17, 2012, PRWeb
ELN Recommendations - Patient-friendly summary in seven languages
February 17, 2012, CML Advocates Network
Can dandelions kill cancer?
February 16, 2012, Global Edmonton
Stephens v. Skanska USA Bldg., INC.
February 16, 2012, LEAGLE
Bone Marrow Drive Held For Local Firefighter
February 16, 2012, News.com
Nilotinib Continues To Produce Deep Response in Patients
February 2012, Clinical Oncology
Francis Collins: 3 Scientific Breakthroughs Changing Medicine VIDEO
February 15, 2012, Medscape
Incyte Reports 2011 Fourth-Quarter and Full-Year Financial Results; Provides 2012 Financial Guidance; Updates Shareholders on Key Clinical Programs
February 15, 2012, Eon
A global attack on cancer
February 15, 2012, The Londoner
Ariad wins key patent for leukemia drug
February 15, 2012, The Boston Globe
Incyte Reports 2011 Fourth-Quarter and Full-Year Financial Results; Provides 2012 Financial Guidance; Updates Shareholders on Key Clinical Programs
February 15, 2012, MarketWatch
Hematologic Cancers in Pregnancy Pose Substantial Risks
February 14, 2012, Medscape
Bone marrow drive for San Diego firefighter
February 14, 2012, UT San Diego
Seattle's Sage Bionetworks seeks a drug-discovery revolution
February 13, 2012, The Seattle Times
Looming shortage of cancer drugs causing concern for many
February 13, 2012, WHPTV.com
Ariad's stock jumps on drug sales projection
February 13, 2012, Boston Business Journal
Therapy targets leukemia stem cells
February 13, 2012, Eurekalert
A man's need sparks bone marrow donor drive
February 11, 2011, Fort Dodge Messenger
All You Can Eat Pasta Dinner/Fundraiser for Cancer Charity
February 11, 2012, windsoriteDOTca
In-vivo proof of concept in malignant melanoma
February 9, 2012, Reuters
Outwitting Chronic Myeloid Leukemia
February 9, 2012, DailyRx
Can The Man From Heinz Keep Novartis On Top?
February 8, 2012, Forbes
Bio-Path completes second cohort dosing of leukemia drug trial
February 8 , 2012, Pharmaceutical Business Review
Blood cancer fundraiser scheduled for Friday
February 8, 2012, Easter & Associates
Ambit Biosciences Appoints Athena Countouriotis as Chief Medical Officer
February 8, 2012, The Sacramento Bee
Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial
February 7, 2012, Haematologica
Local men join NEPA firefighters in charity building climb
February 7, 2012, Thedailyreview.com
Gleevec wins wider approval for use in GI cancer
February 7, 2012, OncologyNurseAdvisor
UPDATE: Governor urges community to support bone marrow drive
February 6, 2012, Guampdm.com
Fundraiser for leukemia research set
February 6, 2012, Observer Today
Med schemes can refuse to pay for super drugs
February 5 2012, Personal Finance
Cyclists to hold 511-km tour for leukemia
February 4, 2012, The Jakarta Post
Kareem: Back-to-basket centers gone
February 4, 2012, ESPN LA
Benzene Leukemia Lawsuit Filed Over Hazardous Workplace
February 3, 2012, Injuryboard
Funding the NIH: Investing in medical research is vital to our health
February 3, 2012, Oregon.Live
Penn State: Inspiring Collaboration VIDEO
February 2, 2012, Penn State
Gleevec indications expanded to include rare cancer
February 2, 2012, The Clinical Advisor
Sunesis Announces Appointment of Dr. Adam R. Craig as Chief Medical Officer
February 2, 2012, MarketWatch
Dreams still come true - Cancer survivor gives back to sick child through organization
February 1, 2012, The advocate
FDA Approves Label Change Recommending Three Years of Novartis' Glivec After GIST Surgery
February 1, 2012, GEN
FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer
January 31, 2012, MarketWatch
2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012
January 31, 2012, Seeking Alpha
Bonney Lake to Host Relay for Life, Mayor Neil Johnson Selected as Guest Speaker
January 30, 2012, Bonney Lake-Sumner Patch
Tasigna Recommended as Second-line CML Therapy - Tasigna receives final recommendation from NICE
January 30, 2012, DailyRx
FDA accepts NDA for Pfizer CML drug
January 30, 2012, Pharmaceutical Business Review
Candid Cancer segment - what to know about getting a second opinion. VIDEO
January 29, 2012,A wider world
Area medical centers provide improvements to cancer treatments
January 28, 2012, greenbaypressgazette.com
CML Update at ASH 2011 - Interview with Elias Jabbour, M.D. VIDEO
January 27, 2012, OncUViewTV
FDA accepts Pfizer leukemia treatment for review
January 27, 2012, CBS Money Watch
Earnings Preview: Pfizer to report on 4th quarter
January 27, 2012, CBS Money Watch
Relentless for a Cure
January 26, 2012, Leukemia & Lymphoma Society
True Chronic Myeloid LeukemiaSpecific Antigen Vaccines
January 26, 2012, Johnny Silva Cancer Research
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ CML
January 26, 2012, Pfizer
For CML, Nilotinib Superior to Imatinib at 24 Months
January 26, 2012, Clinical Oncology
Bristol-Myers Misses Analyst Estimates as Costs Increase to Gain New Drugs
January 26, 2012, Bloomberg
BB Biotech closes 2011 with a positive performance and confirms upward trend
January 26 ,2012, Reuters
Understanding Molecular Response with Respect to Cure VIDEO
January 25, 2012, Patient Power
Bill introduced to allow cancer patients access to easier, more affordable chemo
January 25, 2012, WGMD.com
Novartis Drugs Backed by CHMP
January 25 ,2012, Zacks.com
Kareem Abdul-Jabbar – In His Own Words
January 25, 2012, Coping with cancer
Leukemia Drug and Magnet Material Net Japan Prizes
January 25, 2012, Science Insider
HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells
January 24, 2012, Journal Blood
Biotechs Stocks to Watch: Vertex (NASDAQ:VRTX) and Ariad (NASDAQ:ARIA)
January 24, 2012, Market Playground
Brian Druker wins prestigious Japan Prize
January 24, 2012, Portland Business Journal
Rowley to receive Japan Prize for her role in the development of targeted cancer therapy
January 24, 2012, EurekAlert
Velcade-Belinostat Combination May Be Active In Myelodysplastic Syndromes (ASH 2011)
January 24, 2012, The MDS Beacon
Novartis receives CHMP backing for Glivec label update
January 24, 2012, Zenopa
Chemo Cocktail Produces Better Results
January 24, 2012, DailyRx
Therapy Dose Management During Clinical Development of Oncology Products
January 24, 2012, Drug Discovery & Development
Marathon Against CML Still Not Won
January 24, 2012, DailyRx
Oracle Unveils Oracle® Health Sciences Omics Data Bank as Part of Oracle Health Sciences Translational Research Center
“With the rapidly dropping cost of whole genome sequencing, the challenge for personalized medicine is moving from generation of the data to analysis,” said Dr. Brian Druker
January 23, 2012, Oracle
EMA adopts positive opinion to update Novartis Glivec label to include 3- year treatment for GIST patients after surgery
January 23, 2012, Pharmabiz.com
‘The C-word’ doesn’t slow this family
January 22, 2012, Lake City Reporter.com
Analysis of outcomes in adolescents and young adults with CMLtreated with upfront tyrosine kinase inhibitor therapy
January 22, 2012,Heamatologica
Clinical cardiac safety profile of nilotinib.
January 22, 2012, PubLMed
NCMLS Remembers legendary Etta James
January 21, 2012, NCMLS
Support a Family'- Boyd Dunleavey Leukemia Awareness Day VIDEO
See also the Facebook Page
Januray 21, 2012, CMLeukemia.com
Laura Boyd’s skate expectations
January 21, 2012, The Scottish Sun
Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
January 20, 2012, International Journal of Hematology
CHMP recommends EU approval to update Novartis drug Glivec(R) label to include three year treatment for GIST patients after surgery
January 20, 2012, Reuters
Cancer classic personal for NB's Kevin Bianco
January 19, 2012, NorthJersey.com
Analyst sees Ariad primed for acquisition
January 19, 2012, MassHighTech
Research and Markets: Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011
January 19, 2011, Business Wire
Analyst: Red-hot Ariad is a possible acquisition target
January 19, 2012, Business journal
Alisa Peinhardt, an experienced oncology nurse, now serves as the Director of Patient Care Services for the National CML Society VIDEO
January 18, 2012, Patient Power
A CML Patient Advocate's Perspective on ASH 2011 VIDEO
January 18, 2012, Patient Power
Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+chronic myeloid leukemia progenitors preserving normal stem cells
January 18, 2012, Journal Blood
Abdul-Jabbar named State Department cultural ambassador
January 18, 2012, USA Today
Wollondilly urged to enter World's Greatest Shave
January 17, 2012, Macarthur chronicle
Discount wins final NICE OK for Tasigna
January 17, 2012, Pharma Times
Working toward a cure: Penn State duo developing fish oil-based leukemia treatment
January 16, 2012, Centredaily.com
Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives
January 15, 2012, PubLMed
Cancer treatment: Are Personalized Molecular Profiles in Our Future?
January 13, 2012, PBS Newshour
Continuing Good News for Chronic Myeloid Leukemia Patients
January 13, 2012, Cancer Network
Did You Buy These Stocks?
January 13, 2012, Nasdaq
CORRECT: NICE Backs Novartis's Tasigna For CML, Rejects BMS's Sprycel
January 13, 2012, the Wall Street Journal
Mixed NICE recommendations for CML and diabetes drugs
January 13, 2012, The Pharma Letter
Concert to benefit high school student
January 13, 2012, wausaudailyherald.com
No longer a bitter pill to swallow (chidren)
January 13, 2012, dailyRx
Cancer drugs should be treated equally
January 12, 2012, The Columbus Dispatch
More Than a Decade of CML Experience at OHSU Knight Cancer Institute VIDEO
January 12, 2012, Patient Power
Kedem Pharmaceuticals Initiates Development of Sublingual Anti-Cancer Drug, Gleevec
January 12, 2012, The Sacremento Bee
Living With Chronic Myelogenous Leukemia - Side Effects and Symptom Management VIDEO
January 11, 2012, Patient Power
Ariad: This Bio-Pharma May Deliver Big Returns
January 11, 2012, Seeking Alpha
Kayla Nation: Young Mother with CML Perseveres VIDEO
January 9, 2012, Patient Power
Trivia night to benefit Ronnie Buckwalter
January 9, 2012, AledoTimesRecord.com
Condolences to the family of Zavie Miller
January 9, 2012, CML World
Sharing News
January 9, 2012, Work in progress
AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
January 7, 2012, SFGate
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
January 6, 2012, Journal Blood
Korean Pharmaceutical Company Develops New Leukemia Treatment
January 6, 2012, Arirang
AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
January 6, 2012, PRNewswire
S. Korea approves Asia's first anti-leukemia drug
January 5, 2012, OANA News
KP treats local and Afghan leukemia patients free
January 4, 2012, Central Asia Online
AccuGenomics Seeks to Standardize Gene Expression Tests for Early Leukemia, Lung Cancer Detection
January 4, 2012, OneMedPlace
Brian Druker: Compassionate Care and Personalized Medicine VIDEO
January 3, 2012, Patient Power
TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
January 3, 2012, PRNewswire
Afghans’ free treatment: Health dept fears audit objections
January 2, 2012, Dawncom
Why Does It Take So Long To Go from Mouse to Man?
January 1, 2012, Quest
Made It: 'The more I run, the healthier I become'
December 31, 2011, Tampa Bay Online
Bloomington boy starts 2012 by realizing dream
December 31, 2011, Victoria advocate.com
Fish Oil Derivative Cures Cancer VIDEO
December 30, 2011, Doctor Saputo
Early Treatment for CML: A Closer Watch and Newer Options for Better Long-Term Results VIDEO
December 29, 2011, Patient Power
For Phoenix woman, every day a blessing after cancer VIDEO
December 28, 2011, azcentral.com
With India in global network, stem cell transplant to get easier
December 28, 2011, The Times of India
Key Genetic Error Found In Family Of Blood Cancers
December 28, 2011,Medical News Today
For Phoenix woman, every day a blessing after cancer
December 28, 2011, Tucson Citizen
Fish Oil May Cure Leukemia
December 28, 2011, Diets in Review.com
Daughter giving New Smyrna dad gift of life
December 27, 2011, The Daytona Beach News-Journal
Promising Blood Cancer Treatments
December 26, 2011, MD India
Fish oil may help cure leukemia
December 24, 2011, The Hindu
Eva Schamp celebrates 10 years as cancer survivor
December 23, 2011, gazettetimes.com
Dr. Jorges Cortes: ASH2011 - Two New Winners for CML? VIDEO
December 23, 2011, Medscape News Today
Professor’s Research Supported by $331K NIH Grant
December 23, 2011, Umass Lowell
Fish oil may hold key to leukemia cure
December 22, 2011, MedivalXpress
Powered Device Hailed as Advance for Bone Marrow Biopsy
December 22, 2011, Medscape News Today
Promising treatments for blood cancers presented by JTCancerCenter researchers at ASH meeting
December 22, 2011, EurekAlert
Many cancer cases, now manageable, although roadblocks remain
December 22, 2011, USA TODAY Your life
Ariad Pharmaceuticals Still Might Have Upside
December 21, 2011, Investor Place
ELN Recommendations - Patient-friendly summary in four languages
December 21, 2011, CML Advocates Network
Waging War Against Chronic Myeloid Leukemia
Chronic Myeloid Leukemia responds well to experimental drug ponatinib
December 20, 2011, DailyRX
Raising Awareness of Haematology in Europe
December 20, 2011. AdvocacyEHA
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
December 19, 2011, Journal Blood
The Apothecary Shops Incorporates Innovative Technology Into Patient Medication Reminders
December 19, 2011, PRNewswire
5 Winners Of American Society Of Hematology 2011
December 19, 2011, Seeking Alpha
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
December 19, 2011, Leukemia
YM's Positive Results Have Incyte Investors Worried
December 15, 2011, Seeking Alpha
FDA approves update for Tasigna label
December 15, 2011, Modern Medicine
ENEST: Patients with Ph+CML exhibited deeper responses to nilotinib than imatinib mesylate
December 15, 2011, HemoncToday
Study: Two Sisters Suffer From Lymphoma
December 15, 2011, Heal Blog (blog)
ARIAD Secures Much-Needed Capital for Trials, Commercialization, and Growth (ARIA)
December 15, 2011, WallST
CML updatde from 2011 ASH annual meeting
December 14, 2011, Biotech Strategy Blog
Nilotinib shows promise as first-line therapy in CML
December 14, 2011, HemoncToday
Unlocking CML resistance -Tasigna plus MEK inhibitors overcomes Gleevec resistance
Dec 14, 2011, DailyRx
Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results in Patients With Advanced Leukemias
December 14, 2011, MarketWatch
Food Dude: The Sweete Bye and Bye
December 14, 2011, NewOK.com
Brian Druker: My Vision for CML and the Road to a Cure VIDEO
December 13, 2011, Patient Power
More news for ASH meeting
December 13, 2011, The Pharma Letter
Bio-Path Holdings' Initial Phase I Data in Leukemia Clinical Trial Demonstrates That Its Neutral Lipid Delivery Technology Antisense Drug BP-100-1.01 (Liposomal Grb-2) is Well Tolerated with Activity Seen at Low Starting Dose
December 13, 2011, BusinessWire
BELA Trial: Bosutinib May Be Superior to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
December 13, 2011, MPR
Society fulfills wishes of 11 children latest!
December 13, 2011, The Borneo Post
Two Novartis Phase III studies show twice as many Ph+ CML patients achieve deeper levels of response with Tasigna® compared to Glivec
December 12, 2011, Reuters
Leukemia Drug Helps 47 Percent of Patients, Study Finds
December 12, 2011, Fox News
Study of 2 sisters sheds light on lymphoma evolution
December 12, 2011, EurekAlert
Onyx Trips, Ariad and Pharmacyclics Shine at Blood Cancer Meeting
December 12, 2011, The Street
CLAG in Combination with Imatinib Mesylate Shows Promise in Relapsed or Refractory Acute Myeloid Leukemia
December 12, 2011, MPR
CytRx Announces the Presentation of Favorable Phase 2 Clinical Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia at ASH Conference
December 12, 2011, MarketWatch
Celator(R) Pharmaceuticals and the Leukemia & Lymphoma Society(R) Announce Positive Data from Phase 2b Study of CPX-351 at the American Society of Hematology Annual Meeting
December 12, 2011,MarketWatch
Stemline Therapeutics, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference
December 12, 2011, The Sacramento Bee
Ariad Cancer Drug Positive Trial May Boost Approval Chances
December 12, 2011, Bloomberg Businessweek
Pre-Market NASDAQ Movers (ENDP, BPAX, ARIA, ONXX, DMND, NUAN, ASML, CSCO)
December 12, 2011,International Business Time
HyperCVAD Plus Dasatinib Effective in Patients with Ph+ ALL or CML-LB
December 11, 2011, MPR
ASH: Bone Marrow Best for Unrelated Donor SCT
December 11, 2011,, Medpage Today
ARIAD Announces Preliminary Data from Pivotal Pace Trial of Ponatinib, Its Investigational pan-BCR-ABL Inhibitor
December 11, 2011, MarketWatch
Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Approach to Patients with Treatment-Naive or Refractory Chronic-Phase Disease
December 10, 2011, Hematology
Educational Session: Managing Chronic Myeloid Leukemia as a Chronic Disease
December 10, 2011, Hematology
Minimal Residual Disease and Discontinuation of Therapy in Chronic Myeloid Leukemia: Can We Aim at a Cure?
December 10, 2011, Hematology
Sarah Cannon Research Institute Presents Findings of Blood Cancer Clinical Trials at National Conference
December 10, 2011, MarketWatch
Girl's Disney dream comes true
December 10, 2011, The Post and Courier
New method to destroy chronic myeloid leukemia cells discovered
December 10, 2011, Health Jockey
The Path of Science and Hope: Ph+ CML VIDEO
December 9, 2011, Novartis
Thorburn: Like home runs, singles can lead to wins against cancer mortality
December 9, 2011, Colorado Cancer blog
Scientists discover how to beat resistance to standard leukaemia drug
December 9, 2011, MedicalXPress
Scientists discover how to beat resistance to standard leukaemia drug
December 8, 2011, Cancer Research UK
Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
December 8, 2011, MarketWatch
NICE backs two Novartis CML drugs; BMS denied
December 7, 2011, PMLive
ASH Calls on Congress to Take Action to Prevent Drug Shortages
December 6, 2011, The American Society of Hematology
ARIAD to Present at the Oppenheimer 22nd Annual Healthcare Conference
December 6, 2011, MarketWatch
Nice has recommended Glivec, Tasigna for the first line treatment of CML
December 6, 2011, The National Institute for Health and Clinical Excellence (NICE)
NICE Backs Novartis' Glivec, Tasigna for CML, Rejects Sprycel
December 6, 2011, NASDAQ
Experts Question Benefits of High-Cost Cancer Care
December 5, 2011, Medscape News
ARIAD Announces Investor Meeting and Webcast at American Society of Hematology Meeting
December 5, 2011, MarketWatch
When "personalized gene-targeted cancer therapy" really means "making it up as you go along"
December 5, 2011, ScienceBlogs
What's Hot at ASH 2011?
December 2, 2011, Medscape Today
Novartis highlights advances for patients with breast cancer and hematological diseases with over 160 SABCS and ASH abstracts
December 2, 2011, Reuters
Patients suffering from blood cancer: Khyber Pakhtunkhwa government launches Rs 7.2 billion free treatment project
December 2, 2011, Business Recorder
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, American Society of Hematology
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, Sacramento Bee
Which is better for Chronic Myeloid Leukemia?
December 1, 2011, DailyRx
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, PRNewswire
National experts from the John Theurer Cancer Center will present 31 studies at the 2011 ASH Meeting
December 1, 2011, Physorg.com
New Method That Reveals Complete Set of Aberrant Signaling Pathways That Give Rise to Cancers
December 1, 2011, HealthNewsDigest.com
OTCtipReporter.com: OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), Amwest Imaging Incorporated (OTCBB: AMWI), Umami Sustainable Seafood Inc. (OTCBB: UMAM): Sign up for our FREE Stock Picks Today!
November 30, 2011, TechZone360
Menthol Cigarettes Not Less Harmful, say Experts
November 29,2011, The Sacremento Bee
Depression in Blood Cancer Patients
November 28, 2011, About.com
Hematopoietic stem cells may explain why elderly more prone to leukemia and infections
November 28, 2011, DailyRX
OncoVista Innovative Therapies Engages Oncology Therapeutic Development to Initiate a Phase Ib Study of Cordycepin in Patients With Refractory TdT Positive Leukemia
November 28, 2011,MarketWatch
ARIAD to Present at the 2011 Deutsche Bank BioFEST
November 28, 2011, MarketWatch
New CML Health Education Center on Patient Power
November 27, 2011, Patient Power
Helping One of Their Own (Child with CML)
November 26, 2011, TheEveningSun
Expanding Chronic Myeloid Leukemia Treatment Options
November 26, 2011, dailyRX
Schusterman Caps Israel-to-Tulsa Oil Career With KKR Sale
November 25,2011, Bloomberg Businessweek
Wakeboarder battles Leukemia, but she 'lives strong' VIDEO
November 24, 2011, My Fox Orlando
A giving sacrifice - Her five year old son was diagnosed with CML just under two years ago
November 22, 2011, Leominster Champion
Chronic myeloid leukemia research focuses on genes and drug therapies
November 22, 2011, DailyRX
BIG Girls Care this Holiday Season
November 21, 2011, Trib Local BurrRidge/Willowbrook
Medical Resources: Understanding Leukemia
November 21, 2011, Online Nursing Degrees
Push is on to stay one step ahead of cancer
November 21, 2011, Boston.com
MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
November 21, 2011, Sacramento Bee
Canadian researchers find potential new leukemia treatment with old antibiotic drug
November 20. 2011, Canadian Biotechnologist 2.0
Oral chemo insurance legislation in works
November 19, 2011, Central Wisconsin hub
The Importance of Drugs From the Sea
November 19, 2011, Fox News
Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib
November 18, 2011, Journal Blood
Lab Notes: Cancer Drug for TB?
November 18, 2011, Medpage Today
Kareem Abdul-Jabbar on being honored with Double Helix Medal, NBA lockoutNovember 17, 2011, CNNARIAD Announces Interim Safety and Efficacy Data from Pivotal Ponatinib PACE Trial to Be Presented at Annual American Society of Hematology Meeting
November 17, 2011, Business Wire
Finding Emotional Support for Long-term Illness
November 16, 2011, OncologyNurseAdvisor
Coaches for Cancer Tournament
November 16, 2011, abc4.com
How cancer has made me feel like the luckiest person around
November 15, 2011, Parenting Post
Donating marrow through the Be The Match Registry could save a life
November 15, 2011, Courier-Herald
Bobcats help lift leukemia-stricken fan
November 15, 2011, Bozeman Daily Chronicle
Laboratory honors NBA icon, researchers
November 15, 2011, Newsday
Signs, Symptoms and Definition of Leukemia
November 15, 2011, EmpowHer
Franchisee Battles New Storm against Pizza Hut
November 15, 2011, Blue Maumau
Bio-Path Holdings Reports Third Quarter 2011 Financial Results
November 15, 2011, MarketWatch
Asuragen to Present at Upcoming Association for Molecular Pathology 17th Annual Meeting
November 15, 2011, MarketWatch
Pregnancy and a Cancer Diagnosis VIDEO
November 14, 2011, Patient Power
Florida Blood Center holding New Smyrna Beach blood/bone marrow drive
November 13, 2011, The Daytona Beach News-Journal
NBA star to talk about health, exercise
November 13, 2011, Indystar.com
Ariad falls as drug tied to side effects
November 13, 2011, The Boston Globe
Pfizer To Present Clinical Data From Its Hematology Portfolio At The 53rd Annual Meeting Of The American Society Of Hematology
November 13, 2011, PharmPro
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results.
November 11, 2011, PubMed
Women, younger patients with CML at risk for decreased health-related quality of life
November 11, 2011, HemoncToday
Some drugs are Easier to Stick with Than Others - CML patients more likely to adhere to dasatinib than nilotinib
November 11, 2011, DailyRX
FDA Drug Safety Communication: Sprycel (dasatinib) and risk of pulmonary arterial hypertension
November 10, 2011, U.S. Food and Drug Administration
PGI to hold 3 day conference from Nov 10
November 10, 2011, Day & Night News
Kareem Abdul-Jabbar Cancer in remission
November 10, 2011, The Post Chronicle
CML Patients May Need Fewer Bone Marrow Biopsies in the Future VIDEO
November 10, 2011, Patient Power
Tamera Simonson: 19-year CML Survivor VIDEO
November 10, 2011, Patient Power
New Evidence for Taking Medication at the Right Dose VIDEO
November 10, 2011, Patient Power
National Caregiver Month recognizes and supports those helping care for loved ones
November 9, 2011, JSOnline
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
November 9, 2011, BusinessWire
ARIAD to Present at the Lazard Capital Markets Healthcare Conference
November 9, 2011, MarketWatch
Karyopharm Therapeutics Announces Presentations by Seven Collaborators Showing Major Progress in Advancing Selective Inhibitors of Nuclear Export (SINE) for Hematologic Malignancies at American Society of Hematology (ASH) Meeting
November 8, 2011,PRNewswire
CytRx Reports Third Quarter 2011 Financial Results – (Bafetinib, CML)
November 8, 2011, MarketWatch
Mini-Transplants - Age no longer barrier to stem cell transplants for older patients
November 7, 2011, Seattle Cancer Care Alliance
Ariad Pharma: Early Efficacy, Safety of Leukemia Drug 'Striking'
November 7, 2011, The Street
10-Q: ARIAD PHARMACEUTICALS INC
November 7, 2011. Middle East North Africa Financial Network
Study Sheds Light on Persisting CML
November 2011, Volume 06:11, ClinicalOncology
Study Links Gene Mutations With MDS Morphology
November 2011,Volume 06:11, ClinicalOncology
Sharon Diane Moore
November 6, 2011, Livingston Daily
Changing lives one run at a time
November 6, 2011, Florida Today
Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study.
November 3, 2011, CancerCancel
Dr. Ruben Mesa Joins 23andMe's Myeloproliferative Neoplasms Initiative as Scientific Advisor
November 3, 2011, PRNewswire
Imatinib has adverse effect on growth in children with chronic myeloid leukemia.
November 2, 2011, Pediatr Blood Cancer.
Third 2011-12 Winning Attitude Recipient Announced
November 2, 2011, Colorado Buffaloes
Clolar-Cytarabine Regimen Prior To Stem Cell Transplant May Be Effective And Safe In Older, High-Risk MDS Patients
November 2, 2011, The MDS Beacon
Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor
November 2, 2011,7th Space
Age No Longer Should be a Barrier to Stem Cell Transplantation for Older Patients with Blood Cancers
November 1, 2011, NewsWise
Transplant Protocol Benefits Elderly With Hematologic Cancers
November 1, 2011, The Oncology Report
Solution Supplier Expands Offerings
November 1, 2011 , GEN
Lea Morrison: A Winner on Many Levels
October 31, 2011, Boston Foundation for Sight
The Cancer Drug Dark Ages Are Coming to an End
October 31, 2011, Xconomy
Asuragen Launches BCR-ABL1 Calibrator Panels for IS Standardization
October 31, 2011, MarketWatch,
Matchmaker: A Day for Bone Marrow Donors
October 28, 2011, BelmontPatch
Bristol-Myers 3Q profit rises 2 pct. as sales jump
October 27, 2011, The Associated Press
CML: live long and prosper
October 27, 2011, Journal Blood
The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors
October 27, 2011, Journal Blood
Del Mar Pharmaceuticals Initiates Glioblastoma Clinical Trial
October 25, 2011, MarketWatch
Novartis new drugs soar but 2,000 jobs to go
October 25, 2011, PharmaTimes
Acute Myeloid Leukemia Test Cleared By FDA
October 24, 2011, ThirdAge
Nurse, doctor see cancer from both side
October 24, 2011, CNN Health
Too much of a good thing, not so good
October 21, 2011, bclocalnews.com
Myelodysplasia gene mutation can aid diagnosis
October 21, 2011, OncologyNurseAdvisor
Leukemia still a threat despite years of treatment? Blame stem cells
October 20, 2011, City of Hope
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies
October 20, 2011, Journal Blood
Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study
October 20, 2011, Journal Blood
New Smyrna man needs match for bone marrow transplant
October 20, 2011, The Daytona Beach New- Journal
Benzene Wrongful Death Lawsuit Results in $7.5M Verdict
October 18, 2011, AboutLawsuits.com
New cancer meds caught in insurance squeeze
October 14, 2011, MiamiHerald.com
Leukemia patient turns to social media to save his own life
October 13, 2011, The Takeaway
Imatinib is receptive to a collaboration
October 13, 2011, Journal Blood
Finding clues in our blood
October 12, 2011, northshoreoflongisland.com
ARIAD to Present at the 18th Annual Newsmakers in the Biotech Industry Conference
October 12, 2011, Business Wire
CML-Expert Information About Diagnosis and Treatment - A Live Telephone/Web Education Program Offering Live Spanish Interpretation Featuring International CML Expert Michael J. Mauro, MD
October 11, 2011, MarketWatch
FDA: Increased PAH Risk Seen With Dasatinib
October 11, 2011, Internal Medicine News Digital Network
Steve Jobs' Death Spotlights Hard-to-Detect Cancers
October 6, 2011, Fox News
Keeping his faith: Fundraiser benefits area musician battling cancer
October 4, 2011, The Advertiser.com
CytRx's ENABLE Phase 2 Trial Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia to be Presented at the Prestigious 53rd Annual ASH Meeting
October 4, 2001, MarketWatch
Initial Data from Bio-Path Holdings' Phase I Clinical Trial Accepted for Presentation at American Society of Hematology Annual Meeting
October 4, 2011, MarketWatch
Navigating the Net Wisely in a Health Crisis
October 3, 2011, New York Times
Leukemia stem cells are a lingering threat despite many years of treatment
October 3, 2011, City of Hope
CV drug shows promise as a leukemia treatment
October 3, 2011, OncologyNurseAdvisor
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice
October 2, 2004, Journal Blood
Recent advances in the path toward the cure for chronic myeloid leukemia
September 30, 2011, NCBI
Will every patient be an "N-of-1" when it comes to cancer?
September 30, 2011, Medpage Today
Andrew Matheson, The Point After: Watsonville's comeback kid living life on the field while battling leukemia
September 30, 2011, Santa Cruz Sentinel
Rod's story, how the love of a father is moving mountains - children from Philippines
September 29, 2011, The Max Foundation
Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2011
September 28, 2011, Bradenton.com
Benzene Leukemia Lawsuit Filed by Man Who Grew Up Near Oil Refinery
September 27, 2011, aboutlawsuits.com
Data from Evaluation of Signature(R) LTx Leukemia Test to Be Presented at Upcoming Planet XMAP
September 27, 2011, Marketwatch
Vaccine researchers find a possible new approach to overcoming leukemia
September 26, 2011, City of Hope
ARIAD continues to achieve endpoints in ponatinib follow-up
September 26, 2011, Proactive Investors
The National CML Society and NBA's all-time leading scorer team up against leukemia, one anniversary at a time
September 24, 2011, Las Vegas Review-Journal
Reflections on Advocacy: Making Our Voices Heard - NCMLS on Capitol Hill 9/20/11
September 23, 2011, The National CML Society
How International CML Day in India was celebrated
September 23, 2011, The Max Foundation
Studying blood cancers has helped unlock mysteries of disease, paved the way to better treatments
September 23, 2011, AnnArbor.com
CML Awareness Day and Joy Smith, MP
September 23, 2011, Digital Journal
CML - Pathways to Discovery - Dr. Janet D. Rowley VIDEO
September 22, 2011, NationalCMLSociety
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
September 22, 2011, Blood Journal
The CML Society Marks CML Awareness Day with Stepping Stone Ceremonies
September 22, 2011, Digital Journal
Annual Nobel Predictions Announced, but Forecasting Prizes Remains a Tricky Business
September 21, 2011, Scientific American
Spooky theory, leukemia drugs top Nobel tips: Thomson Reuters
September 21, 2011, Reuters
How Thai doctors are having success treating a common form of leukaemia
September 20, 2011, Bangkok Post
International CML Day – Health Corner
September 20,2011, ExpressIndia
Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment.
September 19, 2011, Journal Blood
Pat Shares Her Health Story And Her Life As A Two Time Cancer Survivor VIDEO
September 15, 2011, EmpowHER
Convocation keynote: Keep the excitement of research and patient care alive
September 15, 2011, University of Massachusetts Medical School
Making the Miraculous Happen
September 15, 2011, Sherdog
Brazilian Hair Treatment Comes Under F.D.A. Fire
September 14, 2011, New York Times
Abandoned premature baby now Iraqi vet who lost both legs, cancer survivor searches for real parents
September 13, 2011, Daily News
An Immune System Trained to Kill Cancer
September 13, 2011, The New York Times
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
September 12, 2011, The Journal of experimaqntal medicine
Cardiovascular drug may offer new treatment for some difficult types of leukemia
September 12, 2011, EurekAlert
Nilotinib vs. Imatinib: Development of BCR-ABL Mutations
September 2011’, Volume 06:09, Clinical Oncology
Novartis Must Not Win This Case
September 10, 2011,News Click
India’s drug ‘lifeline’ under threat
September 8, 2011, New Internationalist
Acute leukemia gene seemingly unfolded
September 8, 2011, HealthJockey.com
Nilotinib trumps imatinib in leukemia study
September 7, 2011, OncologyNurseAdvisor
Glivec case transferred to new apex court Bench
September 6, 2011, Business Line
Leukemia Predisposition Gene Discovered
September 5, 2011, Medical News Today
Cancer survivor fights disease through advocacy work
September 2, 2011, Coastweek.com
Modified Citrus Pectin Packs Powerful Immune Punch
September 1, 2011, The Wall Street Journal
Ottawa issues warning about leukemia drug
September 1, 2011, The Chronicle Herald
Genetic fault behind rare cancer uncovered
August 31, 2011, Cancer Research UK
Leukemia drug Sprycel linked to dangerous side effect
August 30, 2011, The Canadian Press
Bosutinib a potential second-line treatment for chronic-phase CML
August 30, 2011, Hemonc Today
Widnes leukaemia patient says trial treatment at Royal Liverpool Hospital changed her life
August 29, 2011, Wirralnews
Advances in treatment of chronic myeloid leukemia
August 26, 2011, 7th Space Interactive
Imatinib Mesylate (Gleevec) as Protein-tyrosine Kinase Inhibitor Elicits Smooth Muscle Relaxation in Isolated Human Prostatic Tissue.
August 26, 2011, PublMed.gov
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
August 25, 2011, Journal Blood
'Nail in the coffin' for rare leukaemia patients, says Borehamwood man
August 23, 2011, Borehamwood & Elstree Times
ENESTnd: Nilotinib superior to imatinib for response, disease-specific death in chronic-phase CML at 2 years
August 23, 2011, Hemonc today
Pfizer Announces European Medicines Agency Acceptance of Regulatory Submissions For Two Investigational Cancer Therapies
August 23, 2011, Vadvert.co.uk
CytRx President and CEO Steven Kriegsman and CMO Dr. Daniel Levitt Discuss Company Advantages and Oncology Clinical Pipeline Attributes in OncLive Interview
August 22, 2011, Market Watch
Nilotinib Still Trumps Imatinib in Chronic CML
August 20, 2011,Medpage Today
20-Year Leukemia Survivor to Wed; Bay Area Woman Gives Back to Others Facing Similar Plight
August 19, 2011,Rafu.com
New discount persuades NICE to back Novartis' Tasigna
August 18, 2011,InPharm
Leukaemia patients given hope by NHS drugs watchdog
August 18, 2011, The Telegraph
European Watchdog OKs Pfizer Drugs
August 18, 2011, Zacks
Expert Insights: CML Updates From Summer 2011
August 17, 2011, Medscape education
Bio-Path Holdings Reports Second Quarter 2011 Financial Results
August 15, 2011, Business Wire
Cepheid Launches New Test
August 15, 2011, Daily Markets
Bonney Lake Mayor Steps Away from Civic Duties to Undergo Cancer Treatment
August 15, 2011,BonneyLake-SumnerPatch
Free medication for Blood Cancer at SCB
August 14, 2011, IBNLive
First Cohort Successfully Completed in Bio-Path Holdings' Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia
August 11, 2011, The Wall Street Journal
China Medical receives SFDA approval for 2 diagnostic tests
August 11, 2011, Proactiveinvestors
'Serial killer' cells eradicate leukemia tumours
August 10, 2011, CTV.ca
New leukemia treatment exceeds 'wildest expectations'
August 10, 2011, MSNBC.com
Genetically Modified "Serial Killer" T Cells Obliterate Tumors in Patients with Chronic Lymphocytic Leukemia, Penn Researchers Report
August 10, 2011, Penn Medicine
Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
August 9, 2011, The Sacremento Bee
Bcr-abl signals to desensitize chronic myeloid leukemia cells to interferon alpha via accelerating the degradation of its receptor
August 5, 2011, Journal Blood
Other Diseases, Age, and Disease Status May Predict Outcome In MDS Patients Undergoing Reduced-Intensity Transplantation
August 5, 2011, The MDS Beacon
Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia
August 3, 2011, Cold Spring Harbor Laboratory
How Do Tumors Grow?
August 2, 2011, Scientific American
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
August 2, 2011, 7th Space
ARIAD shares rise on EU review of potential cancer drug
August 1, 2011, Boston Business Journal
Funding veterinary medicine advances cancer treatments of human patients
July 29, 2011, OpenPR
NanoString Offers New Tool for Analyzing 25 Leukemia Fusion Genes in a Single Reaction
July 28, 2011, BusinessWire
Cancer can't hold back Minnesota wakeboarder VIDEO
July 27, 2011, Startribune.com
Scientists Integrate Single-Cell Processing and RT-qPCR for Parallel Analysis of Hundreds of Cells
July 27, 2011, GEN
NSAIDs associated with reduced risk for myeloid leukemias in adult women
July 26, 2011,Hemonctoday
Obesity and the risk of chronic myelogenous leukemia: is this another example of the neoplastic effects of increased body fat?
July 22, 2011, Leukemia
Canadians newly diagnosed with chronic myeloid leukemia now have new treatment option
July 22, 2011, CNW
A report from the front line of cancer treatment
July 20. 2011, io9.com
Sunesis Announces Publication of Phase 1b Data of Vosaroxin in Relapsed or Refractory Acute Leukemia
July 20, 2011, MarketWatch.com
Is your car killing you with benzene?
July 19, 2011, American Cancer Society
John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
July 18, 2011, Physorg.com
Optimizing the Selection of Kinase Inhibitors for Chronic Myeloid Leukemia Patients
July 15, 2011, Medscape News
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population
July 12, 2011, Journal Blood
Biomarker Predicts Worse Outcome in Chronic Myeloid Leukemia
July 11, 2011, The Oncology Report
Association of community cancer centers’ education project reveals most effective practices for treating CML patients in the community setting
July 11, 2011, Media Newswire
Patients Abandon Oral Chemotherapies Due to High Copays
July 2011, ClinicalOncology
One of the ‘’Easy Cancers’’
July 9, 2011, dailyRX
Man Claims Sunscreen Gave Him Leukemia
July 8, 2011, Courthouse News Service
Marker Found that Enables Segregation of True Human Hematopoietic Stem Cells from Multipotent Progenitors
July 8, 2011, GEN News
Found: the mother of all blood cells
July 7, 2011,NewScientist
The American Society of Hematology Honors Janet Rowley, MD, and Brian Druker, MD, with Ernest Beutler Lecture and Prize
July 7, 2011, Hematology.org
Worcestershire campaign to keep NHS leukaemia drug
July 5, 2011, News Hereford & Worcester
Transforming a diagnosis into inspiration
July 1, 2011, Las Vegas Review-Journal
Coventry Resident Attempts 100-Plus Mile Swim for Charity
July 1, 2001,CoventryPatch
Stopping Dasatinib and Nilotinib Explored in Chronic Myeloid Leukemia
June 30, 2011, Oncology Stat
Lincoln Leukaemia patient protests cancer funds withdrawal
June 30, 2011, Lincolnshire
Using the Web to understand your medical condition
June 29, 2011, Komonews.com
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
June 29, 2011, PrNewswire
Tasigna receives Canadian approval
June 27, 2011, CNW
The Latest Weapon Against Cancer: Evolution
June 25, 2011, The Wall Street Journal
A message from a mending heart
June 25, 2011, Dayton Daily News
CML Patients Taking Imatinib Have Similar Mortality Rates to People in General Population - Pronostic
March 23, 2011, Journal of the National Cancer Institute
Bill Would Ensure Patient Access to Oral Chemotherapies
June 23, 2011, wgrz.com
Ph: not bad at all
June 22, 2011, Journal Blood
Evaluation of BCR-ABL monitoring in Chronic Myelogenous Leukemia in clinical practice VIDEO
June 21, 2011, OncUViewTV
Is There a Virus-Versus-Leukemia Effect?
June 21, 2011, CancerNetwork
Health groups want accessible drugs
June 21, 2011, WWLP.com
Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
June 21, 2011, Journal Blood
Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele
June 21, 2011, Cancer Research
Nilotinib Beats Imatinib at 24 Months in Treatment of CML
June 20, 2011, MedscapeToday
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
June 20, 2011, Journal of Clinical Oncology
Cancer survivors beat the odds, graduate high school VIDEO
June 20, 2011, MSNBC.com
Ariad Pharma - Ahead Of PACE
June 17, 2011, RTTNews
Race brings out the best in survivors
June 17, 2011, adn.com
Stopping CML therapies and eradicating CML: Patient perspective from EHA
June 15, 2011, CML Advocates Network
Faster Response Rates in CML with Bosutinib
June 15, 2011, MedscapeToday
The ghost of personalized medicine
June 14, 2011, The Scientist
Towards a more efficient therapy for a specific form of leukemia
June 14, 2011, AlphaGalileo
Webcasts of EHA Education Sessions are well worth watching
June 14, 2011, Biotech Strategy Blog
Treatment of chronic phase (CP) chronic myeloid leukemia (CML) patients who harbour the BCR-ABL T315I mutation with subcutaneous omacetaxine results in improved survival compared to historical data
June 12 2011, EHA 2011
Cessation of dasatinib or nilotinib therapy in chronic- phase chronic myeloid leukaemia patients with sustained complete molecular responses
June 12, 2011, EHA 2011
CML patients treated with TKI’s who obtain major molecular response are highly protected for transformation and this protection seems to be independent of the 18-month cutoff
June 11, 2011, EHA 2011
A molecular criteria have now been defined to guide decisions about if and when to use dasatinib or nilotinib VIDEO
June 11, 2011, ecancecr,tv
1 of the girls
June 9, 2011, dallasvoice.com
Leukaemia patients protest in Manchester at drugs threat
June 9, 2011, BBC - News Manchester
Cancer survivor: Tell people what you're going through
June 9, 2011, Rapid City Journal
Nilotinib Superior to Imatinib, Fewer Mutations in Treatment of CML-CP
June 6, 2011, Monthly Prescribing Reference
Improved survival in chronic myeloid leukemia (CML) since introduction of imatinib therapy: A single-institution experience in 1,570 patients referred within 1 month from diagnosis
June 6, 2011, ASCO 2011
A new symptom measure in chronic myeloid leukemia
June 6, 2011, ASCO 2011
Not his best time, but 'best' race for veteran runner
June 5, 2011, Sign on San Diego
Bosutinib Achieves Faster Response Rates in Newly Diagnosed Chronic Phase CML Patients Than Imatinib
June 3 , 2011, Monthly Prescribing Reference
Dasatinib Shows Superior Efficacy and Acceptable Tolerability, Supporting First-Line Use in Newly Diagnosed CML-CP
June 3 , 2011, Monthly Prescribing Reference
Leukemia drug tied to impaired growth in kids
June 2, 2011, Caring4Cancer
What can nurses do to help cancer survivors?
May 31, 2011, NursingTimes.com
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis
May 31, 2011, PubLmed
Reframing our thinking about cancer
May 26, 2011, Benefits Canada
Developer of Gleevec sees potential for more cancer drugs, will speak at Moffitt Cancer Center
May 26, 2011, tampabay.com
New Protein Linked to Alzheimer's Disease
May 25, 2011, Science Daily
Understanding Targeted Treatments
May 25, 2011, Cancer.net
Children’s Hospital Los Angeles Team Discovers Key to Fighting Drug-Resistant Leukemia
May 18, 2011, Enhanced Online News
Improved Survival And Treatment For Chronic Blood Disorders
May 18, 2011, Medical News Today
New approach to overcoming TKI resistance
May 18, 2001, ecancermedicalnews
Low incidence rate of opportunistic and viral infections during imatinib
treatment in chronic myeloid leukemia patients in early and late chronic phase
May 16, 2011, Mediterranean Journal of Hematology and Infectious diseases
Study Reveals Origins of a Cancer Affecting the Blood And Bone Marrow
May 12, 2011, Insciences organisation
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase
May 11, 2011, ScienceDirect
Bcr-Abl Kinase Domain Mutation Analysis in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inihibitors: Recommendations From an Expert Panel on Behalf of European LeukemiaNet
May 11, 2011, Oncology Stat
OHSU, cancer patients celebrate ten years of Gleevec
May 10, 2011, K103FM
Oregon Health & Science University celebrates 10th anniversary of cancer drug Gleevec
May 10, 2011, OregonLive.com
High Dose Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients - Systematic Review and Meta-Analysis
May 9, 2011, Oncology Stat
NICE provisionally rejects leukaemia drugs Sprycel, Tasigna and Glivec
May 6, 2011, Firstword
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology
The soul of a cell: Researchers used advanced instrument to read cells' minds
May 5, 2011, Stanford School of Medicine
ARIAD Reports First Quarter 2011 Financial Results and Development Progress
May 4, 2011, Enhanced Online News
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.
May 3, 2011, Unbound Medline
CML patients’ dilemma
May 2, 2009, The Star Online
Predicting Complete Cytogenetic Response and Subsequent Progression-Free Survival in 2060 Patients With CML on Imatinib Treatment: The EUTOS Score
May 2, 2011, OncologyStat
Day in the Life: OHSU's Brian Druker
April 29, 2011, Portland Business Journal
US Appeals Court Opens Federal Funding for Stem Cell Research
April 29, 2011, ScienceDaily
Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia
April 27, 2011, Wiley Online Library
Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
April 24, 2011, Journal Blood
A Model of Oscillatory Blood Cell Counts in Chronic Myelogenous Leukaemia.
April 22, 2011, Springerlink.com
An Oncologist's Pulitzer-Winning Cancer Biography
April 22, 2011, Wbur.org
Does Pretreatment Fluorescence In Situ Hybridization for BCR–ABL Predict Imatinib-Associated Hematologic Toxicity in Chronic Myeloid Leukemia?
April 20, 2011, OncologyStat
Decoding Cancer Patients' Genomes Is Powerful Diagnostic Tool
April 20, 2011, ScienceDaily
Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
April 20, 2011,Journal of Clinical Oncology
The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile
April 19, 2011, Unbound Medline
A Triumph in the War Against Cancer
Spring 2011, Smithsonian.com
Updates of New Strategies in Chronic Myelogenous Leukemia
Spring 2011, Leukemia Insights, MD Anderson Cancer Center
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia
April 14, 2011,Blood Journal
A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia
April 14 2011, Journal Blood
Study: Revolutionary Treatment Returns Normal Life Expectancy to CML Patients
April 12, 2011, EmpowHer
New drug shows potential for treatment-resistant leukemia
April 11, 2011, Pharmalive
Third Rock’s biggest bet ever is on cancer drugs
April 11, 2011, boston.com
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
April 10, 2011, Journal Blood
ARIAD Presents New Preclinical Data On Ponatinib In Solid Tumors, Demonstrating Inhibition Of All FGF Receptor Kinases
April 6, 2011, Medical News Today
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
April 1, 2011, PubLmed
The 2011 Stanley J. Korsmeyer Award
April 1, 2011, The American Society for Clinical Investigation
Potential Treatment For Chemotherapy-Resistant Chronic Myeloid Leukaemia
March 31, 2011, Medical News Today
Study Reveals No Impact of Age on Outcome in Chronic Myeloid Leukemia Patients Treated With Imatinib
March 30,2011, The American Society of Hematology (ASH)
New approach to leukemia chemotherapy -- is a cure in sight?
March 30, 2011, ScienceDaily
ARIAD And MolecularMD Announce Collaboration for a Companion Diagnostic Test for The T315I BCR-ABL Mutation in Patients With CML
March 28, 2011, Business Wire
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
March 25, 2011, PublMed
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
March 25, 2011, Wiley online Library
CML Patients Taking Imatinib Have Similar Mortality Rates To People In General Population
March 22, 2011, JNCI Journal of the National Cancer Institute
Leukemia Patients Taking Gleevec Achieve ‘Normal’ Death Rate
March 22, 2011, HealthDay News
Gleevec Gets High Marks for Leukemia Treatment
March 22, 2011, WebMD
Imatinib for Chronic Myeloid Leukemia: The Impact of Its Effectiveness and Long-term Side Effects
March 21, 2011, JNCI Journal of the National Cancer InstituteBone Marrow Transplant Centres Alerted To Help
Japan Radiation Victims
March 16, 2011, Medical News Today
Second-Line TKIs Offer Expanded Treatment Options For Newly Diagnosed Patients With CML
March 14, 2011, Medical News Today
Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?
March 7, 2011, Leukemia Research
Discontinuation of imatinib may be possible in chronic myelogenous leukemia
March 3, 2011, Cancer Journal for Clinicians
FDA Warns GERD Drugs May Deplete Magnesium
March 2, 2011, Medpage Today
Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy;
February 28, 2011, Haematologica
Second-generation drugs called into first-line therapy for CML
February 25, 2011, Hemonctoday
Survival of chronic myeloid leukemia stem cells is independent of BCR-ABL tyrosine kinase activity
February 23, 2011, Oregon Health & Science University (OSHU)
The renaissance of interferon therapy for the treatment of myeloid malignancies
February 22, 2011, Journal Blood
Changing the paradigm in frontline CML therapy VIDEO
Prof Giuseppe Saglio - University of Turin, Italy;
Dr Delphine Rea - Saint Louis Hospital, Paris;
Jan Geissler - Co-Founder, CML Advocates Network
February 21, 2011, ecancer.tv
What`s new in chronic myeloid leukemia research and treatment?
February 17, 2011, American cancer Society
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
February 2011, PublMed
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
February 8, 2011, JNCI Journal of the National Cancer Institute
A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients
February 8, 2011,7th Space Interactive
The Matriarch of Modern Cancer Genetics
February 7, 2011, The New York Times
Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study.
February 5, 2011, PublMed
Scientists reprogram marrow cells from patient with chronic myeloid leukemia
February 4, 2011, The Medicals News
Hematology: Curing CML with imatinib—a dream come true?
February 1, 2011, Nature Reviews Clinical Oncology
World Cancer Day 2011 - A World without Cancer One Day?
February 2011, Dr. Toh Han Chong, National Cancer Center, Singapore
Southampton scientists begin patient trials of new leukemia cancer vaccine
January 31, 2011, Physorg.com
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
January 31,2011, PharmaLive
Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors.
January 26, 2011, PubLMed
Bosutinib as a treatment for newly diagnosed chronic myeloid leukaemia VIDEO
February 18, 2011, ecancerTV
Fertility in Women Diagnosed with Chronic Myeloid Leukemia
January 18, 2011, Preservation of fertility
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
January 17, 2011, Unbound Medline
Cancer: Should we stop trying to cure it?
January 15, 2011, Guardian.co.uk
Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia
January 10, 2011, Wiley Online Library
Blood test to spot cancer gets big boost from J&J
January 5,2011, USA.TODAY.com
Time-specific blockade of PDGFR with Imatinib (Glivec) causes cataract and disruption of lens fiber cells in neonatal mice.
December 27, 2010, BipPortfolio
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
December 23, 2010, The New England Journal of Medicine
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
December 22, 2010, Unbound Medline
Cancer Cells May Be Able to Urge Their Own Death
December 22, 2010, CancerCompass
ASH 2010 Report: A new era in first line CML treatment coming up?
December 15, 2010, CML Advocates Network
Vital Discovery in Leukemia Stem Cell
December 15, 2010, Med India
Chronic Myeloid Leukemia: New Approaches Needed
December 15, 2010, MedicalNewsToday
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
December 15, 2010, CMLHope.com
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
December 13, 2010, The Journal of Clinical Investigation
BCR-ABL kinase is dead; long live the CML stem cell
December 13, 2010, The Journal of Clinical Investigation
Zen Meditation Can Help Bring Pain Under Control
December 10, 2010, HealthDay news
Treatment of the elderly population with haematological cancers: What's new from the American Society of Hematology 2010 meeting?
December 8, 2010, ecancermedicalscience
Industry update: Bosutinib produces molecular response as first-line CML therapy
December 8, 2010, CancerNetwork.com
Deeper molecular responses seen with dasatinib in new chronic myeloid leukemia
December 7, 2010, CancerNetwork.net
Dasatinib moves ahead of imatinib as front-line therapy for newly diagnosed CML in chronic phase
December 7, 2010, CancerNetwork.com
Nilotinib exerts positive effect in early chronic phase Ph+ CML
December 7, 2010, CancerNetwork.com
ASH meeting: Pfizer’s bosutinib disappoints in myeloid leukemia trial; Novartis’ Tasigna beats Glivec in CML study
December 7, 2010, Thepharmaletter
ASH: New CML Drug Still Beating Out Its Predecessor
December 7, 2010, Medpage Today
Persistence of BCR-ABL-Expressing leukemic stem cells in chronic myeloid leukemia (CML) patients in complete remission with undetectable molecular disease
December 7, 2010, ASH 2010
Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy
December 6, 2010, Haematologica
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Digital Journal
Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Dagorret
ASH: Early assessment of molecular response identified increased risk for treatment failure in CML
December 6, 2010, Hemonctoday
Novel CML Drug Active After Failures of Imatinib, Dasatinib, and Nilotinib
December 6, 2010, Oncology Stat
ASH 2010: JAK2-Mediated Extrinsic Survival of CML Stem Cells: Exploring the Potential Combination of BCR-ABL and JAK2 Inhibitors In Vivo
December 6, 2010, ASH2010
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia
December 5, 2010, ASH2010
Provocative Questions For CML Patients and Their Doctors (With Dr. M. Talpaz) VIDEO
December 5, 2010, Patient Power , ASH 2010, Orlando
Do 3rd Generation Medicines Lie Ahead for CML? (with Dr. Neil Shah ) VIDEO
December 4, 2010, Patient Power , ASH 2010, Orlando
Progress in Chronic Leukemias (with Dr. Alison Loren) VIDEO
December 4, 2010, Patient Power , ASH 2010, Orlando
ASH 2010: Ponatinib for refractory chronic myelogenous leukaemia
December 4, 2010, EcancerMedicalScience
ASH 2010: Nilotinib promising for early chronic phase, Philidelphia-positive chronic myeloid leukaemia
December 4, 2010, Ecancermedicalscience
Pfizer Plans Regulatory Submissions Of Bosutinib In Chronic Myeloid Leukemia
December 4, 2010, Medical NewsToday
Nilotinib associated with stable outcomes in Ph+CML
December 4, 2010, Hemonctoday
Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias
December 4, 2010, Hematology.org
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 4, 2010, Hematology
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
December 2, 2010, Dovepress
Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
November 29, 2010, PubLMed
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
November 26, 2010, 7th Space
CML—The Changing Landscape of Front-line Therapy: Part I: Interview With Dr. Jane Apperley
November 23, 2010, OncologyStat - CMLSupport
Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia
November 19, 2010, Leukemia
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
November 18, 2010, BMC Blood Disorders
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
November 16, 2010, SciElO Brazil
Mutated Gene Linked to Poor Survival in Acute Myeloid Leukemia
November 16, 2010, National Cancer Institute
Nilotinib Attenuates Renal Injury and Prolongs Survival in Chronic Kidney Disease
November 13, 2010, JASN
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
November 12, 2010, MedecineNet.com
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia.
November 9, 2010, PubLMed
Leukemia breakthrough suggested in lab finding
November 7, 2010, Globe and Mail
Canadian researchers transform skin into blood
November 7,2010, National Post
FDA Approves SPRYCEL (dasatinib) as Treatment for Adult Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
October 28, 2010,FierceBiotech
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR.
October 24, 2010,PubLMed
Nurse Practitioner Carolyn Blasdel – Montreal – August 2010 VIDEO
October 2010, CML Society of Canada
Stem Cell Transplants Available to Expanding Group of Patients
October 2010, PatientPower.info
An Evening with the CML Experts™ featuring Dr. Michael Mauro - Phoenix, Arizona VIDEO
October 2010,The National CML Society
Could Some Patients Stop Taking Their CML Pills?
October 2010, Patient Power
Dr. Georges Mathé, Transplant Pioneer, Dies at 88
October 2010, New York Times
CML: The Current Landscape - an interview with Dr. Jorge Cortes VIDEO
October 2010, The National CML Society (US)
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
October 2010, The Lancet Oncology, Early Online Publication
Some With Once-Deadly Leukemia Can Take a Break From GleevecSmall minority of CML patients went off the drug for 2 years with no sign of recurrence
October 2010, Healthday, U.S. News
CML Society of Canada - CML Awareness Day celebrates great progress against blood cancer but much more needed to ensure best outcomes for Canadian patients
September 2010, CNW Group
Philadelphia chromosome’ led to breakthrough in cancer treatment
September 2010, Philadelphia Business Journal
Do we have to kill the last CML cell?
September 2010, Nature.com
Dr. Sawyers on Outsmarting Cancer VIDEO
Dr. Charles Sawyers tells Katie Couric about the difficulties in treating different kinds of cancers, and importance of drug cocktails
September 2010, CBSNEWS.com
50th Anniversary of the Discovery of the Philadelphia Chromosome
September 28, 2010, WorldNews
Leukemia Types, Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML)
10 sept 2010, Healthcommunities.com
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.
September 2010, ResearchGate
Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome
August 23, 2010, Fox Chase Center
Technique to Preserve Fertility in Young Women May Be Unsafe for Patients With Leukemia
August 16, 2010, Science Daily
Living with chronic myeloid leukemia VIDEO
Chronic myeloid leukemia, or CML, was once considered a death sentence but new treatment options have turned CML into a chronic, yet manageable disease for most patients.
August 2010,Info4YourLife
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib
August 2010, Journal Blood
A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
August 2010, Leukemia Research
Dasatinib, an immunomodulator?
August 2010, Journal Blood
New lab test could identify imatinib resistance
July 2010, Sciences News
Protein That Predicts Prognosis of Leukemia Patients May Also Be a Therapeutic Target
July 10, 2010, Science Daily
Chronic myeloid leukemia: mechanisms of blastic transformation
July 1, 2010, The Journal of Clinical Investigation
Major Molecular Response in CML Patients Treated with Tyrosine Kinase Inhibitors: The Paradigm for Monitoring Targeted Cancer Therapy
June 21, 2010, The Oncologist
Novartis gets US FDA approval for new Tasigna indication; agency panel backs HRA Pharma's ulipristal
June 18, 2010, Thepharmaletter
Cord blood transplants a viable option in leukemia
June 15, 2010, Reuters
The 'Dandelion' problem: IFN-a, imatinib and reactivation of dormancy
June 15, 2010, ecancernews
Newer Drugs Improve Upon Gleevec for Chronic Myeloid Leukemia VIDEO
June 04, 2010, MD Anderson Cancer Center
Update on Tyrosine Kinase Inhibitor Therapy for Chronic ...
June 2010, ASHP Advantage
Remission During Chronic Phase CML: Watching for Relapse
May 19, 2010, WebMD
Benefits of Banking Cord Blood
May 10, 2010, Suite101
PCR Confusion – A CML Patient’s Perspective
May 18, 2010, Cancernetwork.com
Differing age patterns in chronic myeloid leukemia by racial ethnic group.
May 2010, Journal of Clinical Oncology
South Korean firm develops drug to kill leukemia stem cells
April 22, 2010, BioSpectrum
Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death
March 31, 2010, Mendeley
BioSante announce positive data from GVAX leukemia vaccine in CML
March 2010, Pharma Strategy Blog
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
February 2010, PubLMed
Living With a Formerly Fatal Blood Cancer
January 2010, The New York Times
Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
January 9, 2010,
Hindawi Publishing CorporationPrevalence of Large Granular Lymphocyte Proliferation in Chronic Myeloid Leukemia (CML) Patients Treated with Dasatinib
December 5, 2009, ASH 2009
Individual Telomere Lengths in Chronic Myeloid Leukemia
November 2009, Neoplasia
Adelaide researchers on road to myeloid leukemia cure
October 2009, NEWS.COM.AU
Emergence of Chronic Myelogenous Leukemia From a Background of Myeloproliferative Disorder: JAK2V617F as a Potential Risk Factor for BCR-ABL Translocation
October 2009, Clinical Lymphoma, Myeloma & Leukemia
Update of recent studies in chronic myeloid leukemia
June 26, 2009, Journal of hematology & oncology
A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment
June 2009, Wiley Online Library
Stanford researchers harness nanoparticles to track cancer cell changes
April 14, 2009, Stanford School of Medicine
Chronic Myeloid Leukemia Therapy: Focus on Second Generation ...
April 2009, moffitt.org
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy
March 2009, Blood Journal
Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML
March 26, 2009, eurekalert.org
Scientists Identify Molecular Signature for Leukemia Stem Cells
March 10, 2009, e! Science News
Scientists uncover indicator that warns leukemia is progressing to more dangerous form
February 17,2009, e! Science News
Artificial Human Bone Marrow Created In A Test Tube
December 22, 2008, Science Daily
Translation of the Philadelphia chromosome into therapy for CML
December 15, 2008, Journal Blood
Cancer drugs may treat type 1 diabetes
November 11, 2008, Bio-Medecine
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
October 6, 2008, Stanford School of Medicine
Targeted therapies for CML: practical considerations and comparisons
August 10, 2008, HemOncToday
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia
June 12, 2007, The Journal of Clinical Investigation
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
Hypertriglyceridemia may be severe in CML patients treated with interferon-α
July 11, 2006, Wiley Online Library
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
Indications for Imatinib Mesylate Therapy and Clinical Management
March 4, 2004, The Oncologist
Quantitative Polymerase Chain Reaction Monitoring of BCR-ABL during Therapy with Imatinib Mesylate (STI571; Gleevec) in Chronic-Phase Chronic Myelogenous Leukemia
January 9, 2003, Clinical cancer research
Powerful Anti-Cancer Drug Emerges from Basic Biology
May 8, 2001, The New York Times
April 4, 2012. Seeking Alpha
Piramal to present data on its three IND candidates at AACR annual meeting in Chicago
April 4, 2012, Pharmabiz.com
ARIAD: Xiaotian Zhu on Ponatinib
April 3, 2012, Executive video
Positive Data on Novartis' Glivec
April 3, 2012, Zacks
Research and Markets: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2012
April 2, 2012, Business Wire
ARIAD Presents New Preclinical Data on Ponatinib and AP26113
April 2, 2012,The Wall Street Journal
Are Cancer Stem Cells Ready for Prime Time?
April 1, 2012, The Scientist
Clinical Conundrums - quiz for the community hematologist/oncologist
March 2012, Clinical Oncology
Leukemia Drug Fails Mesothelioma Trial
March 31, 2012, Surviving Mesothelioma
Pulling together to help C.J.
March 30, 2012, Petaluma360.com
Petrov diagnosed with acute leukaemia
March 30, 2012, Foxsports
A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line
March 30, 2012, 7th Space
Fighting cancer on the home front
March 30, 2012, IrishTimes.com
New inhibitors of a cancer-causing protein may lead to targeted therapeutics
March 29, 2012, Physorg.com
Cancer Research Depends On Clinical Trial Participants
March 29, 2012, 10TV.com
Novartis versus India patent case postponed to July 10
March 29, 2012, Pharma Times
Despite Significant Advances in the Treatment of Chronic Myeloid Leukemia (CML) Over the Last Decade, Hematologist-Oncologists Report High Unmet Need for New Therapies in TKI Treatment-Resistant Patients
March 29, 2012, Market Watch
NIH scientists resolve how chromosomal mix-ups lead to tumors
March 28, 2012, PharmPro
Myeloid Malignancies Underreported In U.S
March 28, 2012, Newswise
Fighter pilot donates bone marrow
March 28, 2012, The Korea Herald
One in a Million – Children with CML
March 28, 2012, Petaluma Patch
Study in JAMA reports significant survival benefit in certain GIST patients taking Novartis drug GlivecR for three years after surgery
March 27, 2012,Reuter
Relay for Life unites people in the Story County community.
March 24, 2012, Iowa State Daily
How bodies resist cancer drugs
March 23, 2012, Science Alert
Phase 1 Dose-Escalation Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients With Select Hematologic Malignancies VIDEO
March 22, 2012, The Science Network
"NICE" news for Novartis CML drugs, but not for Bristol-Myers
March 22, 2012, Pharma Letter
It’s In The Genes: East Asians More Likely To Be Resistant To Some Cancer Drugs
March 21, 2012, Asian Scientist
Envita Medical Centers cancer treatment
March 20, 2012, abc15.com
‘We want a world without blood cancer,’ Bowie survivors say
March 20, 2012, Gazette.net
For the Treatment of Refractory Chronic Myeloid Leukemia, Interviewed Thought Leaders Indicate That Ponatinib Has Efficacy Advantages over Sprycel, the Sales Leading Agent in the United States
March 19, 2012, Market Watch
Genetic Variation in East Asians Found to Explain Resistance to Cancer Drugs
March 18, 2012, Science Daily
Ohio legislator wants insurance coverage to be same for oral, injectable chemotherapy treatments
March 17, 2012, Cleveland.com
The Reactivity of the Cellular Transcriptome to Xenobiotic Compound Perturbation
March 16, 2012, The New York Academy of Sciences
Inovio Pharmaceuticals Reports 2011 Fourth Quarter and Year-End Financial Results
March 15, 2012,Bradenton.com
AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board
March 15, 2012, Market Watch
Scientists map genetic evolution of leukemia
March 14, 2012, Medical Xpress
Postal worker saves life of British cancer patient VIDEO
March 15, 2012, msnbc.com
Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs
Indian Supreme Court to Rule on Gleevec Patent
March 12, 2012, Patent Docs
Lisa Velasco: Managing CML With A Husband's Strong Support VIDEO
March 11, 2012, Patient Power
Del Norte students trying to raise $10,000 to fight cancer
March 10, 2012, Pomerado News
Pfizer Looks Set To Dominate With Takeovers
March 9, 2012, Seeking Alpha
Insights into early child hood leukemia - Early T cell precursor acute lymphoblastic leukemia has myeloid aspects
March 8, 2012, daily RX
Imatinib helpful after interferon fails in CML treatment
March 8, 2012, OncologyNurseAdvisor
Planned Pregnancy in CML Patient in Molecular Remission
March 6, 2012, Hindawi
Pain is more Painful in Poor Place - Chronic pain tougher to manage for young patients
Mar 6, 2012, Daily Rx
India’s Supreme Court to Hear Dispute on Drug Patents
March 6, 2012, The New York Times
Possible bone marrow match for firefighter
March 5, 2012, U-T News San Diego
Ariad Pharmaceuticals - Much to live up to
March 5, 2012, Edison Investment Research
A local university student has become the 3,000th bone marrow donor in South Korea.
March 4, 2012, The Korea Herald
I won my cancer battle thanks to wonder drug
March 2, 2012, Weekly News
Cancer drugs to help halt Ebola virus
March 2, 2012,PakTibune
Leukemia drugs found effective limiting Ebola
March 1, 2012, The Vancouver Sun
Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR–ABL inhibitors as first-line therapy
February 2012, Leukemia
Myelofibrosis Drug Shrinks Symptoms
February 29, 2012, Medpage Today
Cancer: Solving an age-old problem
February 29, 2012, Nature
Rare disease day – 29 February 2012
February 29, 2012, rarediseaseday.org
Leukemia Survival Up with Gleevec
February 29, 2012, MedPage Today
Cancer drugs could halt Ebola virus
February 29, 2012, MSN News
Blood ambassadors
February 29, 2012, Goulburn Post
Drug Helps Leukemia Patients Live Longer
February 29, 2012, Ivanhoe
ARIAD Reports 2011 Financial Results and Outlines Key Development and Commercialization Plans for 2012
February 28, 2012, Market Watch
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 28, 2012, OncologyNurseAdvisor
EU approves new label for Novartis drug Glivec extending adjuvant therapy to 3-years for certain GIST patients
February 28, 2012, Pharmabiz.com
Imatinib Effective in CML Patients Who Failed Interferon
February 27, 2012, Medscape Today
Dr. Erba Describes Proper Diagnostic Testing of CML VIDEO
February 27, 2012, Onc Live
Managing Chronic Myeloid Leukemia Treatment
February 27, 2012, Onc Live
Ten-Year CML Survival Estimate of 68 Percent With Imatinib
February 27, 2012, DoctorsLounge
CML patients can benefit from imatinib after unsuccessful interferon therapies
February 27, 2012, News-Medical.net
Novartis' Glivec extends European GIST licence
February 27, 2012, PMLiVE
Novartis explains stance over India patent law challenge
February 27, 2012, Pharma Times Online
GOING?TO?THE?TOP
February 27, 2012, Sun-Gazette
Blocking the Blockers – CML stem cell enzyme may become new target
February 26, 2012, Daily RX
Cutting-edge research dulled by lack of funding
February 26, 2012, DentonRc.com
Exploring Disease Risk and Treatment Options for CML VIDEO
February 24, 2012, Patient Power
Dr. Liu makes the case for genomics and personalized medicine
February 24, 2012, The CT mirror
Novartis again urged to drop India patent lawsuit
February 24, 2012, PharmaTimes Online
Montrealer looking for a bone marrow hero
February 23, 2012, CTV.ca
Protest against Novartis' Indian lawsuit on Glivec
February 23, 2012, AFP
New heart drug will get government subsidy
February 21, 2012, The Australian
Hopes high for dandelion root trials in Windsor
February 20, 2012, The Windsor Star
Gleevec reformulated eliminates morphine tolerance in animal study
February 20, 2012, dailyRx
Ont. researchers probe use of dandelion root on cancer cells
February 19, 2012, Nanaimo Daily News
John Mailes freed from death sentence
February 19, 2012, Herald Sun
New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat of Leukemia from Benzene
February 17, 2012, Timesunion.com
New Lawsuit Filed on Benzene Leukemia: AttorneyOne.com Provides Advice and Solutions for the ongoing Threat of Leukemia from Benzene
February 17, 2012, PRWeb
ELN Recommendations - Patient-friendly summary in seven languages
February 17, 2012, CML Advocates Network
Can dandelions kill cancer?
February 16, 2012, Global Edmonton
Stephens v. Skanska USA Bldg., INC.
February 16, 2012, LEAGLE
Bone Marrow Drive Held For Local Firefighter
February 16, 2012, News.com
Nilotinib Continues To Produce Deep Response in Patients
February 2012, Clinical Oncology
Francis Collins: 3 Scientific Breakthroughs Changing Medicine VIDEO
February 15, 2012, Medscape
Incyte Reports 2011 Fourth-Quarter and Full-Year Financial Results; Provides 2012 Financial Guidance; Updates Shareholders on Key Clinical Programs
February 15, 2012, Eon
A global attack on cancer
February 15, 2012, The Londoner
Ariad wins key patent for leukemia drug
February 15, 2012, The Boston Globe
Incyte Reports 2011 Fourth-Quarter and Full-Year Financial Results; Provides 2012 Financial Guidance; Updates Shareholders on Key Clinical Programs
February 15, 2012, MarketWatch
Hematologic Cancers in Pregnancy Pose Substantial Risks
February 14, 2012, Medscape
Bone marrow drive for San Diego firefighter
February 14, 2012, UT San Diego
Seattle's Sage Bionetworks seeks a drug-discovery revolution
February 13, 2012, The Seattle Times
Looming shortage of cancer drugs causing concern for many
February 13, 2012, WHPTV.com
Ariad's stock jumps on drug sales projection
February 13, 2012, Boston Business Journal
Therapy targets leukemia stem cells
February 13, 2012, Eurekalert
A man's need sparks bone marrow donor drive
February 11, 2011, Fort Dodge Messenger
All You Can Eat Pasta Dinner/Fundraiser for Cancer Charity
February 11, 2012, windsoriteDOTca
In-vivo proof of concept in malignant melanoma
February 9, 2012, Reuters
Outwitting Chronic Myeloid Leukemia
February 9, 2012, DailyRx
Can The Man From Heinz Keep Novartis On Top?
February 8, 2012, Forbes
Bio-Path completes second cohort dosing of leukemia drug trial
February 8 , 2012, Pharmaceutical Business Review
Blood cancer fundraiser scheduled for Friday
February 8, 2012, Easter & Associates
Ambit Biosciences Appoints Athena Countouriotis as Chief Medical Officer
February 8, 2012, The Sacramento Bee
Plasma exposure of imatinib and its correlation with clinical response in the Tyrosine Kinase Inhibitor Optimization and Selectivity Trial
February 7, 2012, Haematologica
Local men join NEPA firefighters in charity building climb
February 7, 2012, Thedailyreview.com
Gleevec wins wider approval for use in GI cancer
February 7, 2012, OncologyNurseAdvisor
UPDATE: Governor urges community to support bone marrow drive
February 6, 2012, Guampdm.com
Fundraiser for leukemia research set
February 6, 2012, Observer Today
Med schemes can refuse to pay for super drugs
February 5 2012, Personal Finance
Cyclists to hold 511-km tour for leukemia
February 4, 2012, The Jakarta Post
Kareem: Back-to-basket centers gone
February 4, 2012, ESPN LA
Benzene Leukemia Lawsuit Filed Over Hazardous Workplace
February 3, 2012, Injuryboard
Funding the NIH: Investing in medical research is vital to our health
February 3, 2012, Oregon.Live
Penn State: Inspiring Collaboration VIDEO
February 2, 2012, Penn State
Gleevec indications expanded to include rare cancer
February 2, 2012, The Clinical Advisor
Sunesis Announces Appointment of Dr. Adam R. Craig as Chief Medical Officer
February 2, 2012, MarketWatch
Dreams still come true - Cancer survivor gives back to sick child through organization
February 1, 2012, The advocate
FDA Approves Label Change Recommending Three Years of Novartis' Glivec After GIST Surgery
February 1, 2012, GEN
FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer
January 31, 2012, MarketWatch
2 Potentially Solid Transdermal Drug Biotechs With Catalysts For 2012
January 31, 2012, Seeking Alpha
Bonney Lake to Host Relay for Life, Mayor Neil Johnson Selected as Guest Speaker
January 30, 2012, Bonney Lake-Sumner Patch
Tasigna Recommended as Second-line CML Therapy - Tasigna receives final recommendation from NICE
January 30, 2012, DailyRx
FDA accepts NDA for Pfizer CML drug
January 30, 2012, Pharmaceutical Business Review
Candid Cancer segment - what to know about getting a second opinion. VIDEO
January 29, 2012,A wider world
Area medical centers provide improvements to cancer treatments
January 28, 2012, greenbaypressgazette.com
CML Update at ASH 2011 - Interview with Elias Jabbour, M.D. VIDEO
January 27, 2012, OncUViewTV
FDA accepts Pfizer leukemia treatment for review
January 27, 2012, CBS Money Watch
Earnings Preview: Pfizer to report on 4th quarter
January 27, 2012, CBS Money Watch
Relentless for a Cure
January 26, 2012, Leukemia & Lymphoma Society
True Chronic Myeloid LeukemiaSpecific Antigen Vaccines
January 26, 2012, Johnny Silva Cancer Research
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ CML
January 26, 2012, Pfizer
For CML, Nilotinib Superior to Imatinib at 24 Months
January 26, 2012, Clinical Oncology
Bristol-Myers Misses Analyst Estimates as Costs Increase to Gain New Drugs
January 26, 2012, Bloomberg
BB Biotech closes 2011 with a positive performance and confirms upward trend
January 26 ,2012, Reuters
Understanding Molecular Response with Respect to Cure VIDEO
January 25, 2012, Patient Power
Bill introduced to allow cancer patients access to easier, more affordable chemo
January 25, 2012, WGMD.com
Novartis Drugs Backed by CHMP
January 25 ,2012, Zacks.com
Kareem Abdul-Jabbar – In His Own Words
January 25, 2012, Coping with cancer
Leukemia Drug and Magnet Material Net Japan Prizes
January 25, 2012, Science Insider
HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells
January 24, 2012, Journal Blood
Biotechs Stocks to Watch: Vertex (NASDAQ:VRTX) and Ariad (NASDAQ:ARIA)
January 24, 2012, Market Playground
Brian Druker wins prestigious Japan Prize
January 24, 2012, Portland Business Journal
Rowley to receive Japan Prize for her role in the development of targeted cancer therapy
January 24, 2012, EurekAlert
Velcade-Belinostat Combination May Be Active In Myelodysplastic Syndromes (ASH 2011)
January 24, 2012, The MDS Beacon
Novartis receives CHMP backing for Glivec label update
January 24, 2012, Zenopa
Chemo Cocktail Produces Better Results
January 24, 2012, DailyRx
Therapy Dose Management During Clinical Development of Oncology Products
January 24, 2012, Drug Discovery & Development
Marathon Against CML Still Not Won
January 24, 2012, DailyRx
Oracle Unveils Oracle® Health Sciences Omics Data Bank as Part of Oracle Health Sciences Translational Research Center
“With the rapidly dropping cost of whole genome sequencing, the challenge for personalized medicine is moving from generation of the data to analysis,” said Dr. Brian Druker
January 23, 2012, Oracle
EMA adopts positive opinion to update Novartis Glivec label to include 3- year treatment for GIST patients after surgery
January 23, 2012, Pharmabiz.com
‘The C-word’ doesn’t slow this family
January 22, 2012, Lake City Reporter.com
Analysis of outcomes in adolescents and young adults with CMLtreated with upfront tyrosine kinase inhibitor therapy
January 22, 2012,Heamatologica
Clinical cardiac safety profile of nilotinib.
January 22, 2012, PubLMed
NCMLS Remembers legendary Etta James
January 21, 2012, NCMLS
Support a Family'- Boyd Dunleavey Leukemia Awareness Day VIDEO
See also the Facebook Page
Januray 21, 2012, CMLeukemia.com
Laura Boyd’s skate expectations
January 21, 2012, The Scottish Sun
Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa.
January 20, 2012, International Journal of Hematology
CHMP recommends EU approval to update Novartis drug Glivec(R) label to include three year treatment for GIST patients after surgery
January 20, 2012, Reuters
Cancer classic personal for NB's Kevin Bianco
January 19, 2012, NorthJersey.com
Analyst sees Ariad primed for acquisition
January 19, 2012, MassHighTech
Research and Markets: Chronic Myelocytic Leukemia (CML) Global Clinical Trials Review, H2, 2011
January 19, 2011, Business Wire
Analyst: Red-hot Ariad is a possible acquisition target
January 19, 2012, Business journal
Alisa Peinhardt, an experienced oncology nurse, now serves as the Director of Patient Care Services for the National CML Society VIDEO
January 18, 2012, Patient Power
A CML Patient Advocate's Perspective on ASH 2011 VIDEO
January 18, 2012, Patient Power
Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+chronic myeloid leukemia progenitors preserving normal stem cells
January 18, 2012, Journal Blood
Abdul-Jabbar named State Department cultural ambassador
January 18, 2012, USA Today
Wollondilly urged to enter World's Greatest Shave
January 17, 2012, Macarthur chronicle
Discount wins final NICE OK for Tasigna
January 17, 2012, Pharma Times
Working toward a cure: Penn State duo developing fish oil-based leukemia treatment
January 16, 2012, Centredaily.com
Design, synthesis, and in vitro antiproliferative activity of novel Dasatinib derivatives
January 15, 2012, PubLMed
Cancer treatment: Are Personalized Molecular Profiles in Our Future?
January 13, 2012, PBS Newshour
Continuing Good News for Chronic Myeloid Leukemia Patients
January 13, 2012, Cancer Network
Did You Buy These Stocks?
January 13, 2012, Nasdaq
CORRECT: NICE Backs Novartis's Tasigna For CML, Rejects BMS's Sprycel
January 13, 2012, the Wall Street Journal
Mixed NICE recommendations for CML and diabetes drugs
January 13, 2012, The Pharma Letter
Concert to benefit high school student
January 13, 2012, wausaudailyherald.com
No longer a bitter pill to swallow (chidren)
January 13, 2012, dailyRx
Cancer drugs should be treated equally
January 12, 2012, The Columbus Dispatch
More Than a Decade of CML Experience at OHSU Knight Cancer Institute VIDEO
January 12, 2012, Patient Power
Kedem Pharmaceuticals Initiates Development of Sublingual Anti-Cancer Drug, Gleevec
January 12, 2012, The Sacremento Bee
Living With Chronic Myelogenous Leukemia - Side Effects and Symptom Management VIDEO
January 11, 2012, Patient Power
Ariad: This Bio-Pharma May Deliver Big Returns
January 11, 2012, Seeking Alpha
Kayla Nation: Young Mother with CML Perseveres VIDEO
January 9, 2012, Patient Power
Trivia night to benefit Ronnie Buckwalter
January 9, 2012, AledoTimesRecord.com
Condolences to the family of Zavie Miller
January 9, 2012, CML World
Sharing News
January 9, 2012, Work in progress
AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
January 7, 2012, SFGate
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
January 6, 2012, Journal Blood
Korean Pharmaceutical Company Develops New Leukemia Treatment
January 6, 2012, Arirang
AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
January 6, 2012, PRNewswire
S. Korea approves Asia's first anti-leukemia drug
January 5, 2012, OANA News
KP treats local and Afghan leukemia patients free
January 4, 2012, Central Asia Online
AccuGenomics Seeks to Standardize Gene Expression Tests for Early Leukemia, Lung Cancer Detection
January 4, 2012, OneMedPlace
Brian Druker: Compassionate Care and Personalized Medicine VIDEO
January 3, 2012, Patient Power
TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
January 3, 2012, PRNewswire
Afghans’ free treatment: Health dept fears audit objections
January 2, 2012, Dawncom
Why Does It Take So Long To Go from Mouse to Man?
January 1, 2012, Quest
Made It: 'The more I run, the healthier I become'
December 31, 2011, Tampa Bay Online
Bloomington boy starts 2012 by realizing dream
December 31, 2011, Victoria advocate.com
Fish Oil Derivative Cures Cancer VIDEO
December 30, 2011, Doctor Saputo
Early Treatment for CML: A Closer Watch and Newer Options for Better Long-Term Results VIDEO
December 29, 2011, Patient Power
For Phoenix woman, every day a blessing after cancer VIDEO
December 28, 2011, azcentral.com
With India in global network, stem cell transplant to get easier
December 28, 2011, The Times of India
Key Genetic Error Found In Family Of Blood Cancers
December 28, 2011,Medical News Today
For Phoenix woman, every day a blessing after cancer
December 28, 2011, Tucson Citizen
Fish Oil May Cure Leukemia
December 28, 2011, Diets in Review.com
Daughter giving New Smyrna dad gift of life
December 27, 2011, The Daytona Beach News-Journal
Promising Blood Cancer Treatments
December 26, 2011, MD India
Fish oil may help cure leukemia
December 24, 2011, The Hindu
Eva Schamp celebrates 10 years as cancer survivor
December 23, 2011, gazettetimes.com
Dr. Jorges Cortes: ASH2011 - Two New Winners for CML? VIDEO
December 23, 2011, Medscape News Today
Professor’s Research Supported by $331K NIH Grant
December 23, 2011, Umass Lowell
Fish oil may hold key to leukemia cure
December 22, 2011, MedivalXpress
Powered Device Hailed as Advance for Bone Marrow Biopsy
December 22, 2011, Medscape News Today
Promising treatments for blood cancers presented by JTCancerCenter researchers at ASH meeting
December 22, 2011, EurekAlert
Many cancer cases, now manageable, although roadblocks remain
December 22, 2011, USA TODAY Your life
Ariad Pharmaceuticals Still Might Have Upside
December 21, 2011, Investor Place
ELN Recommendations - Patient-friendly summary in four languages
December 21, 2011, CML Advocates Network
Waging War Against Chronic Myeloid Leukemia
Chronic Myeloid Leukemia responds well to experimental drug ponatinib
December 20, 2011, DailyRX
Raising Awareness of Haematology in Europe
December 20, 2011. AdvocacyEHA
Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival
December 19, 2011, Journal Blood
The Apothecary Shops Incorporates Innovative Technology Into Patient Medication Reminders
December 19, 2011, PRNewswire
5 Winners Of American Society Of Hematology 2011
December 19, 2011, Seeking Alpha
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells
December 19, 2011, Leukemia
YM's Positive Results Have Incyte Investors Worried
December 15, 2011, Seeking Alpha
FDA approves update for Tasigna label
December 15, 2011, Modern Medicine
ENEST: Patients with Ph+CML exhibited deeper responses to nilotinib than imatinib mesylate
December 15, 2011, HemoncToday
Study: Two Sisters Suffer From Lymphoma
December 15, 2011, Heal Blog (blog)
ARIAD Secures Much-Needed Capital for Trials, Commercialization, and Growth (ARIA)
December 15, 2011, WallST
CML updatde from 2011 ASH annual meeting
December 14, 2011, Biotech Strategy Blog
Nilotinib shows promise as first-line therapy in CML
December 14, 2011, HemoncToday
Unlocking CML resistance -Tasigna plus MEK inhibitors overcomes Gleevec resistance
Dec 14, 2011, DailyRx
Threshold Pharmaceuticals Announces Promising Phase 1 Clinical Trial Results in Patients With Advanced Leukemias
December 14, 2011, MarketWatch
Food Dude: The Sweete Bye and Bye
December 14, 2011, NewOK.com
Brian Druker: My Vision for CML and the Road to a Cure VIDEO
December 13, 2011, Patient Power
More news for ASH meeting
December 13, 2011, The Pharma Letter
Bio-Path Holdings' Initial Phase I Data in Leukemia Clinical Trial Demonstrates That Its Neutral Lipid Delivery Technology Antisense Drug BP-100-1.01 (Liposomal Grb-2) is Well Tolerated with Activity Seen at Low Starting Dose
December 13, 2011, BusinessWire
BELA Trial: Bosutinib May Be Superior to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
December 13, 2011, MPR
Society fulfills wishes of 11 children latest!
December 13, 2011, The Borneo Post
Two Novartis Phase III studies show twice as many Ph+ CML patients achieve deeper levels of response with Tasigna® compared to Glivec
December 12, 2011, Reuters
Leukemia Drug Helps 47 Percent of Patients, Study Finds
December 12, 2011, Fox News
Study of 2 sisters sheds light on lymphoma evolution
December 12, 2011, EurekAlert
Onyx Trips, Ariad and Pharmacyclics Shine at Blood Cancer Meeting
December 12, 2011, The Street
CLAG in Combination with Imatinib Mesylate Shows Promise in Relapsed or Refractory Acute Myeloid Leukemia
December 12, 2011, MPR
CytRx Announces the Presentation of Favorable Phase 2 Clinical Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia at ASH Conference
December 12, 2011, MarketWatch
Celator(R) Pharmaceuticals and the Leukemia & Lymphoma Society(R) Announce Positive Data from Phase 2b Study of CPX-351 at the American Society of Hematology Annual Meeting
December 12, 2011,MarketWatch
Stemline Therapeutics, Inc. to Present at the Oppenheimer 22nd Annual Healthcare Conference
December 12, 2011, The Sacramento Bee
Ariad Cancer Drug Positive Trial May Boost Approval Chances
December 12, 2011, Bloomberg Businessweek
Pre-Market NASDAQ Movers (ENDP, BPAX, ARIA, ONXX, DMND, NUAN, ASML, CSCO)
December 12, 2011,International Business Time
HyperCVAD Plus Dasatinib Effective in Patients with Ph+ ALL or CML-LB
December 11, 2011, MPR
ASH: Bone Marrow Best for Unrelated Donor SCT
December 11, 2011,, Medpage Today
ARIAD Announces Preliminary Data from Pivotal Pace Trial of Ponatinib, Its Investigational pan-BCR-ABL Inhibitor
December 11, 2011, MarketWatch
Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Approach to Patients with Treatment-Naive or Refractory Chronic-Phase Disease
December 10, 2011, Hematology
Educational Session: Managing Chronic Myeloid Leukemia as a Chronic Disease
December 10, 2011, Hematology
Minimal Residual Disease and Discontinuation of Therapy in Chronic Myeloid Leukemia: Can We Aim at a Cure?
December 10, 2011, Hematology
Sarah Cannon Research Institute Presents Findings of Blood Cancer Clinical Trials at National Conference
December 10, 2011, MarketWatch
Girl's Disney dream comes true
December 10, 2011, The Post and Courier
New method to destroy chronic myeloid leukemia cells discovered
December 10, 2011, Health Jockey
The Path of Science and Hope: Ph+ CML VIDEO
December 9, 2011, Novartis
Thorburn: Like home runs, singles can lead to wins against cancer mortality
December 9, 2011, Colorado Cancer blog
Scientists discover how to beat resistance to standard leukaemia drug
December 9, 2011, MedicalXPress
Scientists discover how to beat resistance to standard leukaemia drug
December 8, 2011, Cancer Research UK
Stemline Therapeutics, Inc. Announces Two Poster Presentations of SL-401 Efficacy Data Against Lymphoid Cancers at the 53rd Annual Meeting of the American Society of Hematology (ASH)
December 8, 2011, MarketWatch
NICE backs two Novartis CML drugs; BMS denied
December 7, 2011, PMLive
ASH Calls on Congress to Take Action to Prevent Drug Shortages
December 6, 2011, The American Society of Hematology
ARIAD to Present at the Oppenheimer 22nd Annual Healthcare Conference
December 6, 2011, MarketWatch
Nice has recommended Glivec, Tasigna for the first line treatment of CML
December 6, 2011, The National Institute for Health and Clinical Excellence (NICE)
NICE Backs Novartis' Glivec, Tasigna for CML, Rejects Sprycel
December 6, 2011, NASDAQ
Experts Question Benefits of High-Cost Cancer Care
December 5, 2011, Medscape News
ARIAD Announces Investor Meeting and Webcast at American Society of Hematology Meeting
December 5, 2011, MarketWatch
When "personalized gene-targeted cancer therapy" really means "making it up as you go along"
December 5, 2011, ScienceBlogs
What's Hot at ASH 2011?
December 2, 2011, Medscape Today
Novartis highlights advances for patients with breast cancer and hematological diseases with over 160 SABCS and ASH abstracts
December 2, 2011, Reuters
Patients suffering from blood cancer: Khyber Pakhtunkhwa government launches Rs 7.2 billion free treatment project
December 2, 2011, Business Recorder
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, American Society of Hematology
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, Sacramento Bee
Which is better for Chronic Myeloid Leukemia?
December 1, 2011, DailyRx
2011 ASH Annual Meeting to Highlight Latest Hematology Research, Clinical Care Breakthroughs
December 1, 2011, PRNewswire
National experts from the John Theurer Cancer Center will present 31 studies at the 2011 ASH Meeting
December 1, 2011, Physorg.com
New Method That Reveals Complete Set of Aberrant Signaling Pathways That Give Rise to Cancers
December 1, 2011, HealthNewsDigest.com
OTCtipReporter.com: OncoVista Innovative Therapies, Inc. (OTCBB: OVIT), Amwest Imaging Incorporated (OTCBB: AMWI), Umami Sustainable Seafood Inc. (OTCBB: UMAM): Sign up for our FREE Stock Picks Today!
November 30, 2011, TechZone360
Menthol Cigarettes Not Less Harmful, say Experts
November 29,2011, The Sacremento Bee
Depression in Blood Cancer Patients
November 28, 2011, About.com
Hematopoietic stem cells may explain why elderly more prone to leukemia and infections
November 28, 2011, DailyRX
OncoVista Innovative Therapies Engages Oncology Therapeutic Development to Initiate a Phase Ib Study of Cordycepin in Patients With Refractory TdT Positive Leukemia
November 28, 2011,MarketWatch
ARIAD to Present at the 2011 Deutsche Bank BioFEST
November 28, 2011, MarketWatch
New CML Health Education Center on Patient Power
November 27, 2011, Patient Power
Helping One of Their Own (Child with CML)
November 26, 2011, TheEveningSun
Expanding Chronic Myeloid Leukemia Treatment Options
November 26, 2011, dailyRX
Schusterman Caps Israel-to-Tulsa Oil Career With KKR Sale
November 25,2011, Bloomberg Businessweek
Wakeboarder battles Leukemia, but she 'lives strong' VIDEO
November 24, 2011, My Fox Orlando
A giving sacrifice - Her five year old son was diagnosed with CML just under two years ago
November 22, 2011, Leominster Champion
Chronic myeloid leukemia research focuses on genes and drug therapies
November 22, 2011, DailyRX
BIG Girls Care this Holiday Season
November 21, 2011, Trib Local BurrRidge/Willowbrook
Medical Resources: Understanding Leukemia
November 21, 2011, Online Nursing Degrees
Push is on to stay one step ahead of cancer
November 21, 2011, Boston.com
MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
November 21, 2011, Sacramento Bee
Canadian researchers find potential new leukemia treatment with old antibiotic drug
November 20. 2011, Canadian Biotechnologist 2.0
Oral chemo insurance legislation in works
November 19, 2011, Central Wisconsin hub
The Importance of Drugs From the Sea
November 19, 2011, Fox News
Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib
November 18, 2011, Journal Blood
Lab Notes: Cancer Drug for TB?
November 18, 2011, Medpage Today
Kareem Abdul-Jabbar on being honored with Double Helix Medal, NBA lockoutNovember 17, 2011, CNNARIAD Announces Interim Safety and Efficacy Data from Pivotal Ponatinib PACE Trial to Be Presented at Annual American Society of Hematology Meeting
November 17, 2011, Business Wire
Finding Emotional Support for Long-term Illness
November 16, 2011, OncologyNurseAdvisor
Coaches for Cancer Tournament
November 16, 2011, abc4.com
How cancer has made me feel like the luckiest person around
November 15, 2011, Parenting Post
Donating marrow through the Be The Match Registry could save a life
November 15, 2011, Courier-Herald
Bobcats help lift leukemia-stricken fan
November 15, 2011, Bozeman Daily Chronicle
Laboratory honors NBA icon, researchers
November 15, 2011, Newsday
Signs, Symptoms and Definition of Leukemia
November 15, 2011, EmpowHer
Franchisee Battles New Storm against Pizza Hut
November 15, 2011, Blue Maumau
Bio-Path Holdings Reports Third Quarter 2011 Financial Results
November 15, 2011, MarketWatch
Asuragen to Present at Upcoming Association for Molecular Pathology 17th Annual Meeting
November 15, 2011, MarketWatch
Pregnancy and a Cancer Diagnosis VIDEO
November 14, 2011, Patient Power
Florida Blood Center holding New Smyrna Beach blood/bone marrow drive
November 13, 2011, The Daytona Beach News-Journal
NBA star to talk about health, exercise
November 13, 2011, Indystar.com
Ariad falls as drug tied to side effects
November 13, 2011, The Boston Globe
Pfizer To Present Clinical Data From Its Hematology Portfolio At The 53rd Annual Meeting Of The American Society Of Hematology
November 13, 2011, PharmPro
Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results.
November 11, 2011, PubMed
Women, younger patients with CML at risk for decreased health-related quality of life
November 11, 2011, HemoncToday
Some drugs are Easier to Stick with Than Others - CML patients more likely to adhere to dasatinib than nilotinib
November 11, 2011, DailyRX
FDA Drug Safety Communication: Sprycel (dasatinib) and risk of pulmonary arterial hypertension
November 10, 2011, U.S. Food and Drug Administration
PGI to hold 3 day conference from Nov 10
November 10, 2011, Day & Night News
Kareem Abdul-Jabbar Cancer in remission
November 10, 2011, The Post Chronicle
CML Patients May Need Fewer Bone Marrow Biopsies in the Future VIDEO
November 10, 2011, Patient Power
Tamera Simonson: 19-year CML Survivor VIDEO
November 10, 2011, Patient Power
New Evidence for Taking Medication at the Right Dose VIDEO
November 10, 2011, Patient Power
National Caregiver Month recognizes and supports those helping care for loved ones
November 9, 2011, JSOnline
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
November 9, 2011, BusinessWire
ARIAD to Present at the Lazard Capital Markets Healthcare Conference
November 9, 2011, MarketWatch
Karyopharm Therapeutics Announces Presentations by Seven Collaborators Showing Major Progress in Advancing Selective Inhibitors of Nuclear Export (SINE) for Hematologic Malignancies at American Society of Hematology (ASH) Meeting
November 8, 2011,PRNewswire
CytRx Reports Third Quarter 2011 Financial Results – (Bafetinib, CML)
November 8, 2011, MarketWatch
Mini-Transplants - Age no longer barrier to stem cell transplants for older patients
November 7, 2011, Seattle Cancer Care Alliance
Ariad Pharma: Early Efficacy, Safety of Leukemia Drug 'Striking'
November 7, 2011, The Street
10-Q: ARIAD PHARMACEUTICALS INC
November 7, 2011. Middle East North Africa Financial Network
Study Sheds Light on Persisting CML
November 2011, Volume 06:11, ClinicalOncology
Study Links Gene Mutations With MDS Morphology
November 2011,Volume 06:11, ClinicalOncology
Sharon Diane Moore
November 6, 2011, Livingston Daily
Changing lives one run at a time
November 6, 2011, Florida Today
Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study.
November 3, 2011, CancerCancel
Dr. Ruben Mesa Joins 23andMe's Myeloproliferative Neoplasms Initiative as Scientific Advisor
November 3, 2011, PRNewswire
Imatinib has adverse effect on growth in children with chronic myeloid leukemia.
November 2, 2011, Pediatr Blood Cancer.
Third 2011-12 Winning Attitude Recipient Announced
November 2, 2011, Colorado Buffaloes
Clolar-Cytarabine Regimen Prior To Stem Cell Transplant May Be Effective And Safe In Older, High-Risk MDS Patients
November 2, 2011, The MDS Beacon
Gynecomastia during imatinib mesylate treatment for gastrointestinal stromal tumor
November 2, 2011,7th Space
Age No Longer Should be a Barrier to Stem Cell Transplantation for Older Patients with Blood Cancers
November 1, 2011, NewsWise
Transplant Protocol Benefits Elderly With Hematologic Cancers
November 1, 2011, The Oncology Report
Solution Supplier Expands Offerings
November 1, 2011 , GEN
Lea Morrison: A Winner on Many Levels
October 31, 2011, Boston Foundation for Sight
The Cancer Drug Dark Ages Are Coming to an End
October 31, 2011, Xconomy
Asuragen Launches BCR-ABL1 Calibrator Panels for IS Standardization
October 31, 2011, MarketWatch,
Matchmaker: A Day for Bone Marrow Donors
October 28, 2011, BelmontPatch
Bristol-Myers 3Q profit rises 2 pct. as sales jump
October 27, 2011, The Associated Press
CML: live long and prosper
October 27, 2011, Journal Blood
The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors
October 27, 2011, Journal Blood
Del Mar Pharmaceuticals Initiates Glioblastoma Clinical Trial
October 25, 2011, MarketWatch
Novartis new drugs soar but 2,000 jobs to go
October 25, 2011, PharmaTimes
Acute Myeloid Leukemia Test Cleared By FDA
October 24, 2011, ThirdAge
Nurse, doctor see cancer from both side
October 24, 2011, CNN Health
Too much of a good thing, not so good
October 21, 2011, bclocalnews.com
Myelodysplasia gene mutation can aid diagnosis
October 21, 2011, OncologyNurseAdvisor
Leukemia still a threat despite years of treatment? Blame stem cells
October 20, 2011, City of Hope
Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies
October 20, 2011, Journal Blood
Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population study
October 20, 2011, Journal Blood
New Smyrna man needs match for bone marrow transplant
October 20, 2011, The Daytona Beach New- Journal
Benzene Wrongful Death Lawsuit Results in $7.5M Verdict
October 18, 2011, AboutLawsuits.com
New cancer meds caught in insurance squeeze
October 14, 2011, MiamiHerald.com
Leukemia patient turns to social media to save his own life
October 13, 2011, The Takeaway
Imatinib is receptive to a collaboration
October 13, 2011, Journal Blood
Finding clues in our blood
October 12, 2011, northshoreoflongisland.com
ARIAD to Present at the 18th Annual Newsmakers in the Biotech Industry Conference
October 12, 2011, Business Wire
CML-Expert Information About Diagnosis and Treatment - A Live Telephone/Web Education Program Offering Live Spanish Interpretation Featuring International CML Expert Michael J. Mauro, MD
October 11, 2011, MarketWatch
FDA: Increased PAH Risk Seen With Dasatinib
October 11, 2011, Internal Medicine News Digital Network
Steve Jobs' Death Spotlights Hard-to-Detect Cancers
October 6, 2011, Fox News
Keeping his faith: Fundraiser benefits area musician battling cancer
October 4, 2011, The Advertiser.com
CytRx's ENABLE Phase 2 Trial Results with Bafetinib in Relapsed B-Cell Chronic Lymphocytic Leukemia to be Presented at the Prestigious 53rd Annual ASH Meeting
October 4, 2001, MarketWatch
Initial Data from Bio-Path Holdings' Phase I Clinical Trial Accepted for Presentation at American Society of Hematology Annual Meeting
October 4, 2011, MarketWatch
Navigating the Net Wisely in a Health Crisis
October 3, 2011, New York Times
Leukemia stem cells are a lingering threat despite many years of treatment
October 3, 2011, City of Hope
CV drug shows promise as a leukemia treatment
October 3, 2011, OncologyNurseAdvisor
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice
October 2, 2004, Journal Blood
Recent advances in the path toward the cure for chronic myeloid leukemia
September 30, 2011, NCBI
Will every patient be an "N-of-1" when it comes to cancer?
September 30, 2011, Medpage Today
Andrew Matheson, The Point After: Watsonville's comeback kid living life on the field while battling leukemia
September 30, 2011, Santa Cruz Sentinel
Rod's story, how the love of a father is moving mountains - children from Philippines
September 29, 2011, The Max Foundation
Research and Markets: Global Chronic Myeloid Leukemia Drug Pipeline Capsule - 2011
September 28, 2011, Bradenton.com
Benzene Leukemia Lawsuit Filed by Man Who Grew Up Near Oil Refinery
September 27, 2011, aboutlawsuits.com
Data from Evaluation of Signature(R) LTx Leukemia Test to Be Presented at Upcoming Planet XMAP
September 27, 2011, Marketwatch
Vaccine researchers find a possible new approach to overcoming leukemia
September 26, 2011, City of Hope
ARIAD continues to achieve endpoints in ponatinib follow-up
September 26, 2011, Proactive Investors
The National CML Society and NBA's all-time leading scorer team up against leukemia, one anniversary at a time
September 24, 2011, Las Vegas Review-Journal
Reflections on Advocacy: Making Our Voices Heard - NCMLS on Capitol Hill 9/20/11
September 23, 2011, The National CML Society
How International CML Day in India was celebrated
September 23, 2011, The Max Foundation
Studying blood cancers has helped unlock mysteries of disease, paved the way to better treatments
September 23, 2011, AnnArbor.com
CML Awareness Day and Joy Smith, MP
September 23, 2011, Digital Journal
CML - Pathways to Discovery - Dr. Janet D. Rowley VIDEO
September 22, 2011, NationalCMLSociety
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
September 22, 2011, Blood Journal
The CML Society Marks CML Awareness Day with Stepping Stone Ceremonies
September 22, 2011, Digital Journal
Annual Nobel Predictions Announced, but Forecasting Prizes Remains a Tricky Business
September 21, 2011, Scientific American
Spooky theory, leukemia drugs top Nobel tips: Thomson Reuters
September 21, 2011, Reuters
How Thai doctors are having success treating a common form of leukaemia
September 20, 2011, Bangkok Post
International CML Day – Health Corner
September 20,2011, ExpressIndia
Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment.
September 19, 2011, Journal Blood
Pat Shares Her Health Story And Her Life As A Two Time Cancer Survivor VIDEO
September 15, 2011, EmpowHER
Convocation keynote: Keep the excitement of research and patient care alive
September 15, 2011, University of Massachusetts Medical School
Making the Miraculous Happen
September 15, 2011, Sherdog
Brazilian Hair Treatment Comes Under F.D.A. Fire
September 14, 2011, New York Times
Abandoned premature baby now Iraqi vet who lost both legs, cancer survivor searches for real parents
September 13, 2011, Daily News
An Immune System Trained to Kill Cancer
September 13, 2011, The New York Times
BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia
September 12, 2011, The Journal of experimaqntal medicine
Cardiovascular drug may offer new treatment for some difficult types of leukemia
September 12, 2011, EurekAlert
Nilotinib vs. Imatinib: Development of BCR-ABL Mutations
September 2011’, Volume 06:09, Clinical Oncology
Novartis Must Not Win This Case
September 10, 2011,News Click
India’s drug ‘lifeline’ under threat
September 8, 2011, New Internationalist
Acute leukemia gene seemingly unfolded
September 8, 2011, HealthJockey.com
Nilotinib trumps imatinib in leukemia study
September 7, 2011, OncologyNurseAdvisor
Glivec case transferred to new apex court Bench
September 6, 2011, Business Line
Leukemia Predisposition Gene Discovered
September 5, 2011, Medical News Today
Cancer survivor fights disease through advocacy work
September 2, 2011, Coastweek.com
Modified Citrus Pectin Packs Powerful Immune Punch
September 1, 2011, The Wall Street Journal
Ottawa issues warning about leukemia drug
September 1, 2011, The Chronicle Herald
Genetic fault behind rare cancer uncovered
August 31, 2011, Cancer Research UK
Leukemia drug Sprycel linked to dangerous side effect
August 30, 2011, The Canadian Press
Bosutinib a potential second-line treatment for chronic-phase CML
August 30, 2011, Hemonc Today
Widnes leukaemia patient says trial treatment at Royal Liverpool Hospital changed her life
August 29, 2011, Wirralnews
Advances in treatment of chronic myeloid leukemia
August 26, 2011, 7th Space Interactive
Imatinib Mesylate (Gleevec) as Protein-tyrosine Kinase Inhibitor Elicits Smooth Muscle Relaxation in Isolated Human Prostatic Tissue.
August 26, 2011, PublMed.gov
Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice
August 25, 2011, Journal Blood
'Nail in the coffin' for rare leukaemia patients, says Borehamwood man
August 23, 2011, Borehamwood & Elstree Times
ENESTnd: Nilotinib superior to imatinib for response, disease-specific death in chronic-phase CML at 2 years
August 23, 2011, Hemonc today
Pfizer Announces European Medicines Agency Acceptance of Regulatory Submissions For Two Investigational Cancer Therapies
August 23, 2011, Vadvert.co.uk
CytRx President and CEO Steven Kriegsman and CMO Dr. Daniel Levitt Discuss Company Advantages and Oncology Clinical Pipeline Attributes in OncLive Interview
August 22, 2011, Market Watch
Nilotinib Still Trumps Imatinib in Chronic CML
August 20, 2011,Medpage Today
20-Year Leukemia Survivor to Wed; Bay Area Woman Gives Back to Others Facing Similar Plight
August 19, 2011,Rafu.com
New discount persuades NICE to back Novartis' Tasigna
August 18, 2011,InPharm
Leukaemia patients given hope by NHS drugs watchdog
August 18, 2011, The Telegraph
European Watchdog OKs Pfizer Drugs
August 18, 2011, Zacks
Expert Insights: CML Updates From Summer 2011
August 17, 2011, Medscape education
Bio-Path Holdings Reports Second Quarter 2011 Financial Results
August 15, 2011, Business Wire
Cepheid Launches New Test
August 15, 2011, Daily Markets
Bonney Lake Mayor Steps Away from Civic Duties to Undergo Cancer Treatment
August 15, 2011,BonneyLake-SumnerPatch
Free medication for Blood Cancer at SCB
August 14, 2011, IBNLive
First Cohort Successfully Completed in Bio-Path Holdings' Phase I Clinical Trial of Lead Product Candidate Liposomal Grb-2 in Leukemia
August 11, 2011, The Wall Street Journal
China Medical receives SFDA approval for 2 diagnostic tests
August 11, 2011, Proactiveinvestors
'Serial killer' cells eradicate leukemia tumours
August 10, 2011, CTV.ca
New leukemia treatment exceeds 'wildest expectations'
August 10, 2011, MSNBC.com
Genetically Modified "Serial Killer" T Cells Obliterate Tumors in Patients with Chronic Lymphocytic Leukemia, Penn Researchers Report
August 10, 2011, Penn Medicine
Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test
August 9, 2011, The Sacremento Bee
Bcr-abl signals to desensitize chronic myeloid leukemia cells to interferon alpha via accelerating the degradation of its receptor
August 5, 2011, Journal Blood
Other Diseases, Age, and Disease Status May Predict Outcome In MDS Patients Undergoing Reduced-Intensity Transplantation
August 5, 2011, The MDS Beacon
Unconventional hunt for new cancer targets leads to a powerful drug candidate for leukemia
August 3, 2011, Cold Spring Harbor Laboratory
How Do Tumors Grow?
August 2, 2011, Scientific American
Dasatinib preferentially induces apoptosis by inhibiting Lyn kinase in nilotinib-resistant chronic myeloid leukemia cell line
August 2, 2011, 7th Space
ARIAD shares rise on EU review of potential cancer drug
August 1, 2011, Boston Business Journal
Funding veterinary medicine advances cancer treatments of human patients
July 29, 2011, OpenPR
NanoString Offers New Tool for Analyzing 25 Leukemia Fusion Genes in a Single Reaction
July 28, 2011, BusinessWire
Cancer can't hold back Minnesota wakeboarder VIDEO
July 27, 2011, Startribune.com
Scientists Integrate Single-Cell Processing and RT-qPCR for Parallel Analysis of Hundreds of Cells
July 27, 2011, GEN
NSAIDs associated with reduced risk for myeloid leukemias in adult women
July 26, 2011,Hemonctoday
Obesity and the risk of chronic myelogenous leukemia: is this another example of the neoplastic effects of increased body fat?
July 22, 2011, Leukemia
Canadians newly diagnosed with chronic myeloid leukemia now have new treatment option
July 22, 2011, CNW
A report from the front line of cancer treatment
July 20. 2011, io9.com
Sunesis Announces Publication of Phase 1b Data of Vosaroxin in Relapsed or Refractory Acute Leukemia
July 20, 2011, MarketWatch.com
Is your car killing you with benzene?
July 19, 2011, American Cancer Society
John Theurer Cancer Center researchers shared 14 leading edge studies at recent ASCO meeting
July 18, 2011, Physorg.com
Optimizing the Selection of Kinase Inhibitors for Chronic Myeloid Leukemia Patients
July 15, 2011, Medscape News
Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population
July 12, 2011, Journal Blood
Biomarker Predicts Worse Outcome in Chronic Myeloid Leukemia
July 11, 2011, The Oncology Report
Association of community cancer centers’ education project reveals most effective practices for treating CML patients in the community setting
July 11, 2011, Media Newswire
Patients Abandon Oral Chemotherapies Due to High Copays
July 2011, ClinicalOncology
One of the ‘’Easy Cancers’’
July 9, 2011, dailyRX
Man Claims Sunscreen Gave Him Leukemia
July 8, 2011, Courthouse News Service
Marker Found that Enables Segregation of True Human Hematopoietic Stem Cells from Multipotent Progenitors
July 8, 2011, GEN News
Found: the mother of all blood cells
July 7, 2011,NewScientist
The American Society of Hematology Honors Janet Rowley, MD, and Brian Druker, MD, with Ernest Beutler Lecture and Prize
July 7, 2011, Hematology.org
Worcestershire campaign to keep NHS leukaemia drug
July 5, 2011, News Hereford & Worcester
Transforming a diagnosis into inspiration
July 1, 2011, Las Vegas Review-Journal
Coventry Resident Attempts 100-Plus Mile Swim for Charity
July 1, 2001,CoventryPatch
Stopping Dasatinib and Nilotinib Explored in Chronic Myeloid Leukemia
June 30, 2011, Oncology Stat
Lincoln Leukaemia patient protests cancer funds withdrawal
June 30, 2011, Lincolnshire
Using the Web to understand your medical condition
June 29, 2011, Komonews.com
Inovio Pharmaceuticals' Prostate Cancer DNA Vaccine Demonstrates Strong T Cell Responses in Monkeys; Company on Track for Phase I Clinical Trial
June 29, 2011, PrNewswire
Tasigna receives Canadian approval
June 27, 2011, CNW
The Latest Weapon Against Cancer: Evolution
June 25, 2011, The Wall Street Journal
A message from a mending heart
June 25, 2011, Dayton Daily News
CML Patients Taking Imatinib Have Similar Mortality Rates to People in General Population - Pronostic
March 23, 2011, Journal of the National Cancer Institute
Bill Would Ensure Patient Access to Oral Chemotherapies
June 23, 2011, wgrz.com
Ph: not bad at all
June 22, 2011, Journal Blood
Evaluation of BCR-ABL monitoring in Chronic Myelogenous Leukemia in clinical practice VIDEO
June 21, 2011, OncUViewTV
Is There a Virus-Versus-Leukemia Effect?
June 21, 2011, CancerNetwork
Health groups want accessible drugs
June 21, 2011, WWLP.com
Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
June 21, 2011, Journal Blood
Imatinib sensitivity in BCR-ABL1-positive chronic myeloid leukemia cells is regulated by the remaining normal ABL1 allele
June 21, 2011, Cancer Research
Nilotinib Beats Imatinib at 24 Months in Treatment of CML
June 20, 2011, MedscapeToday
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
June 20, 2011, Journal of Clinical Oncology
Cancer survivors beat the odds, graduate high school VIDEO
June 20, 2011, MSNBC.com
Ariad Pharma - Ahead Of PACE
June 17, 2011, RTTNews
Race brings out the best in survivors
June 17, 2011, adn.com
Stopping CML therapies and eradicating CML: Patient perspective from EHA
June 15, 2011, CML Advocates Network
Faster Response Rates in CML with Bosutinib
June 15, 2011, MedscapeToday
The ghost of personalized medicine
June 14, 2011, The Scientist
Towards a more efficient therapy for a specific form of leukemia
June 14, 2011, AlphaGalileo
Webcasts of EHA Education Sessions are well worth watching
June 14, 2011, Biotech Strategy Blog
Treatment of chronic phase (CP) chronic myeloid leukemia (CML) patients who harbour the BCR-ABL T315I mutation with subcutaneous omacetaxine results in improved survival compared to historical data
June 12 2011, EHA 2011
Cessation of dasatinib or nilotinib therapy in chronic- phase chronic myeloid leukaemia patients with sustained complete molecular responses
June 12, 2011, EHA 2011
CML patients treated with TKI’s who obtain major molecular response are highly protected for transformation and this protection seems to be independent of the 18-month cutoff
June 11, 2011, EHA 2011
A molecular criteria have now been defined to guide decisions about if and when to use dasatinib or nilotinib VIDEO
June 11, 2011, ecancecr,tv
1 of the girls
June 9, 2011, dallasvoice.com
Leukaemia patients protest in Manchester at drugs threat
June 9, 2011, BBC - News Manchester
Cancer survivor: Tell people what you're going through
June 9, 2011, Rapid City Journal
Nilotinib Superior to Imatinib, Fewer Mutations in Treatment of CML-CP
June 6, 2011, Monthly Prescribing Reference
Improved survival in chronic myeloid leukemia (CML) since introduction of imatinib therapy: A single-institution experience in 1,570 patients referred within 1 month from diagnosis
June 6, 2011, ASCO 2011
A new symptom measure in chronic myeloid leukemia
June 6, 2011, ASCO 2011
Not his best time, but 'best' race for veteran runner
June 5, 2011, Sign on San Diego
Bosutinib Achieves Faster Response Rates in Newly Diagnosed Chronic Phase CML Patients Than Imatinib
June 3 , 2011, Monthly Prescribing Reference
Dasatinib Shows Superior Efficacy and Acceptable Tolerability, Supporting First-Line Use in Newly Diagnosed CML-CP
June 3 , 2011, Monthly Prescribing Reference
Leukemia drug tied to impaired growth in kids
June 2, 2011, Caring4Cancer
What can nurses do to help cancer survivors?
May 31, 2011, NursingTimes.com
Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis
May 31, 2011, PubLmed
Reframing our thinking about cancer
May 26, 2011, Benefits Canada
Developer of Gleevec sees potential for more cancer drugs, will speak at Moffitt Cancer Center
May 26, 2011, tampabay.com
New Protein Linked to Alzheimer's Disease
May 25, 2011, Science Daily
Understanding Targeted Treatments
May 25, 2011, Cancer.net
Children’s Hospital Los Angeles Team Discovers Key to Fighting Drug-Resistant Leukemia
May 18, 2011, Enhanced Online News
Improved Survival And Treatment For Chronic Blood Disorders
May 18, 2011, Medical News Today
New approach to overcoming TKI resistance
May 18, 2001, ecancermedicalnews
Low incidence rate of opportunistic and viral infections during imatinib
treatment in chronic myeloid leukemia patients in early and late chronic phase
May 16, 2011, Mediterranean Journal of Hematology and Infectious diseases
Study Reveals Origins of a Cancer Affecting the Blood And Bone Marrow
May 12, 2011, Insciences organisation
Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase
May 11, 2011, ScienceDirect
Bcr-Abl Kinase Domain Mutation Analysis in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inihibitors: Recommendations From an Expert Panel on Behalf of European LeukemiaNet
May 11, 2011, Oncology Stat
OHSU, cancer patients celebrate ten years of Gleevec
May 10, 2011, K103FM
Oregon Health & Science University celebrates 10th anniversary of cancer drug Gleevec
May 10, 2011, OregonLive.com
High Dose Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients - Systematic Review and Meta-Analysis
May 9, 2011, Oncology Stat
NICE provisionally rejects leukaemia drugs Sprycel, Tasigna and Glivec
May 6, 2011, Firstword
Imatinib Is Effective in Children With Previously Untreated Chronic Myelogenous Leukemia in Early Chronic Phase: Results of the French National Phase IV Trial
May 5, 2011, Journal of Clinical Oncology
The soul of a cell: Researchers used advanced instrument to read cells' minds
May 5, 2011, Stanford School of Medicine
ARIAD Reports First Quarter 2011 Financial Results and Development Progress
May 4, 2011, Enhanced Online News
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia.
May 3, 2011, Unbound Medline
CML patients’ dilemma
May 2, 2009, The Star Online
Predicting Complete Cytogenetic Response and Subsequent Progression-Free Survival in 2060 Patients With CML on Imatinib Treatment: The EUTOS Score
May 2, 2011, OncologyStat
Day in the Life: OHSU's Brian Druker
April 29, 2011, Portland Business Journal
US Appeals Court Opens Federal Funding for Stem Cell Research
April 29, 2011, ScienceDaily
Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia
April 27, 2011, Wiley Online Library
Bcr-Abl kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
April 24, 2011, Journal Blood
A Model of Oscillatory Blood Cell Counts in Chronic Myelogenous Leukaemia.
April 22, 2011, Springerlink.com
An Oncologist's Pulitzer-Winning Cancer Biography
April 22, 2011, Wbur.org
Does Pretreatment Fluorescence In Situ Hybridization for BCR–ABL Predict Imatinib-Associated Hematologic Toxicity in Chronic Myeloid Leukemia?
April 20, 2011, OncologyStat
Decoding Cancer Patients' Genomes Is Powerful Diagnostic Tool
April 20, 2011, ScienceDaily
Considerations in the Management of Patients With Philadelphia Chromosome–Positive Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitor Therapy
April 20, 2011,Journal of Clinical Oncology
The ABL Switch Control Inhibitor DCC-2036 Is Active against the Chronic Myeloid Leukemia Mutant BCR-ABLT315I and Exhibits a Narrow Resistance Profile
April 19, 2011, Unbound Medline
A Triumph in the War Against Cancer
Spring 2011, Smithsonian.com
Updates of New Strategies in Chronic Myelogenous Leukemia
Spring 2011, Leukemia Insights, MD Anderson Cancer Center
A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia
April 14, 2011,Blood Journal
A tumor suppressor function of the Msr1 gene in leukemia stem cells of chronic myeloid leukemia
April 14 2011, Journal Blood
Study: Revolutionary Treatment Returns Normal Life Expectancy to CML Patients
April 12, 2011, EmpowHer
New drug shows potential for treatment-resistant leukemia
April 11, 2011, Pharmalive
Third Rock’s biggest bet ever is on cancer drugs
April 11, 2011, boston.com
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score
April 10, 2011, Journal Blood
ARIAD Presents New Preclinical Data On Ponatinib In Solid Tumors, Demonstrating Inhibition Of All FGF Receptor Kinases
April 6, 2011, Medical News Today
A molecular and functional analysis of large granular lymphocyte expansions in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
April 1, 2011, PubLmed
The 2011 Stanley J. Korsmeyer Award
April 1, 2011, The American Society for Clinical Investigation
Potential Treatment For Chemotherapy-Resistant Chronic Myeloid Leukaemia
March 31, 2011, Medical News Today
Study Reveals No Impact of Age on Outcome in Chronic Myeloid Leukemia Patients Treated With Imatinib
March 30,2011, The American Society of Hematology (ASH)
New approach to leukemia chemotherapy -- is a cure in sight?
March 30, 2011, ScienceDaily
ARIAD And MolecularMD Announce Collaboration for a Companion Diagnostic Test for The T315I BCR-ABL Mutation in Patients With CML
March 28, 2011, Business Wire
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
March 25, 2011, PublMed
Progressive peripheral arterial occlusive disease and other vascular events during nilotinib therapy in CML
March 25, 2011, Wiley online Library
CML Patients Taking Imatinib Have Similar Mortality Rates To People In General Population
March 22, 2011, JNCI Journal of the National Cancer Institute
Leukemia Patients Taking Gleevec Achieve ‘Normal’ Death Rate
March 22, 2011, HealthDay News
Gleevec Gets High Marks for Leukemia Treatment
March 22, 2011, WebMD
Imatinib for Chronic Myeloid Leukemia: The Impact of Its Effectiveness and Long-term Side Effects
March 21, 2011, JNCI Journal of the National Cancer InstituteBone Marrow Transplant Centres Alerted To Help
Japan Radiation Victims
March 16, 2011, Medical News Today
Second-Line TKIs Offer Expanded Treatment Options For Newly Diagnosed Patients With CML
March 14, 2011, Medical News Today
Can grapefruit juice decrease the cost of imatinib for the treatment of chronic myelogenous leukemia?
March 7, 2011, Leukemia Research
Discontinuation of imatinib may be possible in chronic myelogenous leukemia
March 3, 2011, Cancer Journal for Clinicians
FDA Warns GERD Drugs May Deplete Magnesium
March 2, 2011, Medpage Today
Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapy;
February 28, 2011, Haematologica
Second-generation drugs called into first-line therapy for CML
February 25, 2011, Hemonctoday
Survival of chronic myeloid leukemia stem cells is independent of BCR-ABL tyrosine kinase activity
February 23, 2011, Oregon Health & Science University (OSHU)
The renaissance of interferon therapy for the treatment of myeloid malignancies
February 22, 2011, Journal Blood
Changing the paradigm in frontline CML therapy VIDEO
Prof Giuseppe Saglio - University of Turin, Italy;
Dr Delphine Rea - Saint Louis Hospital, Paris;
Jan Geissler - Co-Founder, CML Advocates Network
February 21, 2011, ecancer.tv
What`s new in chronic myeloid leukemia research and treatment?
February 17, 2011, American cancer Society
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study
February 2011, PublMed
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib
February 8, 2011, JNCI Journal of the National Cancer Institute
A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients
February 8, 2011,7th Space Interactive
The Matriarch of Modern Cancer Genetics
February 7, 2011, The New York Times
Clinical value of assessing the response to imatinib monitored by interphase FISH and RQ-PCR for BCR-ABL in peripheral blood for long-term survival of chronic phase CML patients: results of the Niigata CML-multi-institutional co-operative clinical study.
February 5, 2011, PublMed
Scientists reprogram marrow cells from patient with chronic myeloid leukemia
February 4, 2011, The Medicals News
Hematology: Curing CML with imatinib—a dream come true?
February 1, 2011, Nature Reviews Clinical Oncology
World Cancer Day 2011 - A World without Cancer One Day?
February 2011, Dr. Toh Han Chong, National Cancer Center, Singapore
Southampton scientists begin patient trials of new leukemia cancer vaccine
January 31, 2011, Physorg.com
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
January 31,2011, PharmaLive
Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors.
January 26, 2011, PubLMed
Bosutinib as a treatment for newly diagnosed chronic myeloid leukaemia VIDEO
February 18, 2011, ecancerTV
Fertility in Women Diagnosed with Chronic Myeloid Leukemia
January 18, 2011, Preservation of fertility
Controversies in the treatment of CML in children and adolescents: TKIs versus BMT?
January 17, 2011, Unbound Medline
Cancer: Should we stop trying to cure it?
January 15, 2011, Guardian.co.uk
Effects of imatinib mesylate on the pharmacokinetics of paracetamol (acetaminophen) in Korean patients with chronic myelogenous leukaemia
January 10, 2011, Wiley Online Library
Blood test to spot cancer gets big boost from J&J
January 5,2011, USA.TODAY.com
Time-specific blockade of PDGFR with Imatinib (Glivec) causes cataract and disruption of lens fiber cells in neonatal mice.
December 27, 2010, BipPortfolio
Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
December 23, 2010, The New England Journal of Medicine
Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
December 22, 2010, Unbound Medline
Cancer Cells May Be Able to Urge Their Own Death
December 22, 2010, CancerCompass
ASH 2010 Report: A new era in first line CML treatment coming up?
December 15, 2010, CML Advocates Network
Vital Discovery in Leukemia Stem Cell
December 15, 2010, Med India
Chronic Myeloid Leukemia: New Approaches Needed
December 15, 2010, MedicalNewsToday
Seven-year follow-up of patients receiving imatinib for the treatment of newly diagnosed chronic myelogenous leukemia by the TARGET system.
December 15, 2010, CMLHope.com
Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
December 13, 2010, The Journal of Clinical Investigation
BCR-ABL kinase is dead; long live the CML stem cell
December 13, 2010, The Journal of Clinical Investigation
Zen Meditation Can Help Bring Pain Under Control
December 10, 2010, HealthDay news
Treatment of the elderly population with haematological cancers: What's new from the American Society of Hematology 2010 meeting?
December 8, 2010, ecancermedicalscience
Industry update: Bosutinib produces molecular response as first-line CML therapy
December 8, 2010, CancerNetwork.com
Deeper molecular responses seen with dasatinib in new chronic myeloid leukemia
December 7, 2010, CancerNetwork.net
Dasatinib moves ahead of imatinib as front-line therapy for newly diagnosed CML in chronic phase
December 7, 2010, CancerNetwork.com
Nilotinib exerts positive effect in early chronic phase Ph+ CML
December 7, 2010, CancerNetwork.com
ASH meeting: Pfizer’s bosutinib disappoints in myeloid leukemia trial; Novartis’ Tasigna beats Glivec in CML study
December 7, 2010, Thepharmaletter
ASH: New CML Drug Still Beating Out Its Predecessor
December 7, 2010, Medpage Today
Persistence of BCR-ABL-Expressing leukemic stem cells in chronic myeloid leukemia (CML) patients in complete remission with undetectable molecular disease
December 7, 2010, ASH 2010
Dynamics of mutant BCR-ABL-positive clones after cessation of tyrosine kinase inhibitor therapy
December 6, 2010, Haematologica
Pfizer Announces Phase 3 Results of Investigational Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Digital Journal
Compound Bosutinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia
December 6, 2010, Dagorret
ASH: Early assessment of molecular response identified increased risk for treatment failure in CML
December 6, 2010, Hemonctoday
Novel CML Drug Active After Failures of Imatinib, Dasatinib, and Nilotinib
December 6, 2010, Oncology Stat
ASH 2010: JAK2-Mediated Extrinsic Survival of CML Stem Cells: Exploring the Potential Combination of BCR-ABL and JAK2 Inhibitors In Vivo
December 6, 2010, ASH2010
Distinct Impact of Imatinib on Growth In Prepubertal and Pubertal Children with Chronic Myeloid Leukemia
December 5, 2010, ASH2010
Provocative Questions For CML Patients and Their Doctors (With Dr. M. Talpaz) VIDEO
December 5, 2010, Patient Power , ASH 2010, Orlando
Do 3rd Generation Medicines Lie Ahead for CML? (with Dr. Neil Shah ) VIDEO
December 4, 2010, Patient Power , ASH 2010, Orlando
Progress in Chronic Leukemias (with Dr. Alison Loren) VIDEO
December 4, 2010, Patient Power , ASH 2010, Orlando
ASH 2010: Ponatinib for refractory chronic myelogenous leukaemia
December 4, 2010, EcancerMedicalScience
ASH 2010: Nilotinib promising for early chronic phase, Philidelphia-positive chronic myeloid leukaemia
December 4, 2010, Ecancermedicalscience
Pfizer Plans Regulatory Submissions Of Bosutinib In Chronic Myeloid Leukemia
December 4, 2010, Medical NewsToday
Nilotinib associated with stable outcomes in Ph+CML
December 4, 2010, Hemonctoday
Breakthrough Therapies and a New Gene Target Advance the Treatment and Understanding of Hard-to-Treat Leukemias
December 4, 2010, Hematology.org
Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation
December 4, 2010, Hematology
Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase
December 2, 2010, Dovepress
Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia
November 29, 2010, PubLMed
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
November 26, 2010, 7th Space
CML—The Changing Landscape of Front-line Therapy: Part I: Interview With Dr. Jane Apperley
November 23, 2010, OncologyStat - CMLSupport
Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia
November 19, 2010, Leukemia
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
November 18, 2010, BMC Blood Disorders
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
November 16, 2010, SciElO Brazil
Mutated Gene Linked to Poor Survival in Acute Myeloid Leukemia
November 16, 2010, National Cancer Institute
Nilotinib Attenuates Renal Injury and Prolongs Survival in Chronic Kidney Disease
November 13, 2010, JASN
Low Vitamin D Linked to Deterioration in Certain Leukemia Patients
November 12, 2010, MedecineNet.com
Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia.
November 9, 2010, PubLMed
Leukemia breakthrough suggested in lab finding
November 7, 2010, Globe and Mail
Canadian researchers transform skin into blood
November 7,2010, National Post
FDA Approves SPRYCEL (dasatinib) as Treatment for Adult Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia
October 28, 2010,FierceBiotech
Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR.
October 24, 2010,PubLMed
Nurse Practitioner Carolyn Blasdel – Montreal – August 2010 VIDEO
October 2010, CML Society of Canada
Stem Cell Transplants Available to Expanding Group of Patients
October 2010, PatientPower.info
An Evening with the CML Experts™ featuring Dr. Michael Mauro - Phoenix, Arizona VIDEO
October 2010,The National CML Society
Could Some Patients Stop Taking Their CML Pills?
October 2010, Patient Power
Dr. Georges Mathé, Transplant Pioneer, Dies at 88
October 2010, New York Times
CML: The Current Landscape - an interview with Dr. Jorge Cortes VIDEO
October 2010, The National CML Society (US)
Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
October 2010, The Lancet Oncology, Early Online Publication
Some With Once-Deadly Leukemia Can Take a Break From GleevecSmall minority of CML patients went off the drug for 2 years with no sign of recurrence
October 2010, Healthday, U.S. News
CML Society of Canada - CML Awareness Day celebrates great progress against blood cancer but much more needed to ensure best outcomes for Canadian patients
September 2010, CNW Group
Philadelphia chromosome’ led to breakthrough in cancer treatment
September 2010, Philadelphia Business Journal
Do we have to kill the last CML cell?
September 2010, Nature.com
Dr. Sawyers on Outsmarting Cancer VIDEO
Dr. Charles Sawyers tells Katie Couric about the difficulties in treating different kinds of cancers, and importance of drug cocktails
September 2010, CBSNEWS.com
50th Anniversary of the Discovery of the Philadelphia Chromosome
September 28, 2010, WorldNews
Leukemia Types, Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML)
10 sept 2010, Healthcommunities.com
Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.
September 2010, ResearchGate
Fox Chase Celebrates the 50th Anniversary of the Discovery of the Philadelphia Chromosome
August 23, 2010, Fox Chase Center
Technique to Preserve Fertility in Young Women May Be Unsafe for Patients With Leukemia
August 16, 2010, Science Daily
Living with chronic myeloid leukemia VIDEO
Chronic myeloid leukemia, or CML, was once considered a death sentence but new treatment options have turned CML into a chronic, yet manageable disease for most patients.
August 2010,Info4YourLife
Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib
August 2010, Journal Blood
A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib
August 2010, Leukemia Research
Dasatinib, an immunomodulator?
August 2010, Journal Blood
New lab test could identify imatinib resistance
July 2010, Sciences News
Protein That Predicts Prognosis of Leukemia Patients May Also Be a Therapeutic Target
July 10, 2010, Science Daily
Chronic myeloid leukemia: mechanisms of blastic transformation
July 1, 2010, The Journal of Clinical Investigation
Major Molecular Response in CML Patients Treated with Tyrosine Kinase Inhibitors: The Paradigm for Monitoring Targeted Cancer Therapy
June 21, 2010, The Oncologist
Novartis gets US FDA approval for new Tasigna indication; agency panel backs HRA Pharma's ulipristal
June 18, 2010, Thepharmaletter
Cord blood transplants a viable option in leukemia
June 15, 2010, Reuters
The 'Dandelion' problem: IFN-a, imatinib and reactivation of dormancy
June 15, 2010, ecancernews
Newer Drugs Improve Upon Gleevec for Chronic Myeloid Leukemia VIDEO
June 04, 2010, MD Anderson Cancer Center
Update on Tyrosine Kinase Inhibitor Therapy for Chronic ...
June 2010, ASHP Advantage
Remission During Chronic Phase CML: Watching for Relapse
May 19, 2010, WebMD
Benefits of Banking Cord Blood
May 10, 2010, Suite101
PCR Confusion – A CML Patient’s Perspective
May 18, 2010, Cancernetwork.com
Differing age patterns in chronic myeloid leukemia by racial ethnic group.
May 2010, Journal of Clinical Oncology
South Korean firm develops drug to kill leukemia stem cells
April 22, 2010, BioSpectrum
Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death
March 31, 2010, Mendeley
BioSante announce positive data from GVAX leukemia vaccine in CML
March 2010, Pharma Strategy Blog
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
February 2010, PubLMed
Living With a Formerly Fatal Blood Cancer
January 2010, The New York Times
Successful Pregnancy and Delivery in a Patient with Chronic Myeloid Leukemia while on Dasatinib Therapy
January 9, 2010,
Hindawi Publishing CorporationPrevalence of Large Granular Lymphocyte Proliferation in Chronic Myeloid Leukemia (CML) Patients Treated with Dasatinib
December 5, 2009, ASH 2009
Individual Telomere Lengths in Chronic Myeloid Leukemia
November 2009, Neoplasia
Adelaide researchers on road to myeloid leukemia cure
October 2009, NEWS.COM.AU
Emergence of Chronic Myelogenous Leukemia From a Background of Myeloproliferative Disorder: JAK2V617F as a Potential Risk Factor for BCR-ABL Translocation
October 2009, Clinical Lymphoma, Myeloma & Leukemia
Update of recent studies in chronic myeloid leukemia
June 26, 2009, Journal of hematology & oncology
A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment
June 2009, Wiley Online Library
Stanford researchers harness nanoparticles to track cancer cell changes
April 14, 2009, Stanford School of Medicine
Chronic Myeloid Leukemia Therapy: Focus on Second Generation ...
April 2009, moffitt.org
Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy
March 2009, Blood Journal
Data suggesting that omacetaxine can eradicate leukemic stem cells may offer a breakthrough for CML
March 26, 2009, eurekalert.org
Scientists Identify Molecular Signature for Leukemia Stem Cells
March 10, 2009, e! Science News
Scientists uncover indicator that warns leukemia is progressing to more dangerous form
February 17,2009, e! Science News
Artificial Human Bone Marrow Created In A Test Tube
December 22, 2008, Science Daily
Translation of the Philadelphia chromosome into therapy for CML
December 15, 2008, Journal Blood
Cancer drugs may treat type 1 diabetes
November 11, 2008, Bio-Medecine
New Stanford diagnostic test for rare leukemia appears to give faster results, study finds
October 6, 2008, Stanford School of Medicine
Targeted therapies for CML: practical considerations and comparisons
August 10, 2008, HemOncToday
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia
June 12, 2007, The Journal of Clinical Investigation
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
Hypertriglyceridemia may be severe in CML patients treated with interferon-α
July 11, 2006, Wiley Online Library
Pregnancy Among Patients With Chronic Myeloid Leukemia Treated With Imatinib
March 2006, Journal of Clinical Oncology
Indications for Imatinib Mesylate Therapy and Clinical Management
March 4, 2004, The Oncologist
Quantitative Polymerase Chain Reaction Monitoring of BCR-ABL during Therapy with Imatinib Mesylate (STI571; Gleevec) in Chronic-Phase Chronic Myelogenous Leukemia
January 9, 2003, Clinical cancer research
Powerful Anti-Cancer Drug Emerges from Basic Biology
May 8, 2001, The New York Times
